Menu
Back to Browse Journals » OncoTargets and Therapy
OncoTargets and Therapy
- View all (2218)
- Volume 10, 2017 (386)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Journal Articles:
- 2,218 records -
Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study
Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH
OncoTargets and Therapy 2017, 10:3667-3683
Published Date: 20 July 2017
Clinical targeting recombinant immunotoxins for cancer therapy
Li M, Liu ZS, Liu XL, Hui Q, Lu SY, Qu LL, Li YS, Zhou Y, Ren HL, Hu P
OncoTargets and Therapy 2017, 10:3645-3665
Published Date: 20 July 2017
Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
Guo H, Zhang T, Wen X, Zhou JD, Ma J, An C, Zhang W, Xu Z, Lin J, Qian J
OncoTargets and Therapy 2017, 10:3635-3644
Published Date: 20 July 2017
A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy
Qian M, Tao HM, Xu W, Ji HZ
OncoTargets and Therapy 2017, 10:3617-3623
Published Date: 20 July 2017
Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells
Barac A, Mitulovic G, Hallström S, Zehetmayer S, Grasl MC, Erovic BM
OncoTargets and Therapy 2017, 10:3607-3616
Published Date: 19 July 2017
Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis
Fan QW, Liu BR
OncoTargets and Therapy 2017, 10:3591-3606
Published Date: 19 July 2017
Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo
Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS
OncoTargets and Therapy 2017, 10:3579-3589
Published Date: 19 July 2017
Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab
Queudeville M, Handgretinger R, Ebinger M
OncoTargets and Therapy 2017, 10:3567-3578
Published Date: 19 July 2017
The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy
Wang Y, Hu GF, Wang ZH
OncoTargets and Therapy 2017, 10:3557-3566
Published Date: 19 July 2017
Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
Shen L, Wu X, Tan J, Gu M, Teng Y, Wang Z, Yue W
OncoTargets and Therapy 2017, 10:3545-3556
Published Date: 18 July 2017
Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
Pan HW, Su HH, Hsu C, Huang GJ, Wu TT
OncoTargets and Therapy 2017, 10:3531-3543
Published Date: 17 July 2017
Circ-104916 is downregulated in gastric cancer and suppresses migration and invasion of gastric cancer cells
Li J, Zhen L, Zhang Y, Zhao L, Liu H, Cai D, Chen H, Yu J, Qi X, Li G
OncoTargets and Therapy 2017, 10:3521-3529
Published Date: 17 July 2017
Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors
Liu Z, Fan H, Li Y, Liu C
OncoTargets and Therapy 2017, 10:3515-3520
Published Date: 17 July 2017
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V
OncoTargets and Therapy 2017, 10:3501-3513
Published Date: 17 July 2017
An evaluation of the clinical diagnostic value of contrast-enhanced ultrasound combined with contrast-enhanced computed tomography in space-occupying lesions of the kidney
Tian W, Lu JB, Jiao D, Cong ZB
OncoTargets and Therapy 2017, 10:3493-3499
Published Date: 14 July 2017
Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
Zhou CC, Zhang J, Chen Y, Wang H, Hou JQ
OncoTargets and Therapy 2017, 10:3485-3491
Published Date: 14 July 2017
Association between polymorphisms in DNA repair gene XRCC1 and non-melanoma skin cancer risk: a meta-analysis
Wang L, Xu J, Duan B
OncoTargets and Therapy 2017, 10:3475-3483
Published Date: 13 July 2017
Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways
Tan W, Pan M, Liu H, Tian H, Ye Q, Liu H
OncoTargets and Therapy 2017, 10:3467-3474
Published Date: 13 July 2017
PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells
Kumar R, Yu F, Zhen YH, Li B, Wang J, Yang Y, Ge HX, Hu P, Xiu J
OncoTargets and Therapy 2017, 10:3453-3465
Published Date: 13 July 2017
Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition
He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX
OncoTargets and Therapy 2017, 10:3435-3451
Published Date: 12 July 2017
Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases
Liu H, Zhou M
OncoTargets and Therapy 2017, 10:3429-3434
Published Date: 12 July 2017
RNA sequencing identifies gene expression profile changes associated with β-estradiol treatment in U2OS osteosarcoma cells
Chen B, Liu Z, Zhang J, Wang H, Yu B
OncoTargets and Therapy 2017, 10:3421-3427
Published Date: 11 July 2017
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma
Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ
OncoTargets and Therapy 2017, 10:3405-3419
Published Date: 11 July 2017
ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
Mao Y, Wu S
OncoTargets and Therapy 2017, 10:3399-3404
Published Date: 11 July 2017
Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis
Li W, Tao L, Zhang L, Xiu D
OncoTargets and Therapy 2017, 10:3391-3397
Published Date: 11 July 2017
Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study
Wei Y, Wu YP, Xu N, Li XD, Chen SH, Cai H, Zheng QS, Xue XY
OncoTargets and Therapy 2017, 10:3381-3389
Published Date: 10 July 2017
The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia
Aberuyi N, Rahgozar S, Khosravi Dehaghi Z, Moafi A, Masotti A, Paolini A
OncoTargets and Therapy 2017, 10:3373-3380
Published Date: 10 July 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M
OncoTargets and Therapy 2017, 10:3363-3372
Published Date: 10 July 2017
The long noncoding RNA, TINCR, functions as a competing endogenous RNA to regulate PDK1 expression by sponging miR-375 in gastric cancer
Chen ZL, Liu H, Yang HL, Gao YK, Zhang GW, Hu JJ
OncoTargets and Therapy 2017, 10:3353-3362
Published Date: 10 July 2017
Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma
Wang Z, Yang S, Lu H
OncoTargets and Therapy 2017, 10:3345-3351
Published Date: 7 July 2017
Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer
Guo Y, Shi JJ, Zhang J, Li HX, Liu B, Guo H
OncoTargets and Therapy 2017, 10:3337-3344
Published Date: 7 July 2017
Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinoma
Xue F, Hu C, He X
OncoTargets and Therapy 2017, 10:3329-3336
Published Date: 6 July 2017
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells
Woitok M, Klose D, Di Fiore S, Richter W, Stein C, Gresch G, Grieger E, Barth S, Fischer R, Kolberg K, Niesen J
OncoTargets and Therapy 2017, 10:3313-3327
Published Date: 6 July 2017
Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC
Wu Y, Tong R, Zhang Y, Hu B, Zheng K, Ding Z, Peng F, Gong Y, Liu Y, Lu Y
OncoTargets and Therapy 2017, 10:3307-3312
Published Date: 5 July 2017
Novel agents for the treatment of childhood leukemia: an update
Eryılmaz E, Canpolat C
OncoTargets and Therapy 2017, 10:3299-3306
Published Date: 4 July 2017
Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells
Chang YT, Huang C, Tang J, Liaw C, Li R, Liu J, Sheu J, Chang HW
OncoTargets and Therapy 2017, 10:3289-3297
Published Date: 4 July 2017
Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
Yeo SG
OncoTargets and Therapy 2017, 10:3285-3288
Published Date: 4 July 2017
Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors
Han T, Yang X, Xu Y, Zheng Z, Yan Y, Wang N
OncoTargets and Therapy 2017, 10:3277-3283
Published Date: 3 July 2017
The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases
Pan DH, Wen DY, Luo YH, Chen G, Yang H, Chen JQ, He Y
OncoTargets and Therapy 2017, 10:3261-3276
Published Date: 3 July 2017
Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy
Wu C, Zhu X, Liu W, Ruan T, Tao K
OncoTargets and Therapy 2017, 10:3249-3259
Published Date: 30 June 2017
LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism
Ding G, Peng Z, Shang J, Kang Y, Ning HB, Mao CS
OncoTargets and Therapy 2017, 10:3241-3247
Published Date: 30 June 2017
Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02
Huang YD, Hong XL, Hu J, Lu Q
OncoTargets and Therapy 2017, 10:3233-3239
Published Date: 29 June 2017
Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles
Zhang X, Sun YY, Wang P, Yang CF, Li SW
OncoTargets and Therapy 2017, 10:3225-3232
Published Date: 29 June 2017
CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells
Wang M, Lin T, Wang YC, Gao S, Yang ZY, Hong X, Chen GY
OncoTargets and Therapy 2017, 10:3215-3224
Published Date: 29 June 2017
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction
Shimada M, Fukuda M, Fukuda M, Kitazaki T, Hashiguchi K, Ikeda T, Yamaguchi H, Nakatomi K, Ashizawa K, Mukae H
OncoTargets and Therapy 2017, 10:3211-3214
Published Date: 29 June 2017
Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies
Zhao YN, Zheng X, Zhang LJ, Hu Q, Guo YT, Jiang H, Shi SN, Zhang X
OncoTargets and Therapy 2017, 10:3203-3210
Published Date: 29 June 2017
The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis
Zhang YF, Lin JB, Huang WJ, Cao Y, Liu Y, Wang TQ, Zhong WY, Wang DL, Mao RR, Chen XL
OncoTargets and Therapy 2017, 10:3193-3201
Published Date: 28 June 2017
Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report
Zhu Y, Liao X, Wang W, Xu C, Zhuang W, Zhong L, Du K, Chen Y, Chen G, Fang M
OncoTargets and Therapy 2017, 10:3187-3192
Published Date: 27 June 2017
Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
Yao JC, Chan JA, Mita AC, Kundu MG, Hermosillo Reséndiz K, Hu K, Ravichandran S, Strosberg JR, Wolin EM
OncoTargets and Therapy 2017, 10:3177-3186
Published Date: 27 June 2017
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
Cymbaluk-Ploska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Surowiec A, Menkiszak J
OncoTargets and Therapy 2017, 10:3169-3175
Published Date: 27 June 2017
Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials
Li C, Xiang A, Chen X, Yin K, Lu J, Yin W
OncoTargets and Therapy 2017, 10:3155-3168
Published Date: 27 June 2017
Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer
Song S, Li C, Li S, Gao H, Lan X, Xue Y
OncoTargets and Therapy 2017, 10:3145-3154
Published Date: 26 June 2017
Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
Kuang Y, Lu F, Guo J, Xu H, Wang Q, Xu C, Zeng L, Yi S
OncoTargets and Therapy 2017, 10:3131-3144
Published Date: 26 June 2017
The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis
Zhang X, Yin X, Shen P, Sun G, Yang Y, Liu J, Chen N, Zeng H
OncoTargets and Therapy 2017, 10:3123-3130
Published Date: 22 June 2017
Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations
Song X, Wang Z
OncoTargets and Therapy 2017, 10:3119-3122
Published Date: 22 June 2017
Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer
Chen P, Wang C, Cheng B, Nesa EU, Liu Y, Jia Y, Qu Y, Jiang Z, Han J, Cheng Y
OncoTargets and Therapy 2017, 10:3107-3118
Published Date: 21 June 2017
Comprehensive analysis of differential co-expression patterns reveal transcriptional dysregulation mechanism and identify novel prognostic lncRNAs in esophageal squamous cell carcinoma
Li Z, Yao Q, Zhao S, Wang Y, Li Y, Wang Z
OncoTargets and Therapy 2017, 10:3095-3105
Published Date: 21 June 2017
Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
Zhang Y, Xu X, Chen Z, Zhao Z
OncoTargets and Therapy 2017, 10:3083-3093
Published Date: 20 June 2017
Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy
Bai Y, Wu HW, Ma X, Liu Y, Zhang YH
OncoTargets and Therapy 2017, 10:3071-3081
Published Date: 19 June 2017
The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis
Xu H, Ma Y, Deng F, Ju W, Sun X, Wang H
OncoTargets and Therapy 2017, 10:3059-3070
Published Date: 19 June 2017
Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma
Aigner KR, Selak E, Gailhofer S
OncoTargets and Therapy 2017, 10:3049-3057
Published Date: 19 June 2017
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma
Ni W, Song E, Gong M, Li Y, Yao J, An R
OncoTargets and Therapy 2017, 10:3039-3047
Published Date: 19 June 2017
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
Dockery LE, Gunderson CC, Moore KN
OncoTargets and Therapy 2017, 10:3029-3037
Published Date: 19 June 2017
Identification of key genes and molecular mechanisms associated with dedifferentiated liposarcoma based on bioinformatic methods
Yu H, Pei D, Chen L, Zhou X, Zhu H
OncoTargets and Therapy 2017, 10:3017-3027
Published Date: 16 June 2017
Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts
De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P
OncoTargets and Therapy 2017, 10:3007-3015
Published Date: 16 June 2017
Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy
Feng M, Tang C, Feng W, Bao Y, Zheng Y, Shen J
OncoTargets and Therapy 2017, 10:3001-3005
Published Date: 14 June 2017
Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells
Yang Y, Yin W, Wu FY, Fan J
OncoTargets and Therapy 2017, 10:2993-2999
Published Date: 14 June 2017
Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors
Chang H, Kim JS, Choi YJ, Cho J, Woo J, Kim A, Kim JS, Kang EJ
OncoTargets and Therapy 2017, 10:2983-2992
Published Date: 13 June 2017
Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials
Liu YY, Kou CG, Su YY, Zhang YY, You YY, Zhang LL, Wang MH, Fu YL, Ren XJ, Yang YM
OncoTargets and Therapy 2017, 10:2971-2981
Published Date: 13 June 2017
Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
de Groot S, Gelderblom H, Fiocco M, Bovée JVMG, van der Hoeven JJM, Pijl H, Kroep JR
OncoTargets and Therapy 2017, 10:2963-2970
Published Date: 13 June 2017
Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
Yang B, Yan X, Liu L, Jiang C, Hou S
OncoTargets and Therapy 2017, 10:2951-2961
Published Date: 13 June 2017
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
Kan HC, Hou CP, Lin YH, Tsui KH, Chang PL, Chen CL
OncoTargets and Therapy 2017, 10:2943-2949
Published Date: 12 June 2017
WWC3 downregulation correlates with poor prognosis and inhibition of Hippo signaling in human gastric cancer
Hou J, Zhou J
OncoTargets and Therapy 2017, 10:2931-2942
Published Date: 12 June 2017
Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma
Zhang J, Zhang G, Hu P, Deng G, Liu Q, Qiao L, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2923-2930
Published Date: 9 June 2017
Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
Chen X, Zhu X, Liang Z, Li L, Qu S, Chen K, Pan X
OncoTargets and Therapy 2017, 10:2909-2921
Published Date: 9 June 2017
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy Philip D, Banavali S, Dutt A, Prabhash K
OncoTargets and Therapy 2017, 10:2903-2908
Published Date: 9 June 2017
The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis
Hu Z, Yang Y, Zhao Y, Huang Y
OncoTargets and Therapy 2017, 10:2893-2901
Published Date: 9 June 2017
Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
Li M, Yang X, Chen Y, Yang X, Dai X, Sun F, Zhang L, Zhan C, Feng M, Wang Q
OncoTargets and Therapy 2017, 10:2885-2892
Published Date: 7 June 2017
Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma
Xu Y, Jiang X, Cui Y
OncoTargets and Therapy 2017, 10:2873-2883
Published Date: 6 June 2017
PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy
Liu H, Zhang L, Zhang X, Cui Z
OncoTargets and Therapy 2017, 10:2865-2871
Published Date: 6 June 2017
Prognostic value of high IMP3 expression in solid tumors: a meta-analysis
Chen L, Xie Y, Li X, Gu L, Gao Y, Tang L, Chen J, Zhang X
OncoTargets and Therapy 2017, 10:2849-2863
Published Date: 6 June 2017
Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma
Bai X, Li Y, Zhang H, Wang F, He H, Yao J, Liu L, Li S
OncoTargets and Therapy 2017, 10:2837-2847
Published Date: 2 June 2017
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]
Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2017, 10:2835-2836
Published Date: 2 June 2017
SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma
Huang W, Huang H, Wang L, Hu J, Song W
OncoTargets and Therapy 2017, 10:2825-2833
Published Date: 2 June 2017
Letter to the editor regarding the article “Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis”
Yu H, Wang P, Zhang X
OncoTargets and Therapy 2017, 10:2823-2824
Published Date: 6 June 2017
MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2
Wu MH, Ye XX, Wang SC, Li QH, Lai YX, Yi YM
OncoTargets and Therapy 2017, 10:2815-2822
Published Date: 2 June 2017
Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer
Zhan XH, Dong C, Liu G, Li YX, Liu L
OncoTargets and Therapy 2017, 10:2805-2813
Published Date: 1 June 2017
Silencing of AQP3 induces apoptosis of gastric cancer cells via downregulation of glycerol intake and downstream inhibition of lipogenesis and autophagy
Chen L, Li Z, Zhang Q, Wei S, Li B, Zhang X, Zhang L, Li Q, Xu H, Xu Z
OncoTargets and Therapy 2017, 10:2791-2804
Published Date: 1 June 2017
The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma
Wang X, Wang S, Li X, Jin S, Xiong F, Wang X
OncoTargets and Therapy 2017, 10:2781-2789
Published Date: 31 May 2017
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]
Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M
OncoTargets and Therapy 2017, 10:2779-2780
Published Date: 31 May 2017
The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism
Chen L, Sun L, Dong L, Cui P, Xia Z, Li C, Zhu Y
OncoTargets and Therapy 2017, 10:2769-2778
Published Date: 30 May 2017
Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
Wu J, Li A, Yang J, Lu Y, Li J
OncoTargets and Therapy 2017, 10:2761-2768
Published Date: 29 May 2017
Pretreatment combination of platelet counts and neutrophil–lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy
Lin YH, Chang KP, Lin YS, Chang TS
OncoTargets and Therapy 2017, 10:2751-2760
Published Date: 26 May 2017
Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study
Yuan G, Chen J, Wu D, Gao C
OncoTargets and Therapy 2017, 10:2745-2750
Published Date: 26 May 2017
Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer
Xu X, Liu S, Ji X
OncoTargets and Therapy 2017, 10:2739-2744
Published Date: 26 May 2017
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]
Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W
OncoTargets and Therapy 2017, 10:2737-2738
Published Date: 29 May 2017
The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma
Song G, Jing W, Xue S, Guo H, Yu J
OncoTargets and Therapy 2017, 10:2729-2736
Published Date: 25 May 2017
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
Kwon NS, Kim DS, Yun HY
OncoTargets and Therapy 2017, 10:2721-2728
Published Date: 24 May 2017
miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4
Hu H, Wang G, Li C
OncoTargets and Therapy 2017, 10:2711-2720
Published Date: 23 May 2017
MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway
Liu H, Pan Y, Han X, Liu J, Li R
OncoTargets and Therapy 2017, 10:2701-2709
Published Date: 23 May 2017
Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials
Veettil SK, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Chaiyakunapruk N
OncoTargets and Therapy 2017, 10:2689-2700
Published Date: 23 May 2017
Ezh2, a novel target in detection and therapy of breast cancer
Pourakbar S, Pluard TJ, Accurso AD, Farassati F
OncoTargets and Therapy 2017, 10:2685-2687
Published Date: 22 May 2017
Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer
Shao Y, Zhu W, Da J, Xu M, Wang Y, Zhou J, Wang Z
OncoTargets and Therapy 2017, 10:2675-2683
Published Date: 22 May 2017
Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer
Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S
OncoTargets and Therapy 2017, 10:2665-2673
Published Date: 22 May 2017
The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up
Jin H, Sun J, Zhu K, Liu X, Zhang Q, Shen Q, Gao Y, Yu J
OncoTargets and Therapy 2017, 10:2655-2664
Published Date: 22 May 2017
Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
Pang X, Li Q, Ma Z, Shi Y, Ma Y, Li X, Cui W, Zhang W
OncoTargets and Therapy 2017, 10:2645-2654
Published Date: 19 May 2017
The novel long noncoding RNA RP11–357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer
Yang B, Luo TH, Zhang MJ, Lu ZM, Xue XC, Fang GN
OncoTargets and Therapy 2017, 10:2635-2643
Published Date: 18 May 2017
FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis
Liu Y, Zheng Z, Zhang QX, Zhou XL, Feng YK, Yan AQ
OncoTargets and Therapy 2017, 10:2621-2633
Published Date: 18 May 2017
RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1
Yu DP, Zhang C, Gui JQ
OncoTargets and Therapy 2017, 10:2609-2619
Published Date: 17 May 2017
Holliday junction–recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma
Hu B, Wang Q, Wang Y, Chen J, Li P, Han M
OncoTargets and Therapy 2017, 10:2601-2607
Published Date: 17 May 2017
Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study
Sun Y, Wang Y, Han S, Xing B, Li H, Zhu Y, Zhou S, Wang X, Xu J, Tao R
OncoTargets and Therapy 2017, 10:2595-2600
Published Date: 17 May 2017
The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia
Meier-Stephenson V, Riemer J, Narendran A
OncoTargets and Therapy 2017, 10:2581-2593
Published Date: 16 May 2017
Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
Chen L, Zuo YJ, Zhu LH, Zhang YX, Li S, Ma F, Han Y, Song HJ, Xue YW
OncoTargets and Therapy 2017, 10:2569-2580
Published Date: 17 May 2017
Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
Du E, Wang L, Li C, Zhang C, Qu Y, Liu R, Xu Y, Yang K, Zhang Z
OncoTargets and Therapy 2017, 10:2561-2567
Published Date: 15 May 2017
Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:2553-2560
Published Date: 15 May 2017
Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer
Hollis RL, Churchman M, Gourley C
OncoTargets and Therapy 2017, 10:2539-2551
Published Date: 11 May 2017
MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein
Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W
OncoTargets and Therapy 2017, 10:2527-2538
Published Date: 11 May 2017
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
Hirsh V
OncoTargets and Therapy 2017, 10:2513-2526
Published Date: 11 May 2017
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
McCulloch D, Brown C, Iland H
OncoTargets and Therapy 2017, 10:2511-2512
Published Date: 8 May 2017
Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma
Zhong D, Cen H
OncoTargets and Therapy 2017, 10:2501-2509
Published Date: 8 May 2017
Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysis
Wang F, Li H, Long J, Ye S
OncoTargets and Therapy 2017, 10:2491-2499
Published Date: 8 May 2017
Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment
Shi Y, Jia R, Fan X
OncoTargets and Therapy 2017, 10:2483-2489
Published Date: 8 May 2017
Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis
Batson S, Mitchell SA, Windisch R, Damonte E, Munk VC, Reguart N
OncoTargets and Therapy 2017, 10:2473-2482
Published Date: 5 May 2017
Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells
Liu Q, Liu H, Cheng HP, Li Y, Li XD, Zhu CY
OncoTargets and Therapy 2017, 10:2461-2471
Published Date: 5 May 2017
A retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus
Wang Y, Liu JF
OncoTargets and Therapy 2017, 10:2453-2459
Published Date: 5 May 2017
An isolated unusual digit metastasis from esophageal carcinoma: a case report
Chen Y, Tang W, Xiao H, Chen J, Zhao H, Shi J
OncoTargets and Therapy 2017, 10:2449-2452
Published Date: 9 May 2017
Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide
Haq S, Samuel V, Haxho F, Akasov R, Leko M, Burov SV, Markvicheva E, Szewczuk MR
OncoTargets and Therapy 2017, 10:2427-2447
Published Date: 4 May 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M
OncoTargets and Therapy 2017, 10:2425-2426
Published Date: 4 May 2017
Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response
Sun WW, Xu ZH, Lian P, Gao BL, Hu JA
OncoTargets and Therapy 2017, 10:2413-2424
Published Date: 4 May 2017
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]
Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W
OncoTargets and Therapy 2017, 10:2411-2412
Published Date: 3 May 2017
The voice quality after laser surgery versus radiotherapy of T1a glottic carcinoma: systematic review and meta-analysis
Huang GJ, Luo MS, Zhang JX, Liu HB
OncoTargets and Therapy 2017, 10:2403-2410
Published Date: 3 May 2017
Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes
Heinrich B, Klein J, Delic M, Goepfert K, Engel V, Geberzahn L, Lusky M, Erbs P, Preville X, Moehler M
OncoTargets and Therapy 2017, 10:2389-2401
Published Date: 2 May 2017
Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells
Feng S, Wang Y, Zhang R, Yang G, Liang Z, Wang Z, Zhang G
OncoTargets and Therapy 2017, 10:2377-2388
Published Date: 2 May 2017
Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2
Liu W, Yu Q, Ma J, Cheng Y, Zhang H, Luo W, Yao J, Zhang H
OncoTargets and Therapy 2017, 10:2367-2376
Published Date: 2 May 2017
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum]
Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi M, Sachchidanand, Parine NR, Chourasia M
OncoTargets and Therapy 2017, 10:2365-2366
Published Date: 28 April 2017
Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
Ilcus C, Bagacean C, Tempescul A, Popescu C, Parvu A, Cenariu M, Bocsan C, Zdrenghea M
OncoTargets and Therapy 2017, 10:2349-2363
Published Date: 28 April 2017
Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
Hu Y, Zang J, Qin X, Yan D, Cao H, Zhou L, Ni J, Yu S, Wu J, Feng JF
OncoTargets and Therapy 2017, 10:2341-2348
Published Date: 28 April 2017
The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
Bai H, Xiong L, Han B
OncoTargets and Therapy 2017, 10:2335-2340
Published Date: 27 April 2017
No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations
Semlali A, Almutairi M, Parine NR, Al Amri A, Shaik JP, Al Naeem A, Abdulla Ajaj S, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:2325-2333
Published Date: 27 April 2017
B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer [Corrigendum]
Zhao Q, Gui T, Qian Q, Li L, Shen K
OncoTargets and Therapy 2017, 10:2323-2324
Published Date: 27 April 2017
Identification of potential biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma by bioinformatics analysis
Yang B, Chen Z, Huang Y, Han G, Li W
OncoTargets and Therapy 2017, 10:2315-2321
Published Date: 26 April 2017
Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy
Liang B, Zheng ZY, Shi YF, Chen JJ, Hu XD, Qian HL, Shen ZJ, Jiang SF, Yu K, Feng JH
OncoTargets and Therapy 2017, 10:2305-2313
Published Date: 26 April 2017
Role of CT scan in differentiating the type of colorectal cancer
Li ZH, You DY, Gao DP, Yang GJ, Dong XX, Zhang DF, Ding YY
OncoTargets and Therapy 2017, 10:2297-2303
Published Date: 26 April 2017
Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report
Peng Y, Cui H, Liu Z, Liu D, Liu F, Song Y, Duan H, Qiu Y, Li Q
OncoTargets and Therapy 2017, 10:2289-2295
Published Date: 26 April 2017
Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis
Wang L, Liu Y, Zhou W, Li W
OncoTargets and Therapy 2017, 10:2281-2287
Published Date: 26 April 2017
Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs
Liu Y, Sun L, Xiong Z, Sun X, Zhang S, Ma J, Han C
OncoTargets and Therapy 2017, 10:2267-2279
Published Date: 24 April 2017
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection
Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM
OncoTargets and Therapy 2017, 10:2257-2266
Published Date: 21 April 2017
Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer
Ma J, Yang Y, Wang Y, Zhang X, Gu X, Wang Z
OncoTargets and Therapy 2017, 10:2249-2256
Published Date: 21 April 2017
PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro
Cui W, Zheng S, Liu Z, Wang W, Cai Y, Bi R, Cao B, Zhou X
OncoTargets and Therapy 2017, 10:2239-2247
Published Date: 20 April 2017
Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer
Zhang J, Liu Q, Qiao L, Hu P, Deng G, Liang N, Xie J, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2227-2237
Published Date: 20 April 2017
NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo
Lian JP, Lin D, Xie X, Xu Y, Xu L, Meng L, Zhu Y
OncoTargets and Therapy 2017, 10:2219-2226
Published Date: 19 April 2017
Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer
Huang BT, Wu LL, Guo LJ, Xu LY, Huang RH, Lin PX, Chen JZ, Li DR, Chen CZ
OncoTargets and Therapy 2017, 10:2209-2217
Published Date: 19 April 2017
Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients
You J, Zhang H, Shen Y, Chen C, Liu W, Zheng M, Van Poucke S, Guo G, Huang Z
OncoTargets and Therapy 2017, 10:2199-2208
Published Date: 18 April 2017
Allergic conditions are not associated with the risk of non-Hodgkin’s lymphoma or Hodgkin’s lymphoma: a systematic review and meta-analysis
Yang J, Xu H, Liang X, Lv S, Lin B, Jia Y
OncoTargets and Therapy 2017, 10:2189-2198
Published Date: 18 April 2017
Novel insights into circular RNAs in clinical application of carcinomas
Rong D, Tang W, Li Z, Zhou J, Shi J, Wang H, Cao H
OncoTargets and Therapy 2017, 10:2183-2188
Published Date: 18 April 2017
Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
Luo D, Chen W, Tian Y, Li J, Xu X, Chen C, Li F
OncoTargets and Therapy 2017, 10:2173-2181
Published Date: 18 April 2017
Monosomal karyotype in myeloid neoplasias: a literature review
Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F
OncoTargets and Therapy 2017, 10:2163-2171
Published Date: 20 April 2017
Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection
Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D
OncoTargets and Therapy 2017, 10:2155-2162
Published Date: 13 April 2017
Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2147-2154
Published Date: 12 April 2017
Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells
Gan S, Ye J, Wang L, Qu F, Chu C, Tian Y, Yang W, Cui X
OncoTargets and Therapy 2017, 10:2139-2146
Published Date: 12 April 2017
miR-762 can negatively regulate menin in ovarian cancer
Hou R, Yang Z, Wang S, Chu D, Liu Q, Liu J, Jiang L
OncoTargets and Therapy 2017, 10:2127-2137
Published Date: 12 April 2017
A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/AkT/MTOR signaling pathway
Zhao L, Li C, Liu F, Zhao Y, Liu J, Hua Y, Liu J, Huang J, Ge C
OncoTargets and Therapy 2017, 10:2115-2126
Published Date: 12 April 2017
Gastric cancer, nutritional status, and outcome
Liu X, Qiu H, Kong P, Zhou Z, Sun X
OncoTargets and Therapy 2017, 10:2107-2114
Published Date: 12 April 2017
Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
Wagner LM, Adams VR
OncoTargets and Therapy 2017, 10:2097-2106
Published Date: 12 April 2017
Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
Wang X, Miao C, Chen Z, Li W, Yuan S, Yu J, Hu X
OncoTargets and Therapy 2017, 10:2087-2095
Published Date: 11 April 2017
Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors
Rossmeisl JH, Hall-Manning K, Robertson JL, King JN, Davalos RV, Debinski W, Elankumaran S
OncoTargets and Therapy 2017, 10:2077-2085
Published Date: 12 April 2017
Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients
Huang CC, Fang FM, Chen HC, Hsu HC, Huang TL, Su YL, Chang YC
OncoTargets and Therapy 2017, 10:2069-2075
Published Date: 10 April 2017
The role of KPNβ1 in neuro-oncology
Lilley M, Farassati F
OncoTargets and Therapy 2017, 10:2067-2068
Published Date: 10 April 2017
Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date
Levin PA, Dowell JE
OncoTargets and Therapy 2017, 10:2057-2066
Published Date: 7 April 2017
Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7
Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J
OncoTargets and Therapy 2017, 10:2045-2056
Published Date: 7 April 2017
Patient considerations in metastatic colorectal cancer – role of panitumumab
Rogers JE
OncoTargets and Therapy 2017, 10:2033-2044
Published Date: 7 April 2017
Expression and significance of GRHL2 in esophageal cancer
Shao CC, Ji CS, Wang XQ, Hu B
OncoTargets and Therapy 2017, 10:2025-2031
Published Date: 7 April 2017
REG3A promotes the proliferation, migration, and invasion of gastric cancer cells
Chen ZF, Huang ZM, Xue HB, Lin XQ, Chen RP, Chen MJ, Jin RF
OncoTargets and Therapy 2017, 10:2017-2023
Published Date: 6 April 2017
Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
Chen F, Pu F
OncoTargets and Therapy 2017, 10:2009-2016
Published Date: 6 April 2017
Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients
Chen J, Li H, Pang RL, Huang J
OncoTargets and Therapy 2017, 10:2003-2007
Published Date: 6 April 2017
Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer
Yan CS, Jiang Y, Wan YC, Zhang L, Liu JH, Zhou SL, Cheng WJ
OncoTargets and Therapy 2017, 10:1993-2002
Published Date: 6 April 2017
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A
OncoTargets and Therapy 2017, 10:1983-1992
Published Date: 6 April 2017
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation
Andersen MN, Ludvigsen M, Abildgaard N, Petruskevicius I, Hjortebjerg R, Bjerre M, Honoré B, Møller HJ, Andersen NF
OncoTargets and Therapy 2017, 10:1977-1982
Published Date: 4 April 2017
HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population
Zhang ZR, Zou Y, Zhu JH, Zhang RZ, Yang TY, Wang FH, Xia HM, He J, Feng ZC
OncoTargets and Therapy 2017, 10:1969-1975
Published Date: 4 April 2017
Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
Sun S, Yu H, Wang H, Zhao X, Zhao X, Wu X, Qiao J, Chang J, Wang J
OncoTargets and Therapy 2017, 10:1955-1967
Published Date: 3 April 2017
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer
Yan Y, Zhou K, Wang L, Wang F, Chen X, Fan Q
OncoTargets and Therapy 2017, 10:1947-1954
Published Date: 3 April 2017
Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line
Attar R, Cincin ZB, Bireller ES, Cakmakoglu B
OncoTargets and Therapy 2017, 10:1941-1946
Published Date: 31 March 2017
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer
Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W
OncoTargets and Therapy 2017, 10:1933-1939
Published Date: 30 March 2017
Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane
Townsend MH, Anderson MD, Weagel EG, Velazquez EJ, Weber KS, Robison RA, O'Neill KL
OncoTargets and Therapy 2017, 10:1921-1932
Published Date: 30 March 2017
Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication
Liu J, Zheng Y, Gao J, Zhu G, Gao K, Zhang W, Shi F, Shi Q
OncoTargets and Therapy 2017, 10:1915-1920
Published Date: 29 March 2017
Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia
Khan M, Gibbons JL, Ferrajoli A
OncoTargets and Therapy 2017, 10:1909-1914
Published Date: 29 March 2017
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
Liu Y, Mu Y, Zhang A, Ren SD, Wang WH, Xie JP, Zhang YX, Zhou CH
OncoTargets and Therapy 2017, 10:1897-1908
Published Date: 29 March 2017
Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis
Halpern N, Goldberg Y, Kadouri L, Duvdevani M, Hamburger T, Peretz T, Hubert A
OncoTargets and Therapy 2017, 10:1889-1896
Published Date: 29 March 2017
Genetic variants and increased risk of meningioma: an updated meta-analysis
Han X, Wang W, Wang L, Wang X, Li G
OncoTargets and Therapy 2017, 10:1875-1888
Published Date: 28 March 2017
DNMT1 regulates human endometrial carcinoma cell proliferation
Wang X, Li B
OncoTargets and Therapy 2017, 10:1865-1873
Published Date: 29 March 2017
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?
Joshi A, Zanwar S, Noronha V, Patil VM, Chougule A, Kumar R, Janu A, Mahajan A, Kapoor A, Prabhash K
OncoTargets and Therapy 2017, 10:1859-1863
Published Date: 28 March 2017
Pancreatic solitary fibrous tumor in a toddler managed by pancreaticoduodenectomy: a case report and review of the literature
Sheng Q, Xu W, Liu J, Shen B, Deng X, Wu Y, Wu W, Yu S, Wang X, Lv Z
OncoTargets and Therapy 2017, 10:1853-1858
Published Date: 27 March 2017
Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis
Wu J, Cheng G, Zhang C, Zheng Y, Xu H, Yang H, Hua L
OncoTargets and Therapy 2017, 10:1843-1852
Published Date: 27 March 2017
Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial
Lazzari G, Terlizzi A, Della Vittoria Scarpati G, Perri F, De Chiara V, Turi B, Silvano G
OncoTargets and Therapy 2017, 10:1835-1842
Published Date: 24 March 2017
Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression
Xu X, Shen H, Zhu L, Lu J, Zhang L, Luo Z, Wu Y
OncoTargets and Therapy 2017, 10:1827-1834
Published Date: 23 March 2017
Salvage treatment with apatinib for advanced non-small-cell lung cancer
Song Z, Yu X, Lou G, Shi X, Zhang Y
OncoTargets and Therapy 2017, 10:1821-1825
Published Date: 23 March 2017
Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study
Wang T, Hu P, Li B, Zhang J, Cheng Y, Liang Y
OncoTargets and Therapy 2017, 10:1809-1819
Published Date: 23 March 2017
Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy
Robainas M, Otano R, Bueno S, Ait-Oudhia S
OncoTargets and Therapy 2017, 10:1803-1807
Published Date: 23 March 2017
Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis
He H, Zhai X, Liu X, Zheng J, Zhai Y, Gao F, Chen Y, Lu J
OncoTargets and Therapy 2017, 10:1793-1801
Published Date: 23 March 2017
Focal adhesion kinases crucially regulate TGFβ-induced migration and invasion of bladder cancer cells via Src kinase and E-cadherin
Kong D, Chen F, Sima N
OncoTargets and Therapy 2017, 10:1783-1792
Published Date: 23 March 2017
Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis
Cui X, Zhang J, Lv J, Yan Y, Liu X, Wang J, Lv Y, Zhang J
OncoTargets and Therapy 2017, 10:1777-1781
Published Date: 23 March 2017
Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G
OncoTargets and Therapy 2017, 10:1767-1776
Published Date: 23 March 2017
Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)
Saad N, Poudel A, Basnet A, Gajra A
OncoTargets and Therapy 2017, 10:1757-1766
Published Date: 22 March 2017
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis
Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W
OncoTargets and Therapy 2017, 10:1743-1755
Published Date: 22 March 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M
OncoTargets and Therapy 2017, 10:1735-1742
Published Date: 21 March 2017
The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis
Wang J, Shen CX, Fu Y, Yu T, Song J
OncoTargets and Therapy 2017, 10:1725-1734
Published Date: 21 March 2017
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas
Ye ZH, Gao L, Wen DY, He Y, Pang YY, Chen G
OncoTargets and Therapy 2017, 10:1711-1723
Published Date: 21 March 2017
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2017, 10:1709-1710
Published Date: 21 March 2017
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]
Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC
OncoTargets and Therapy 2017, 10:1707-1708
Published Date: 21 March 2017
Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1′S-1′-acetoxychavicol acetate via regulating RSU1
Phuah NH, Azmi MN, Awang K, Nagoor NH
OncoTargets and Therapy 2017, 10:1695-1705
Published Date: 20 March 2017
Primary pancreatic lymphoma: two case reports and a literature review
Yu L, Chen Y, Xing L
OncoTargets and Therapy 2017, 10:1687-1694
Published Date: 20 March 2017
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma
Ning X, Deng Y
OncoTargets and Therapy 2017, 10:1673-1686
Published Date: 20 March 2017
Role of cytokines and chemokines in alcohol-induced tumor promotion
Chen D, Zhang F, Ren H, Luo J, Wang S
OncoTargets and Therapy 2017, 10:1665-1671
Published Date: 17 March 2017
Human omental adipose-derived mesenchymal stem cell-conditioned medium alters the proteomic profile of epithelial ovarian cancer cell lines in vitro
Zhang YL, Dong WH, Wang JJ, Cai J, Wang ZH
OncoTargets and Therapy 2017, 10:1655-1663
Published Date: 17 March 2017
Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas
Jain S, Song R, Xie J
OncoTargets and Therapy 2017, 10:1645-1653
Published Date: 16 March 2017
Evaluation of efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma using magnetic resonance diffusion-weighted imaging
Wu X, Wang J, Ji J, Chen M, Song J
OncoTargets and Therapy 2017, 10:1637-1643
Published Date: 16 March 2017
MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro
Zhou K, Fan Y, Wu P, Duysenbi S, Feng Z, Du G, Zhang T
OncoTargets and Therapy 2017, 10:1625-1635
Published Date: 16 March 2017
CDKL1 promotes tumor proliferation and invasion in colorectal cancer
Qin C, Ren L, Ji M, Lv S, Wei Y, Zhu D, Lin Q, Xu P, Chang W, Xu J
OncoTargets and Therapy 2017, 10:1613-1624
Published Date: 16 March 2017
TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling
Dai Y, Duan H, Duan C, Zhu H, Zhou R, Pei H, Shen L
OncoTargets and Therapy 2017, 10:1603-1611
Published Date: 14 March 2017
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
McCulloch D, Brown C, Iland H
OncoTargets and Therapy 2017, 10:1585-1601
Published Date: 14 March 2017
SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis
Zhang X, Fan Y, Li Z
OncoTargets and Therapy 2017, 10:1575-1583
Published Date: 14 March 2017
Mechanism of immune evasion in breast cancer
Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y
OncoTargets and Therapy 2017, 10:1561-1573
Published Date: 14 March 2017
Knockdown of IQGAP1 inhibits proliferation and epithelial–mesenchymal transition by Wnt/β-catenin pathway in thyroid cancer
Su D, Liu Y, Song T
OncoTargets and Therapy 2017, 10:1549-1559
Published Date: 13 March 2017
Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study
Yang J, Li S, Lv M, Wu Y, Chen Z, Shen Y, Wang B, Chen L, Yi M, Yang J
OncoTargets and Therapy 2017, 10:1535-1548
Published Date: 13 March 2017
Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
Vatte C, Al Amri AM, Cyrus C, Chathoth S, Acharya S, Hashim TM, Al Ali Z, Alshreadah ST, Alsayyah A, Al-Ali AK
OncoTargets and Therapy 2017, 10:1527-1533
Published Date: 13 March 2017
Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report
Deng L, Wang Y, Lu W, Liu Q, Wu J, Jin J
OncoTargets and Therapy 2017, 10:1521-1525
Published Date: 13 March 2017
MTA1 promotes proliferation and invasion in human gastric cancer cells [Retraction]
Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J
OncoTargets and Therapy 2017, 10:1519-1520
Published Date: 10 March 2017
Adverse prognostic impact of TGFB1 T869C polymorphism in non-small-cell lung cancer
Sang Y, Bi X, Liu Y, Zhang W, Wang D
OncoTargets and Therapy 2017, 10:1513-1518
Published Date: 10 March 2017
Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells
Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z
OncoTargets and Therapy 2017, 10:1503-1512
Published Date: 9 March 2017
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM
OncoTargets and Therapy 2017, 10:1487-1502
Published Date: 9 March 2017
Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors
Guo W, Zheng YB, Xu B, Ma F, Li C, Zhang XQ, Wang Y, Chang XT
OncoTargets and Therapy 2017, 10:1475-1485
Published Date: 8 March 2017
Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors
Guo C, Chen X, Xiao W, Wang Q, Sun K, Wang Z
OncoTargets and Therapy 2017, 10:1465-1474
Published Date: 7 March 2017
Chronological changes in lung cancer surgery in a single Japanese institution
Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H
OncoTargets and Therapy 2017, 10:1459-1464
Published Date: 6 March 2017
Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
Sarri AJ, Dias R, Laurienzo CE, Gonçalves MCP, Dias DS, Moriguchi SM
OncoTargets and Therapy 2017, 10:1451-1457
Published Date: 6 March 2017
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2017, 10:1441-1449
Published Date: 6 March 2017
GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis
Zhang F, Wu X, Niu J, Kang X, Cheng L, Lv Y, Wu M
OncoTargets and Therapy 2017, 10:1433-1440
Published Date: 6 March 2017
MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK
Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S, Yuan Z
OncoTargets and Therapy 2017, 10:1423-1431
Published Date: 6 March 2017
Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
Koprivnikar J, McCloskey J, Faderl S
OncoTargets and Therapy 2017, 10:1413-1422
Published Date: 6 March 2017
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO
OncoTargets and Therapy 2017, 10:1403-1412
Published Date: 3 March 2017
HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition
Luan XR, Ma CJ, Wang P, Lou FL
OncoTargets and Therapy 2017, 10:1389-1402
Published Date: 3 March 2017
Arterial stiffness in hematologic malignancies
Mozos I, Borzak G, Caraba A, Mihaescu R
OncoTargets and Therapy 2017, 10:1381-1388
Published Date: 3 March 2017
The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia YX, El Meddeb Hamrouni A, Ben Mrad M, Magné N
OncoTargets and Therapy 2017, 10:1375-1380
Published Date: 3 March 2017
Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D
OncoTargets and Therapy 2017, 10:1363-1373
Published Date: 3 March 2017
MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3
He M, Xue Y
OncoTargets and Therapy 2017, 10:1353-1361
Published Date: 2 March 2017
125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy：a comparison with best supportive care
Song J, Fan X, Zhao Z, Chen M, Chen W, Wu F, Zhang D, Chen L, Tu J, Ji J
OncoTargets and Therapy 2017, 10:1345-1352
Published Date: 2 March 2017
Evidence from a meta-analysis: is nivolumab neurotoxic in cancer patients?
Kong X, Kong Y
OncoTargets and Therapy 2017, 10:1335-1344
Published Date: 1 March 2017
Clarifying the molecular mechanism associated with carfilzomib resistance in human multiple myeloma using microarray gene expression profile and genetic interaction network
Zheng Z, Liu T, Zheng J, Hu J
OncoTargets and Therapy 2017, 10:1327-1334
Published Date: 1 March 2017
Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
Li R, Dong T, Hu C, Lu J, Dai J, Liu P
OncoTargets and Therapy 2017, 10:1317-1325
Published Date: 28 February 2017
Downregulation of long noncoding RNA HOTAIRM1 promotes monocyte/dendritic cell differentiation through competitively binding to endogenous miR-3960
Xin J, Li J, Feng Y, Wang L, Zhang Y, Yang R
OncoTargets and Therapy 2017, 10:1307-1315
Published Date: 1 March 2017
Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study
Losem C, Koenigsmann M, Rudolph C
OncoTargets and Therapy 2017, 10:1295-1305
Published Date: 28 February 2017
Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients
Sun Y, Zhou F, Liu F, Hu Y, Tan S, Liang P, Linghu EQ, Yu X
OncoTargets and Therapy 2017, 10:1285-1294
Published Date: 28 February 2017
Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials
Qiao L, Wang J, Long G, Jiang Y
OncoTargets and Therapy 2017, 10:1279-1284
Published Date: 28 February 2017
MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis
Cai H, Chen X, Tang Y, Deng Y
OncoTargets and Therapy 2017, 10:1269-1278
Published Date: 28 February 2017
Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo
Lv J, Lin S, Peng P, Cai C, Deng J, Wang M, Li X, Lin R, Lin Y, Fang A, Li Q
OncoTargets and Therapy 2017, 10:1261-1267
Published Date: 28 February 2017
Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis
Wang L, Yang D, Lv JY, Yu D, Xin SJ
OncoTargets and Therapy 2017, 10:1247-1260
Published Date: 27 February 2017
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
Luan WK, Qian Y, Ni X, Bu XF, Xia Y, Wang JL, Ruan HR, Ma SJ, Xu B
OncoTargets and Therapy 2017, 10:1237-1246
Published Date: 27 February 2017
A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells
Tong W, Yang L, Yu Q, Yao J, He A
OncoTargets and Therapy 2017, 10:1227-1235
Published Date: 27 February 2017
The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma
Mao Y, Han Y, Shi W
OncoTargets and Therapy 2017, 10:1217-1226
Published Date: 27 February 2017
Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
Semlali A, Jalouli M, Parine NR, Al Amri A, Arafah M, Al Naeem A, Abdullah Ajaj S, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:1207-1216
Published Date: 24 February 2017
Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort
Zhou G, Liu X, Wang X, Jin D, Chen Y, Li G, Li C, Fu D, Xu W, Wang X
OncoTargets and Therapy 2017, 10:1199-1206
Published Date: 24 February 2017
Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial–mesenchymal transition
Xu Y, Wang B, Zhang F, Wang A, Du X, Hu P, Zhu Y, Fang Z
OncoTargets and Therapy 2017, 10:1191-1198
Published Date: 24 February 2017
Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B-virus positive hepatocellular carcinoma after curative resection
Li G, Ji J, Yang F, Xu H, Bai Y
OncoTargets and Therapy 2017, 10:1181-1189
Published Date: 23 February 2017
Aberrant histone modification in CD19+ B cells of the patients with chronic lymphocytic leukemia
Zhou K, Zhang Q, Liu Y, Xiong Y, Wu S, Yang J, Zhou H, Liu X, Wei X, Song Y
OncoTargets and Therapy 2017, 10:1173-1179
Published Date: 23 February 2017
Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis
Huang Y, Sun Y, Peng P, Zhu S, Sun W, Zhang P
OncoTargets and Therapy 2017, 10:1165-1172
Published Date: 23 February 2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2017, 10:1155-1164
Published Date: 23 February 2017
Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population
Fu W, Zhuo Z, Jia W, Zhu J, Zhu S, Lin Z, Wang F, Xia H, He J, Liu G
OncoTargets and Therapy 2017, 10:1149-1154
Published Date: 23 February 2017
Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer
Nakamura S, Fukui T, Suzuki S, Takeda H, Watanabe K, Yoshioka T
OncoTargets and Therapy 2017, 10:1143-1147
Published Date: 23 February 2017
Intrahepatic cholangiocarcinoma: current perspectives
Buettner S, van Vugt JLA, IJzermans JNM, Groot Koerkamp B
OncoTargets and Therapy 2017, 10:1131-1142
Published Date: 22 February 2017
Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study
Zhao YX, Liu S, Hu YB, Ge YY, Lv DM
OncoTargets and Therapy 2017, 10:1123-1129
Published Date: 22 February 2017
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
Liu Y, Zhang B, Shi T, Qin H
OncoTargets and Therapy 2017, 10:1115-1122
Published Date: 24 February 2017
Internal mammary lymph node management – further direction
Vrana D, Gatek J
OncoTargets and Therapy 2017, 10:1111-1114
Published Date: 21 February 2017
Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non–small cell lung cancer
Sheng J, Fang W, Liu X, Xing S, Zhan J, Ma Y, Huang Y, Zhou N, Zhao H, Zhang L
OncoTargets and Therapy 2017, 10:1101-1110
Published Date: 21 February 2017
Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells
Wang Y, Sun J, Wei X, Luan L, Zeng X, Wang C, Zhao W
OncoTargets and Therapy 2017, 10:1091-1100
Published Date: 22 February 2017
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial
Guetz S, Tufman A, von Pawel J, Rittmeyer A, Borgmeier A, Ferré P, Edlich B, Huber RM
OncoTargets and Therapy 2017, 10:1081-1089
Published Date: 21 February 2017
SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma
He Z, Li G, Tang L, Li Y
OncoTargets and Therapy 2017, 10:1071-1079
Published Date: 21 February 2017
Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics
Yi F, Du J, Ni W, Liu W
OncoTargets and Therapy 2017, 10:1059-1069
Published Date: 20 February 2017
MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells
Zhao Y, Dong Q, Wang E
OncoTargets and Therapy 2017, 10:1049-1058
Published Date: 20 February 2017
Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
Che K, Zhao Y, Qu X, Pang Z, Ni Y, Zhang T, Du J, Shen H
OncoTargets and Therapy 2017, 10:1039-1047
Published Date: 20 February 2017
miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1
Zheng L, Chen J, Zhou Z, He Z
OncoTargets and Therapy 2017, 10:1027-1038
Published Date: 20 February 2017
Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer
Gao X, Wen J, Gao P, Zhang G, Zhang G
OncoTargets and Therapy 2017, 10:1017-1026
Published Date: 22 February 2017
Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells
Mang YY, Li L, Ran JH, Zhang SN, Liu J, Li LB, Chen YM, Liu J, Gao Y, Ren G
OncoTargets and Therapy 2017, 10:1003-1016
Published Date: 20 February 2017
Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]
Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T
OncoTargets and Therapy 2017, 10:1001-1002
Published Date: 21 February 2017
Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis
Chen T, Wang H, Yang P, He ZY
OncoTargets and Therapy 2017, 10:993-1000
Published Date: 17 February 2017
Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study
Farzaneh E, Heydari H, Shekarchi AA, Kamran A
OncoTargets and Therapy 2017, 10:985-992
Published Date: 17 February 2017
Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis
Yi SY, Zeng LJ, Kuang Y, Cao ZJ, Zheng CJ, Zhang Y, Liao M, Yang L
OncoTargets and Therapy 2017, 10:973-984
Published Date: 17 February 2017
BRAFV600 mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study
Cohn AL, Day B, Abhyankar S, McKenna E, Riehl T, Puzanov I
OncoTargets and Therapy 2017, 10:965-971
Published Date: 17 February 2017
Axl promotes the proliferation, invasion and migration of Wilms’ tumor and can be used as a prognostic factor
Zhu S, Liu G, Fu W, Hu J, Fu K, Jia W
OncoTargets and Therapy 2017, 10:955-963
Published Date: 16 February 2017
Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis
Hao Y, Fu Q, Guo Y, Ye M, Zhao H, Wang Q, Peng X, Li Q, Wang R, Xiao W
OncoTargets and Therapy 2017, 10:945-953
Published Date: 16 February 2017
Polydatin regulates proliferation, apoptosis and autophagy in multiple myeloma cells through mTOR/p70s6k pathway
Yang B, Zhao S
OncoTargets and Therapy 2017, 10:935-944
Published Date: 16 February 2017
The superiority of 256-slice spiral computed tomography angiography for preoperative evaluation of surrounding arteries in patients with gastric cancer
Wu D, Zhao L, Liu Y, Wang J, Hu W, Feng X, Lv Z, Li Y, Yao X
OncoTargets and Therapy 2017, 10:927-933
Published Date: 16 February 2017
Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
Lan X, Li S, Gao H, Nanding A, Quan L, Yang C, Ding S, Xue Y
OncoTargets and Therapy 2017, 10:919-926
Published Date: 16 February 2017
Association between VEGF–460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
Tan JY, Jiang L, Cheng XW, Wang CL, Chen JS, Huang XQ, Xie P, Xia DM, Wang RS, Zhang Y
OncoTargets and Therapy 2017, 10:909-918
Published Date: 15 February 2017
Carfilzomib boosted combination therapy for relapsed multiple myeloma
Steiner RE, Manasanch EE
OncoTargets and Therapy 2017, 10:895-907
Published Date: 15 February 2017
miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma
Xie F, Yuan Y, Xie L, Ran P, Xiang X, Huang Q, Qi G, Guo X, Xiao C, Zheng S
OncoTargets and Therapy 2017, 10:885-894
Published Date: 15 February 2017
Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma
Yu S, Zhou Z, Cai Q, Liang F, Han P, Chen R, Huang X
OncoTargets and Therapy 2017, 10:879-884
Published Date: 15 February 2017
The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, Zhu H, Zhang Y, Shi F, Yu J
OncoTargets and Therapy 2017, 10:871-877
Published Date: 14 February 2017
Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
Li Z, Yin SC, Zhang L, Liu WG, Chen B, Xing H
OncoTargets and Therapy 2017, 10:859-870
Published Date: 14 February 2017
Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma
Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J
OncoTargets and Therapy 2017, 10:847-857
Published Date: 14 February 2017
Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
Zhang H, Chen F, Wang Z, Wu S
OncoTargets and Therapy 2017, 10:837-845
Published Date: 14 February 2017
The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma
Fu P, Chen F, Pan Q, Zhao X, Zhao C, Cho WC, Chen H
OncoTargets and Therapy 2017, 10:819-835
Published Date: 14 February 2017
AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathway
Chen JJ, Wang ZJ, Yu SS
OncoTargets and Therapy 2017, 10:811-817
Published Date: 13 February 2017
Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer
Chen HY, Chen YM, Wu J, Yang FC, Lv Z, Qian YG, Zheng SS
OncoTargets and Therapy 2017, 10:803-810
Published Date: 13 February 2017
RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1
Guo Y, Zhang PD, Zhang HT, Zhang P, Xu RX
OncoTargets and Therapy 2017, 10:791-801
Published Date: 13 February 2017
Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma
Yao X, Sun S, Zhou X, Zhang Q, Guo W, Zhang L
OncoTargets and Therapy 2017, 10:781-790
Published Date: 13 February 2017
Efficacy of eribulin in breast cancer: a short report on the emerging new data
Eslamian G, Wilson C, Young RJ
OncoTargets and Therapy 2017, 10:773-779
Published Date: 13 February 2017
Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
Zhang W, Pang Q, Yan C, Wang Q, Yang J, Yu S, Liu X, Yuan Z, Wang P, Xiao Z
OncoTargets and Therapy 2017, 10:763-771
Published Date: 13 February 2017
MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1
Wang J, Tang W, Liao M, Liu Y, Ai X
OncoTargets and Therapy 2017, 10:753-761
Published Date: 10 February 2017
Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia
Kohailan M, Alanazi M, Rouabhia M, Al Amri A, Parine NR, Semlali A
OncoTargets and Therapy 2017, 10:745-752
Published Date: 9 February 2017
CUL4A promotes proliferation and metastasis of colorectal cancer cells by regulating H3K4 trimethylation in epithelial–mesenchymal transition
Sui X, Zhou H, Zhu L, Wang D, Fan S, Zhao W
OncoTargets and Therapy 2017, 10:735-743
Published Date: 9 February 2017
Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma
Xu WZ, Li F, Xu ZK, Chen X, Sun B, Cao JW, Liu YG
OncoTargets and Therapy 2017, 10:725-733
Published Date: 8 February 2017
β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma
Yang CM, Ji S, Li Y, Fu LY, Jiang T, Meng FD
OncoTargets and Therapy 2017, 10:711-724
Published Date: 20 February 2017
Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population
Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H
OncoTargets and Therapy 2017, 10:703-709
Published Date: 8 February 2017
ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines
Li JP, Liu Y, Yin YH
OncoTargets and Therapy 2017, 10:691-701
Published Date: 7 February 2017
USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma
Chen Y, Zhou B, Chen D
OncoTargets and Therapy 2017, 10:681-689
Published Date: 7 February 2017
miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1
Wang JH, Wang W, Li JC, Wu LJ, Song M, Meng QG
OncoTargets and Therapy 2017, 10:667-679
Published Date: 7 February 2017
Prognostic implications of Kindlin proteins in human osteosarcoma
Ning K, Zhang H, Wang Z, Li K
OncoTargets and Therapy 2017, 10:657-665
Published Date: 7 February 2017
Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
Huber H, Edenhofer S, Estenfelder S, Stilgenbauer S
OncoTargets and Therapy 2017, 10:645-656
Published Date: 7 February 2017
Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway
Cui Y, Li Q, Li H, Wang Y, Wang H, Chen W, Zhang S, Cao J, Liu T
OncoTargets and Therapy 2017, 10:627-643
Published Date: 3 February 2017
High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma
Ren P, Chen C, Yue J, Zhang J, Yu Z
OncoTargets and Therapy 2017, 10:617-625
Published Date: 9 February 2017
FLT3 inhibitors: clinical potential in acute myeloid leukemia
Hospital MA, Green AS, Maciel TT, Moura IC, Leung AY, Bouscary D, Tamburini J
OncoTargets and Therapy 2017, 10:607-615
Published Date: 3 February 2017
Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
Alakel N, Middeke JM, Schetelig J, Bornhäuser M
OncoTargets and Therapy 2017, 10:597-605
Published Date: 2 February 2017
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial
Tabernero J, Kunzmann V, Scheithauer W, Reni M, Shiansong Li J, Ferrara S, Djazouli K
OncoTargets and Therapy 2017, 10:591-596
Published Date: 2 February 2017
Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents
Yang HL, Song EL, Shen GR, Zhu TH, Jiang TW, Shen H, Niu LP, Wang B, Lu ZY, Qian JP
OncoTargets and Therapy 2017, 10:579-590
Published Date: 2 February 2017
Exploring targeted therapy of osteosarcoma using proteomics data
Chaiyawat P, Settakorn J, Sangsin A, Teeyakasem P, Klangjorhor J, Soongkhaw A, Pruksakorn D
OncoTargets and Therapy 2017, 10:565-577
Published Date: 1 February 2017
Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung
Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A
OncoTargets and Therapy 2017, 10:559-564
Published Date: 31 January 2017
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life
Severi S, Grassi I, Nicolini S, Sansovini M, Bongiovanni A, Paganelli G
OncoTargets and Therapy 2017, 10:551-557
Published Date: 27 January 2017
miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer
Yang F, Li Y, Xu L, Zhu Y, Gao H, Zhen L, Fang L
OncoTargets and Therapy 2017, 10:543-550
Published Date: 27 January 2017
Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer
Shao Q, Liu S, Wang W, zhang Y, Li F, Li J
OncoTargets and Therapy 2017, 10:535-541
Published Date: 31 January 2017
The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma
Zhong GX, Feng SD, Shen RK, Wu Z, Chen F, Zhu X
OncoTargets and Therapy 2017, 10:527-533
Published Date: 8 February 2017
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease
Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M
OncoTargets and Therapy 2017, 10:521-526
Published Date: 24 January 2017
Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma
Wahid M, Jawed A, Dar SA, Mandal RK, Haque S
OncoTargets and Therapy 2017, 10:515-520
Published Date: 24 January 2017
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma
Miguel A, Sendra L, Noé V, Ciudad CJ, Dasi F, Hervas D, Herrero MJ, Aliño SF
OncoTargets and Therapy 2017, 10:503-514
Published Date: 23 January 2017
Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis
Wang J, Yu M, Guan S, Zhang G, Wang J, Cheng Y
OncoTargets and Therapy 2017, 10:493-502
Published Date: 23 January 2017
Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells
Chen T, Yang P, Wang H, He ZY
OncoTargets and Therapy 2017, 10:483-491
Published Date: 21 January 2017
Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis
Shen SD, Zhong SZ, Xiao GF, Zhou HB, Huang WH
OncoTargets and Therapy 2017, 10:477-481
Published Date: 21 January 2017
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, Asghar K
OncoTargets and Therapy 2017, 10:463-476
Published Date: 21 January 2017
Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
Liu W, Wang X, Sun J, Yang Y, Li W, Song J
OncoTargets and Therapy 2017, 10:453-461
Published Date: 23 January 2017
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
Fang S, Zhang H, Zhang Y, Xie W
OncoTargets and Therapy 2017, 10:447-452
Published Date: 18 January 2017
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel
Huang T, Yang L, Wang G, Ding G, Peng B, Wen Y, Wang Z
OncoTargets and Therapy 2017, 10:439-446
Published Date: 18 January 2017
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2017, 10:429-437
Published Date: 18 January 2017
Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
Liang CJ, Xu YC, Li GM, Zhao TJ, Xia F, Li GQ, Zhang D, Wu JX
OncoTargets and Therapy 2017, 10:417-428
Published Date: 18 January 2017
Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer
Zang JL, Hu Y, Xu XY, Ni J, Yan DL, Liu SW, He J, Xue J, Wu JZ, Feng JF
OncoTargets and Therapy 2017, 10:409-415
Published Date: 18 January 2017
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature
Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC
OncoTargets and Therapy 2017, 10:397-407
Published Date: 18 January 2017
FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma
Li F, Li YP, Zhang K, Li Y, He P, Liu YJ, Yuan H, Lu H, Liu J, Che S, Li Z, Bie L
OncoTargets and Therapy 2017, 10:387-395
Published Date: 16 January 2017
Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study
Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J
OncoTargets and Therapy 2017, 10:371-385
Published Date: 16 January 2017
Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma
Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y
OncoTargets and Therapy 2017, 10:363-370
Published Date: 13 January 2017
Letter to the editor regarding "Prognostic role of microRNA-150 in various carcinomas: a meta-analysis"
Li M, Yang Y
OncoTargets and Therapy 2017, 10:361-362
Published Date: 13 January 2017
Advances in antiangiogenic treatment of small-cell lung cancer
Lu H, Jiang Z
OncoTargets and Therapy 2017, 10:353-359
Published Date: 12 January 2017
Chidamide in the treatment of peripheral T-cell lymphoma
Chan TS, Tse E, Kwong YL
OncoTargets and Therapy 2017, 10:347-352
Published Date: 12 January 2017
Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
Chen J, Liu L, Xu J
OncoTargets and Therapy 2017, 10:339-345
Published Date: 11 January 2017
Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
Yang Z, Liu J, Huang Q, Zhang Z, Zhang J, Pan Y, Yang Y, Cheng D
OncoTargets and Therapy 2017, 10:329-338
Published Date: 11 January 2017
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis
Yin SC, Li Z, Huang JY, Miao ZF, Zhang JY, Lu CY, Xu H, Xu HM
OncoTargets and Therapy 2017, 10:319-327
Published Date: 10 January 2017
Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms’ tumor
Sun F, Li W, Wang L, Jiao C
OncoTargets and Therapy 2017, 10:311-317
Published Date: 10 January 2017
Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis
Jiang S, Xu J, Zhuo Z, Hua Z
OncoTargets and Therapy 2017, 10:303-310
Published Date: 10 January 2017
Clinical outcomes of patients with metachronous second primary lung adenocarcinomas
Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z
OncoTargets and Therapy 2017, 10:295-302
Published Date: 10 January 2017
Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2'-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study
Abbaspour Babaei M, Zaman Huri H, Kamalidehghan B, Yeap SK, Ahmadipour F
OncoTargets and Therapy 2017, 10:277-294
Published Date: 10 January 2017
Correlation of SASH1 expression and ultrasonographic features in breast cancer
Gong X, Wu J, Wu J, Liu J, Gu H, Shen H
OncoTargets and Therapy 2017, 10:271-276
Published Date: 10 January 2017
Strategies of temozolomide in future glioblastoma treatment
Lee CY
OncoTargets and Therapy 2017, 10:265-270
Published Date: 9 January 2017
Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy
Dequanter D, Dok R, Nuyts S
OncoTargets and Therapy 2017, 10:259-263
Published Date: 9 January 2017
RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis
Shou FY, Xu F, Li G, Zhao ZH, Mao Y, Yang FF, Wang HM, Guo HY
OncoTargets and Therapy 2017, 10:247-257
Published Date: 9 January 2017
Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection
Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H
OncoTargets and Therapy 2017, 10:239-245
Published Date: 6 January 2017
MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls
He L, Shen Y
OncoTargets and Therapy 2017, 10:227-238
Published Date: 6 January 2017
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma
Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G
OncoTargets and Therapy 2017, 10:217-226
Published Date: 6 January 2017
Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer
Gao H, Song X, Kang T, Yan B, Feng L, Gao L, Ai L, Liu X, Yu J, Li H
OncoTargets and Therapy 2017, 10:205-216
Published Date: 5 January 2017
Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas
He T, Qiu T, Wang X, Gui H, Wang X, Hu Q, Xia H, Qi G, Wu J, Ma H
OncoTargets and Therapy 2017, 10:195-203
Published Date: 4 January 2017
The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer
Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li X, Fu BH, Fu ZZ
OncoTargets and Therapy 2017, 10:185-194
Published Date: 29 December 2016
A comparative study of target volumes based on 18F-FDG PET-CT and ten phases of 4DCT for primary thoracic squamous esophageal cancer
Guo Y, Li J, Zhang P, Zhang Y
OncoTargets and Therapy 2017, 10:177-184
Published Date: 6 January 2017
Pediatric papillary thyroid cancer: current management challenges
Verburg FA, Van Santen HM, Luster M
OncoTargets and Therapy 2017, 10:165-175
Published Date: 28 December 2016
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M
OncoTargets and Therapy 2017, 10:153-163
Published Date: 28 December 2016
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
Zhang Q, Cao J, Xue K, Liu X, Ji D, Guo Y, Hong X
OncoTargets and Therapy 2017, 10:145-151
Published Date: 22 December 2016
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH
OncoTargets and Therapy 2017, 10:137-144
Published Date: 22 December 2016
Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker
Wu D, Cao G, Huang Z, Jin K, Hu H, Yu J, Zeng Y
OncoTargets and Therapy 2017, 10:129-135
Published Date: 23 December 2016
Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
Liu X, Chen J, He YA, Meng X, Li K, He CK, Liu S
OncoTargets and Therapy 2017, 10:121-128
Published Date: 22 December 2016
High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma
Yan H, Tian R, Zhang M, Wu J, Ding M, He J
OncoTargets and Therapy 2017, 10:113-120
Published Date: 21 December 2016
nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
Soliman HH
OncoTargets and Therapy 2017, 10:101-112
Published Date: 21 December 2016
Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study
Wang Y, Meng F, Liu Y, Chen X
OncoTargets and Therapy 2017, 10:95-100
Published Date: 20 December 2016
Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:85-94
Published Date: 20 December 2016
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y
OncoTargets and Therapy 2017, 10:73-83
Published Date: 5 January 2017
Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review
He W, Zou C, Tian ZK, Tan WY, Shen WX, Chen JH, Liu LP, Xu RL
OncoTargets and Therapy 2017, 10:67-72
Published Date: 20 December 2016
A novel synthetic Asiatic acid derivative induces apoptosis and inhibits proliferation and mobility of gastric cancer cells by suppressing STAT3 signaling pathway
Wang G, Jing Y, Cao LS, Gong CC, Gong ZN, Cao XR
OncoTargets and Therapy 2017, 10:55-66
Published Date: 20 December 2016
Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
Cheng Y, Xing SG, Jia WD, Huang M, Bian NN
OncoTargets and Therapy 2017, 10:47-54
Published Date: 19 December 2016
Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP
Lei R, Xue M, Zhang L, Lin ZQ
OncoTargets and Therapy 2017, 10:35-46
Published Date: 19 December 2016
Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report
Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M
OncoTargets and Therapy 2017, 10:31-34
Published Date: 19 December 2016
Potential role of immunotherapy in advanced non-small-cell lung cancer
de Mello RA, Veloso AF, Esrom Catarina P, Nadine S, Antoniou G
OncoTargets and Therapy 2017, 10:21-30
Published Date: 16 December 2016
J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)
Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K
OncoTargets and Therapy 2017, 10:13-19
Published Date: 16 December 2016
Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients
Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:1-11
Published Date: 16 December 2016
Non-secretory multiple myeloma: from biology to clinical management
Dupuis MM, Tuchman SA
OncoTargets and Therapy 2016, 9:7583-7590
Published Date: 15 December 2016
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives
Mulet-Margalef N, Garcia-del-Muro X
OncoTargets and Therapy 2016, 9:7573-7582
Published Date: 15 December 2016
Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner
Cheng G, Yang S, Zhang G, Xu Y, Liu X, Sun W, Zhu L
OncoTargets and Therapy 2016, 9:7563-7571
Published Date: 14 December 2016
Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient
Ju F
OncoTargets and Therapy 2016, 9:7555-7561
Published Date: 13 December 2016
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role
Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E
OncoTargets and Therapy 2016, 9:7545-7553
Published Date: 13 December 2016
The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning
Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R
OncoTargets and Therapy 2016, 9:7537-7544
Published Date: 12 December 2016
A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience
Ranieri G, Niccoli Asabella A, Altini C, Fazio V, Caporusso L, Marech I, Vinciarelli G, Macina F, de Ceglia D, Fanelli M, Ammendola M, Rubini G, Gadaleta CD
OncoTargets and Therapy 2016, 9:7527-7535
Published Date: 12 December 2016
β-Elemene treatment of glioblastoma: a single-center retrospective study
Ma C, Zhou W, Yan Z, Qu M, Bu X
OncoTargets and Therapy 2016, 9:7521-7526
Published Date: 12 December 2016
Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer
He W, Li W, Jiang B, Chang L, Jin C, Tu C, Li Y
OncoTargets and Therapy 2016, 9:7515-7520
Published Date: 12 December 2016
Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells
Souza e Silva V, Chinen LTD, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino ALA, Mello CAL, Alves VS, Fanelli MF
OncoTargets and Therapy 2016, 9:7503-7513
Published Date: 13 December 2016
Overexpression and clinical significance of MYC-associated zinc finger protein in pancreatic carcinoma
Zhu X, Luo W, Liang W, Tang F, Bei C, Ren Y, Qin L, Tan C, Zhang Y, Tan S
OncoTargets and Therapy 2016, 9:7493-7501
Published Date: 12 December 2016
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells
Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M
OncoTargets and Therapy 2016, 9:7481-7492
Published Date: 12 December 2016
Biomarkers in pancreatic adenocarcinoma: current perspectives
Swords DS, Firpo MA, Scaife CL, Mulvihill SJ
OncoTargets and Therapy 2016, 9:7459-7467
Published Date: 9 December 2016
Comprehensive profile of differentially expressed circular RNAs reveals that hsa_circ_0000069 is upregulated and promotes cell proliferation, migration, and invasion in colorectal cancer
Guo J, Li J, Zhu C, Feng W, Shao J, Wan L, Huang M, He J
OncoTargets and Therapy 2016, 9:7451-7458
Published Date: 9 December 2016
Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements
Ocal N, Yildiz B, Karadurmus N, Dogan D, Ozaydin S, Ocal R, Ozturk M, Arpaci F, Bilgic H
OncoTargets and Therapy 2016, 9:7445-7450
Published Date: 9 December 2016
Omega-3 polyunsaturated fatty acids in the prevention of postoperative complications in colorectal cancer: a meta-analysis
Xie H, Chang Y
OncoTargets and Therapy 2016, 9:7435-7443
Published Date: 9 December 2016
Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients
Wen X, Lu F, Liu S
OncoTargets and Therapy 2016, 9:7425-7433
Published Date: 8 December 2016
Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population
Yan WY, Hu J, Xie L, Cheng L, Yang M, Li L, Shi J, Liu BR, Qian X
OncoTargets and Therapy 2016, 9:7415-7424
Published Date: 8 December 2016
Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis
Shi H, Wang X, Wang J, Pan J, Liu J, Ye B
OncoTargets and Therapy 2016, 9:7409-7414
Published Date: 8 December 2016
Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data
Liu Y, Ni R, Zhang H, Miao L, Wang J, Jia W, Wang Y
OncoTargets and Therapy 2016, 9:7397-7407
Published Date: 7 December 2016
Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran
Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S
OncoTargets and Therapy 2016, 9:7385-7395
Published Date: 7 December 2016
Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway
Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J, Jin R, Zhao C, Liang G
OncoTargets and Therapy 2016, 9:7373-7384
Published Date: 5 December 2016
Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma
Peng L, Yang G, Wu C, Wang WS, Wu J, Guo Z
OncoTargets and Therapy 2016, 9:7367-7372
Published Date: 2 December 2016
Next-generation sequencing: advances and applications in cancer diagnosis
Serratì S, De Summa S, Pilato B, Petriella D, Lacalamita R, Tommasi S, Pinto R
OncoTargets and Therapy 2016, 9:7355-7365
Published Date: 2 December 2016
Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches
Lakhlili W, Yasri A, Ibrahimi A
OncoTargets and Therapy 2016, 9:7345-7353
Published Date: 2 December 2016
History and progression of Fat cadherins in health and disease
Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q, Cai X
OncoTargets and Therapy 2016, 9:7337-7343
Published Date: 1 December 2016
Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
Yu H, Zhang LL, Du X, Sheng XG
OncoTargets and Therapy 2016, 9:7331-7335
Published Date: 1 December 2016
Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel
Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, Amanlou M
OncoTargets and Therapy 2016, 9:7315-7330
Published Date: 1 December 2016
Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics
Smaletz O, Chacón M, de Oliveira Koch L, de Carvalho Rocha DR, Cardoso FC
OncoTargets and Therapy 2016, 9:7309-7314
Published Date: 30 November 2016
Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1
Zhang J, Fu J, Pan Y, Zhang X, Shen L
OncoTargets and Therapy 2016, 9:7297-7307
Published Date: 1 December 2016
CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer
Yang K, Gao K, Hu G, Wen Y, Lin C, Li X
OncoTargets and Therapy 2016, 9:7285-7295
Published Date: 30 November 2016
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer
Garon EB, Neidhart JD, Gabrail NY, de Oliveira MR, Balkissoon J, Kabbinavar F
OncoTargets and Therapy 2016, 9:7275-7283
Published Date: 30 November 2016
Androgen deprivation therapy as backbone therapy in the management of prostate cancer
Merseburger AS, Alcaraz A, von Klot CA
OncoTargets and Therapy 2016, 9:7263-7274
Published Date: 29 November 2016
Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression
Xue F, Liu YH, Zhang HW, Wen Y, Yan L, Tang Q, Xiao EH, Zhang DY
OncoTargets and Therapy 2016, 9:7253-7261
Published Date: 28 November 2016
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma
Azzouqa AG, Stevenson JP
OncoTargets and Therapy 2016, 9:7247-7252
Published Date: 25 November 2016
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
Davidson M, Starling N
OncoTargets and Therapy 2016, 9:7235-7245
Published Date: 25 November 2016
Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage Ⅲ non–small cell lung cancer
Kong M, Hong SE
OncoTargets and Therapy 2016, 9:7227-7234
Published Date: 24 November 2016
E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol
Hu YX, He HL, Lu J, Wang Y, Xiao PF, Li JQ, Li J, Sun YN, Lv H, Fan JJ, Yao YH, Chai YH, Hu SY
OncoTargets and Therapy 2016, 9:7219-7225
Published Date: 22 November 2016
Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time
Baek N, Seo OW, Kim M, Hulme J, An SSA
OncoTargets and Therapy 2016, 9:7207-7218
Published Date: 22 November 2016
High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma
Na N, Si T, Huang Z, Miao B, Hong L, Li H, Qiu J, Qiu J
OncoTargets and Therapy 2016, 9:7199-7205
Published Date: 22 November 2016
Effect of smoking on the genetic makeup of toll-like receptors 2 and 6
Kohailan M, Alanazi M, Rouabhia M, Alamri A, Parine NR, Alhadheq A, Basavarajappa S, Abdullah Al-Kheraif AA, Semlali A
OncoTargets and Therapy 2016, 9:7187-7198
Published Date: 21 November 2016
The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma
Wang J, Wang SZ, Song XM, Zeng WJ, Wang SY, Chen F, Ding H
OncoTargets and Therapy 2016, 9:7177-7185
Published Date: 21 November 2016
Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
Liang P, Huang C, Liang S, Li Y, Huang S, Lian Z, Liu J, Tang Y, Lu H
OncoTargets and Therapy 2016, 9:7169-7175
Published Date: 18 November 2016
Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma
Wang QX, Chen ED, Cai YF, Zhou YL, Zheng ZC, Wang YH, Jin YX, Jin WX, Zhang XH, Wang OC
OncoTargets and Therapy 2016, 9:7161-7167
Published Date: 18 November 2016
BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy
Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK
OncoTargets and Therapy 2016, 9:7149-7159
Published Date: 12 December 2016
Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
Wu F, Lu H, Zhu S, Li Z, Zou L, Bai T, Chen J, Yang T, Liang S
OncoTargets and Therapy 2016, 9:7141-7147
Published Date: 1 December 2016
Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference
Kim MG, Ko M, Kim IW, Oh JM
OncoTargets and Therapy 2016, 9:7133-7139
Published Date: 18 November 2016
Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Suzuki SO, Iwaki T, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2016, 9:7123-7131
Published Date: 17 November 2016
Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells
Xie L, Zhao T, Cai J, Su Y, Wang Z, Dong W
OncoTargets and Therapy 2016, 9:7115-7122
Published Date: 17 November 2016
Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases
Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G
OncoTargets and Therapy 2016, 9:7105-7114
Published Date: 17 November 2016
A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
Frithiof H, Aaltonen K, Ryden L
OncoTargets and Therapy 2016, 9:7095-7103
Published Date: 16 November 2016
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial
Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL
OncoTargets and Therapy 2016, 9:7081-7093
Published Date: 16 November 2016
Lrig1 is a positive prognostic marker in hepatocellular carcinoma
Yang B, Dai C, Tan RM, Zhang B, Meng X, Ye J, Wang XQ, Wei L, He F, Chen ZS
OncoTargets and Therapy 2016, 9:7071-7079
Published Date: 15 November 2016
Meta-analysis of outcomes of patients with stage IV colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection
Lee KC, Ou YC, Hu WH, Liu CC, Chen HH
OncoTargets and Therapy 2016, 9:7059-7069
Published Date: 15 November 2016
MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1
Xu D, Chen XF, He QY, Luo CQ
OncoTargets and Therapy 2016, 9:7047-7057
Published Date: 15 November 2016
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
Yang F, Lv S, Lv L, Liu Y, Dong S, Yao Z, Dai X, Zhang X, Wang O
OncoTargets and Therapy 2016, 9:7039-7045
Published Date: 15 November 2016
Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma
Lin M, Tian MM, Zhang WP, Xu L, Jin P
OncoTargets and Therapy 2016, 9:7029-7037
Published Date: 14 November 2016
ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
Chen L, Liu MM, Liu H, Lu D, Zhao XD, Yang XJ
OncoTargets and Therapy 2016, 9:7019-7028
Published Date: 14 November 2016
CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma
Yi W, Liu ZG, Li X, Tang J, Jiang CB, Hu JY, Tu ZW, Wang H, Niu DL, Xia YF
OncoTargets and Therapy 2016, 9:7011-7017
Published Date: 14 November 2016
MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1
Hu ZL, Cui YH, Zhou YH, Zhou KY, Qiao XQ, Li CQ, Wang S
OncoTargets and Therapy 2016, 9:6999-7009
Published Date: 14 November 2016
The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
Zhai R, Tang F, Gong JH, Zhang J, Lei B, Li B, Wei YC, Liang XS, Tang B, He SQ
OncoTargets and Therapy 2016, 9:6987-6998
Published Date: 24 November 2016
Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis
Yang X, Yang L, Dai W, Ye B
OncoTargets and Therapy 2016, 9:6977-6985
Published Date: 11 November 2016
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
Su X, Jiang X, Wang W, Wang H, Xu X, Lin A, Teng X, Wu H, Teng L
OncoTargets and Therapy 2016, 9:6965-6976
Published Date: 11 November 2016
Portulacerebroside A inhibits adhesion, migration, and invasion of human leukemia HL60 cells and U937 cells through the regulation of p38/JNK signaling pathway
Ye QD, Liao XL, Fu P, Dou JY, Chen K, Jiang H
OncoTargets and Therapy 2016, 9:6953-6963
Published Date: 11 November 2016
Comparison of internal target volumes defined on 3-dimensional, 4-dimensonal, and cone-beam CT images of non-small-cell lung cancer
Li F, Li J, Ma Z, Zhang Y, Xing J, Qi H, Shang D
OncoTargets and Therapy 2016, 9:6945-6951
Published Date: 17 November 2016
Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion
Chen B, Xia L, Xu C, Xiao F, Wang Y
OncoTargets and Therapy 2016, 9:6935-6943
Published Date: 9 November 2016
Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells
Pileczki V, Pop L, Braicu C, Budisan L, Bolba Morar G, del C Monroig-Bosque P, Sandulescu RV, Berindan-Neagoe I
OncoTargets and Therapy 2016, 9:6921-6933
Published Date: 11 November 2016
A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma
Zhao YY, Liu L, Zhou T, Zhou NN, Yang YP, Hou X, Li Y, Zhao HY, Huang Y, Zhang L
OncoTargets and Therapy 2016, 9:6915-6920
Published Date: 8 November 2016
miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition
Zhang XG, Zhang T, Yang K, Zhang MH, Wang KM
OncoTargets and Therapy 2016, 9:6909-6914
Published Date: 8 November 2016
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ
OncoTargets and Therapy 2016, 9:6897-6907
Published Date: 10 November 2016
Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer
Lee AR, Park J, Jung KJ, Jee SH, Kim-Yoon SJ
OncoTargets and Therapy 2016, 9:6885-6895
Published Date: 7 November 2016
Hürthle cell carcinoma: current perspectives
Ahmadi S, Stang M, Jiang XS, Sosa JA
OncoTargets and Therapy 2016, 9:6873-6884
Published Date: 7 November 2016
NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q
OncoTargets and Therapy 2016, 9:6865-6871
Published Date: 7 November 2016
FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma
El-Hamamsy M, Ghali RR, Saad AS, Shaheen SM, Salem AM
OncoTargets and Therapy 2016, 9:6857-6863
Published Date: 7 November 2016
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma
Jeannot V, Busser B, Vanwonterghem L, Michallet S, Ferroudj S, Cokol M, Coll JL, Ozturk M, Hurbin A
OncoTargets and Therapy 2016, 9:6843-6855
Published Date: 9 November 2016
Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
Xu Y, Guo Q, Lin J, Chen B, Wen J, Lu T, Xu Y, Zhang M, Pan J, Lin S
OncoTargets and Therapy 2016, 9:6835-6841
Published Date: 4 November 2016
Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management
Wu S, Mo M, Wang Y, Zhang N, Li J, Di G, Shao Z, Wu J, Liu G
OncoTargets and Therapy 2016, 9:6829-6834
Published Date: 4 November 2016
Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
Iovanescu D, Frandes M, Lungeanu D, Burlea A, Miutescu BP, Miutescu E
OncoTargets and Therapy 2016, 9:6819-6828
Published Date: 4 November 2016
Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography
Wang XF, Li KG, Sun HR, Zhao JL, Zheng LF, Zhang ZL, Bai RJ, Zhang GX
OncoTargets and Therapy 2016, 9:6809-6817
Published Date: 3 November 2016
Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis
Yang Y, Xiong Y, Li J, Wu C, Jiang J
OncoTargets and Therapy 2016, 9:6801-6808
Published Date: 3 November 2016
Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials
Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y
OncoTargets and Therapy 2016, 9:6795-6800
Published Date: 7 November 2016
Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking
Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N
OncoTargets and Therapy 2016, 9:6785-6794
Published Date: 2 November 2016
Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study
Luo Y, Ren J, Zhou P, Gao Y, Yang G, Lang J
OncoTargets and Therapy 2016, 9:6775-6783
Published Date: 1 November 2016
The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
Shen ZS, Zhou CC, Li JY, Deng HX, Li Q, Wang J
OncoTargets and Therapy 2016, 9:6763-6773
Published Date: 31 October 2016
Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis
Lv L, Hu WD, Ren YC, Wei XX
OncoTargets and Therapy 2016, 9:6751-6762
Published Date: 31 October 2016
Positive expression of KIF20A indicates poor prognosis of glioma patients
Duan J, Huang W, Shi H
OncoTargets and Therapy 2016, 9:6741-6749
Published Date: 2 November 2016
A current perspective on stereotactic body radiation therapy for pancreatic cancer
Hong JC, Czito BG, Willett CG, Palta M
OncoTargets and Therapy 2016, 9:6733-6739
Published Date: 31 October 2016
Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells
Zheng YP, Sun MM, Chen JY, He LL, Zhao N, Chen KS
OncoTargets and Therapy 2016, 9:6727-6732
Published Date: 31 October 2016
High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma
Zhang L, Xiu DR, Zhan J, He XK, Guo LM, Wang JL, Tao M, Fu W, Zhang HQ
OncoTargets and Therapy 2016, 9:6719-6726
Published Date: 31 October 2016
Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer
Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y
OncoTargets and Therapy 2016, 9:6711-6718
Published Date: 31 October 2016
Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis
Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X
OncoTargets and Therapy 2016, 9:6701-6710
Published Date: 28 October 2016
Efficacy and toxicities of adding molecular targeted agents to first-line chemotherapy in the treatment of advanced biliary tract cancer: a systematic review and meta-analysis
Zhao S, Miao Y, Wang R, Guo H, Jin F, Guo X, Luo T
OncoTargets and Therapy 2016, 9:6695-6700
Published Date: 28 October 2016
Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients
Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H
OncoTargets and Therapy 2016, 9:6689-6693
Published Date: 28 October 2016
Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression
Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H
OncoTargets and Therapy 2016, 9:6679-6687
Published Date: 28 October 2016
Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis
Artene S, Turcu-Stiolica A, Hartley R, Ciurea ME, Daianu O, Brindusa C, Alexandru O, Tataranu LG, Purcaru SO, Dricu A
OncoTargets and Therapy 2016, 9:6669-6677
Published Date: 4 November 2016
SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
Komiya K, Nakamura T, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N
OncoTargets and Therapy 2016, 9:6663-6668
Published Date: 27 October 2016
The medicinal fungus Antrodia cinnamomea regulates DNA repair and enhances the radiosensitivity of human esophageal cancer cells
Liu YM, Liu YK, Wang LW, Huang YC, Huang PI, Tsai TH, Chen YJ
OncoTargets and Therapy 2016, 9:6651-6661
Published Date: 27 October 2016
Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects
Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y
OncoTargets and Therapy 2016, 9:6641-6650
Published Date: 27 October 2016
MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin
Qiang R, Cai N, Wang X, Wang L, Cui K, Wang X, Li X
OncoTargets and Therapy 2016, 9:6631-6640
Published Date: 28 October 2016
BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer
Zhao H, Wang WL, Zhao QH, Hu GM, Deng KH, Liu YL
OncoTargets and Therapy 2016, 9:6619-6629
Published Date: 26 October 2016
Inhibitory effects of silibinin on proliferation and lung metastasis of human high metastasis cell line of salivary gland adenoid cystic carcinoma via autophagy induction
Jiang C, Jin S, Jiang Z, Wang J
OncoTargets and Therapy 2016, 9:6609-6618
Published Date: 26 October 2016
Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis
Ye CY, Wang J, Zheng S, Chai Y
OncoTargets and Therapy 2016, 9:6605-6608
Published Date: 26 October 2016
miR-497 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1
Zhang N, Shen Q, Zhang P
OncoTargets and Therapy 2016, 9:6597-6604
Published Date: 25 October 2016
The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer
Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D
OncoTargets and Therapy 2016, 9:6581-6595
Published Date: 25 October 2016
Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease
Hua J, Ding T, Yang L
OncoTargets and Therapy 2016, 9:6573-6579
Published Date: 25 October 2016
Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y
OncoTargets and Therapy 2016, 9:6569-6572
Published Date: 25 October 2016
Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia
Maklad AM, Bayoumi Y, Senosy Hassan MA, Elawadi AA, AlHussain H, Elyamany A, Aldhahri SF, Al-Qahtani KH, AlQahtani M, Tunio MA
OncoTargets and Therapy 2016, 9:6561-6567
Published Date: 25 October 2016
Cell-free DNA as a diagnostic marker for cancer: current insights
Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V
OncoTargets and Therapy 2016, 9:6549-6559
Published Date: 25 October 2016
WISP-1 overexpression upregulates cell proliferation in human salivary gland carcinomas via regulating MMP-2 expression
Li FJ, Wang XJ, Zhou XL
OncoTargets and Therapy 2016, 9:6539-6548
Published Date: 21 October 2016
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer
Jin F, Han A, Shi F, Kong L, Yu J
OncoTargets and Therapy 2016, 9:6529-6537
Published Date: 21 October 2016
Novel therapeutic strategies for patients with triple-negative breast cancer
Zhang JF, Liu J, Wang Y, Zhang B
OncoTargets and Therapy 2016, 9:6519-6528
Published Date: 21 October 2016
High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells
Chen X, Zhang Q, Luo Y, Gao C, Zhuang X, Xu G, Qaio T
OncoTargets and Therapy 2016, 9:6511-6518
Published Date: 21 October 2016
The diagnostic value of 99TcM-2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl dihydrogen phosphate hypoxia imaging and its evaluation performance for radiotherapy efficacy in non-small-cell lung cancer
Yang Y, Han G, Xu W
OncoTargets and Therapy 2016, 9:6499-6509
Published Date: 21 October 2016
Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines
Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M
OncoTargets and Therapy 2016, 9:6485-6498
Published Date: 20 October 2016
The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China
Xu J, Ding G, Zhang X, Jin B, Lou Y, Zhang Y, Wang H, Wu D, Han B
OncoTargets and Therapy 2016, 9:6479-6484
Published Date: 20 October 2016
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R
OncoTargets and Therapy 2016, 9:6467-6477
Published Date: 20 October 2016
Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis
Maimaiti Y, Liu ZM, Tan J, Abudureyimu K, Huang BX, Liu CP, Guo YW, Wang CW, Nie X, Zhou J, Huang T
OncoTargets and Therapy 2016, 9:6461-6466
Published Date: 19 October 2016
Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gels
Patel DH, Sharma N
OncoTargets and Therapy 2016, 9:6445-6459
Published Date: 19 October 2016
Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database
Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY
OncoTargets and Therapy 2016, 9:6435-6444
Published Date: 19 October 2016
Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
Mürtz P, Penner AH, Pfeiffer AK, Sprinkart AM, Pieper CC, König R, Block W, Schild HH, Willinek WA, Kukuk GM
OncoTargets and Therapy 2016, 9:6425-6433
Published Date: 19 October 2016
Prognostic nutritional index serves as a predicative marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2016, 9:6417-6423
Published Date: 19 October 2016
Double-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data sets
Yang F, Shao ZM
OncoTargets and Therapy 2016, 9:6407-6415
Published Date: 25 October 2016
Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma
He HT, Xu M, Kuang Y, Han XY, Wang MQ, Yang Q
OncoTargets and Therapy 2016, 9:6399-6406
Published Date: 18 October 2016
Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma
Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ
OncoTargets and Therapy 2016, 9:6389-6397
Published Date: 17 October 2016
Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus
Wang S, Shu J, Chen L, Chen X, Zhao J, Li S, Mou X, Tong X
OncoTargets and Therapy 2016, 9:6381-6388
Published Date: 17 October 2016
miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer [Retraction]
Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L
OncoTargets and Therapy 2016, 9:6379-6380
Published Date: 20 October 2016
MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction]
Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY
OncoTargets and Therapy 2016, 9:6377-6378
Published Date: 20 October 2016
Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice
Passaro A, Lazzari C, Karachaliou N, Spitaleri G, Pochesci A, Catania C, Rosell R, de Marinis F
OncoTargets and Therapy 2016, 9:6361-6376
Published Date: 17 October 2016
Cancer: fundamentals behind pH targeting and the double-edged approach
Koltai T
OncoTargets and Therapy 2016, 9:6343-6360
Published Date: 17 October 2016
Rare frequency of gene variation and survival analysis in thymic epithelial tumors
Song Z, Yu X, Zhang Y
OncoTargets and Therapy 2016, 9:6337-6342
Published Date: 14 October 2016
Alveolar rhabdomyosarcoma of the sphenoid sinus mimicking optic neuritis presenting with intermittent visual loss in an adult
Liu W, Jiang L, Jin Y, Yang BT, Lai TYY
OncoTargets and Therapy 2016, 9:6333-6336
Published Date: 14 October 2016
hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A
OncoTargets and Therapy 2016, 9:6325-6332
Published Date: 14 October 2016
18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients
Bai L, Guo CH, Wang JS, Liu X, Li Y, Li M, Guo YM, Duan XY
OncoTargets and Therapy 2016, 9:6315-6324
Published Date: 14 October 2016
Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience
Lin L, Zhao J, Hu J, Huang F, Han J, He Y, Cao X
OncoTargets and Therapy 2016, 9:6305-6314
Published Date: 14 October 2016
Prognostic value of endocan expression in cancers: evidence from meta-analysis
Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L
OncoTargets and Therapy 2016, 9:6297-6304
Published Date: 13 October 2016
Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review
Qi D, Feng L, Li J, Liu B, Zhang Q
OncoTargets and Therapy 2016, 9:6291-6296
Published Date: 13 October 2016
Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR
OncoTargets and Therapy 2016, 9:6281-6290
Published Date: 13 October 2016
CT-detected solitary thyroid calcification: an important imaging feature for papillary carcinoma
Yang T, Huang Y, Jing X, Gai X, Li W
OncoTargets and Therapy 2016, 9:6273-6279
Published Date: 13 October 2016
Locally advanced rectal cancer: management challenges
Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J
OncoTargets and Therapy 2016, 9:6265-6272
Published Date: 13 October 2016
Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis
Song J, Shi W, Zhang Y, Sun M, Liang X, Zheng S
OncoTargets and Therapy 2016, 9:6257-6263
Published Date: 12 October 2016
miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process
Pan Y, Zhang J, Fu H, Shen L
OncoTargets and Therapy 2016, 9:6247-6255
Published Date: 11 October 2016
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2016, 9:6233-6246
Published Date: 11 October 2016
Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma
Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L
OncoTargets and Therapy 2016, 9:6225-6231
Published Date: 11 October 2016
Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis
Yu H, Li H, Zhang J, Liu G
OncoTargets and Therapy 2016, 9:6211-6224
Published Date: 11 October 2016
miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer
He S, Zhang G, Dong H, Ma M, Sun Q
OncoTargets and Therapy 2016, 9:6203-6210
Published Date: 11 October 2016
Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells
Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ
OncoTargets and Therapy 2016, 9:6195-6201
Published Date: 11 October 2016
Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
Zhu S, Miao CW, Wang ZT, Peng L, Li B
OncoTargets and Therapy 2016, 9:6187-6193
Published Date: 13 October 2016
Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation
Meng L, Xu Y, Xu C, Zhang W
OncoTargets and Therapy 2016, 9:6177-6185
Published Date: 11 October 2016
Invasive atypical thymic carcinoid: three case reports and literature review
Zhu S, Wang Z, Liu W, Zong S, Li B
OncoTargets and Therapy 2016, 9:6171-6176
Published Date: 11 October 2016
The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
Zhang B, Zhao L, Yuan Z, Pang Q, Wang P
OncoTargets and Therapy 2016, 9:6161-6169
Published Date: 11 October 2016
miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52
Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN
OncoTargets and Therapy 2016, 9:6151-6160
Published Date: 11 October 2016
Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma
Luo J, Cao C, Zhu Y, Liu P, Liu L, Lu K, Zhang N, Zhou N
OncoTargets and Therapy 2016, 9:6147-6150
Published Date: 11 October 2016
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer
Wu JY, Shih JY
OncoTargets and Therapy 2016, 9:6137-6145
Published Date: 11 October 2016
Prognostic value of microRNA-126 and CRK expression in gastric cancer
Yue S, Shi H, Han J, Zhang T, Zhu W, Zhang D
OncoTargets and Therapy 2016, 9:6127-6135
Published Date: 11 October 2016
Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
Boér K
OncoTargets and Therapy 2016, 9:6119-6125
Published Date: 11 October 2016
Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas
Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N, Ivanova N, Akshulakov S, Auezova L
OncoTargets and Therapy 2016, 9:6111-6117
Published Date: 11 October 2016
Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma YY, Wang W, Shao QS
OncoTargets and Therapy 2016, 9:6099-6109
Published Date: 7 October 2016
Primary breast diffuse large B-cell lymphoma in the era of rituximab
Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, Luo J, Zhou N
OncoTargets and Therapy 2016, 9:6093-6097
Published Date: 7 October 2016
IL-10-1082A/G, -592C/A, and -819T/C polymorphisms in association with lung cancer susceptibility: a meta-analysis
Liu L, Zheng F
OncoTargets and Therapy 2016, 9:6083-6091
Published Date: 7 October 2016
Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
Fan Y, Ma K, Wang C, Ning J, Hu Y, Dong D, Dong X, Geng Q, Li E, Wu Y
OncoTargets and Therapy 2016, 9:6075-6082
Published Date: 6 October 2016
New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?
Van Der Steen N, Caparello C, Rolfo C, Pauwels P, Peters GJ, Giovannetti E
OncoTargets and Therapy 2016, 9:6065-6074
Published Date: 6 October 2016
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
Kashima J, Okuma Y, Hishima T
OncoTargets and Therapy 2016, 9:6059-6063
Published Date: 12 October 2016
Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis
Yu D, Cao T, Han YD, Huang FS
OncoTargets and Therapy 2016, 9:6049-6057
Published Date: 5 October 2016
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
Weisel K
OncoTargets and Therapy 2016, 9:6037-6048
Published Date: 5 October 2016
Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
Sun SL, Wang FC, Dou HL, Zhang LQ, Li JW
OncoTargets and Therapy 2016, 9:6029-6036
Published Date: 5 October 2016
Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy
Wang X, Luo Y, Li M, Yan H, Sun M, Fan T
OncoTargets and Therapy 2016, 9:6021-6027
Published Date: 3 October 2016
miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway
Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong J, Feng J
OncoTargets and Therapy 2016, 9:6009-6019
Published Date: 3 October 2016
Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer
Liu F, Ai F, Tian L, Liu S, Zhao L, Wang X
OncoTargets and Therapy 2016, 9:5999-6008
Published Date: 3 October 2016
CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma
Li L, Li Y, Zhao J, Fan S, Wang L, Li X
OncoTargets and Therapy 2016, 9:5985-5997
Published Date: 29 September 2016
Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study
Huang C, Wang YN, Fan H, Ma X, Tang R, Huan XK, Zhu Y, Xu ZK, Xu H, Yang L
OncoTargets and Therapy 2016, 9:5975-5983
Published Date: 29 September 2016
Expression of OVOL2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma
Fu H, Qi L, Chen L, He Y, Zhang N, Guo H
OncoTargets and Therapy 2016, 9:5963-5973
Published Date: 29 September 2016
Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma
Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ
OncoTargets and Therapy 2016, 9:5955-5961
Published Date: 28 September 2016
BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
Abedin SM, Boddy CS, Munshi HG
OncoTargets and Therapy 2016, 9:5943-5953
Published Date: 28 September 2016
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches
Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE III
OncoTargets and Therapy 2016, 9:5931-5941
Published Date: 29 September 2016
The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study
Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY
OncoTargets and Therapy 2016, 9:5919-5929
Published Date: 27 September 2016
Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: gene expression and apoptosis study
Jalili A, Irani S, Mirfakhraie R
OncoTargets and Therapy 2016, 9:5911-5917
Published Date: 28 September 2016
Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma
Dong XJ, Li X, Yu J, Yu MA, Yu XL, Liang P
OncoTargets and Therapy 2016, 9:5903-5909
Published Date: 26 September 2016
Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study
Wang Y, Sun XR, Feng WM, Bao Y, Zheng YY
OncoTargets and Therapy 2016, 9:5897-5902
Published Date: 26 September 2016
Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification
Ren T, Lin SD, Wang ZF, Shang AJ
OncoTargets and Therapy 2016, 9:5883-5895
Published Date: 27 September 2016
Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy
Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ
OncoTargets and Therapy 2016, 9:5875-5881
Published Date: 26 September 2016
The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
Huang J, Zhang Y, Sheng J, Zhang H, Fang W, Zhan J, Zhou T, Chen Y, Liu L, Zhang L
OncoTargets and Therapy 2016, 9:5867-5874
Published Date: 23 September 2016
Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date
Vachhani P, Chen H
OncoTargets and Therapy 2016, 9:5855-5866
Published Date: 23 September 2016
Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals
Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KRM, Junqueira MS, Bernardes ES, da Silva EO, Tavares MIB, Santos-Oliveira R
OncoTargets and Therapy 2016, 9:5847-5854
Published Date: 23 September 2016
Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma
Barrios CH, Herchenhorn D, Chacón M, Cabrera-Galeana P, Sajben P, Zhang K
OncoTargets and Therapy 2016, 9:5839-5845
Published Date: 23 September 2016
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
Yu SS, Quinn DI, Dorff TB
OncoTargets and Therapy 2016, 9:5825-5837
Published Date: 23 September 2016
An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter
Janczak D, Pawlowski W, Dorobisz T, Janczak D, Dorobisz K, Leśniak M, Ziomek A, Chabowski M
OncoTargets and Therapy 2016, 9:5819-5823
Published Date: 22 September 2016
Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors
Yıldız Y, Sokmensuer C, Yalcin S
OncoTargets and Therapy 2016, 9:5809-5817
Published Date: 22 September 2016
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
Xing J, Luo Y, Wang X, Gao M, Sun M, Ding X, Fan T, Yu J
OncoTargets and Therapy 2016, 9:5803-5808
Published Date: 22 September 2016
A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature
Zhang C, Zhang W, Mu D, Shi X, Zhao L
OncoTargets and Therapy 2016, 9:5797-5802
Published Date: 22 September 2016
Apparent diffusion coefficient values detected by diffusion-weighted imaging in the prognosis of patients with locally advanced esophageal squamous cell carcinoma receiving chemoradiation
Liu S, Zhen F, Sun N, Chen J, Cao Y, Zhang S, Cheng H, Ge X, Sun X
OncoTargets and Therapy 2016, 9:5791-5796
Published Date: 21 September 2016
A case report and literature review of primary resistant Hodgkin lymphoma: a response to anti-PD-1 after failure of autologous stem cell transplantation and brentuximab vedotin
Xu PP, Wang F, Guan CY, Ouyang J, Shao XY, Chen B
OncoTargets and Therapy 2016, 9:5781-5789
Published Date: 21 September 2016
Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis
Xiao J, Zou Y, Lu X, Xie B, Yu Q, He B, He B, Chen Q
OncoTargets and Therapy 2016, 9:5771-5779
Published Date: 21 September 2016
Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer
Wang X, Teng F, Kong L, Yu J
OncoTargets and Therapy 2016, 9:5761-5770
Published Date: 20 September 2016
The expression of NEDD9 and E-cadherin correlates with metastasis and poor prognosis in triple-negative breast cancer patients
Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D
OncoTargets and Therapy 2016, 9:5751-5759
Published Date: 19 September 2016
The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer
Jiang HC, Chen CS, Sun QM, Wu J, Qiu LJ, Gao CE, Liu WQ, Yang J, Jun N, Dong J
OncoTargets and Therapy 2016, 9:5737-5750
Published Date: 26 September 2016
Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study
Chen XR, Liang JZ, Ma SX, Fang WF, Zhou NN, Liao H, Li DL, Chen LK
OncoTargets and Therapy 2016, 9:5729-5736
Published Date: 19 September 2016
Proton beam therapy: clinical utility and current status in prostate cancer
Yamoah K, Johnstone PA
OncoTargets and Therapy 2016, 9:5721-5727
Published Date: 16 September 2016
A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer
Zhai N, Xia Y, Yin R, Liu J, Gao F
OncoTargets and Therapy 2016, 9:5713-5720
Published Date: 16 September 2016
Identifying module biomarkers from gastric cancer by differential correlation network
Liu X, Chang X
OncoTargets and Therapy 2016, 9:5701-5711
Published Date: 19 September 2016
Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients [Retraction]
Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L
OncoTargets and Therapy 2016, 9:5699-5700
Published Date: 20 September 2016
Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
Ai D, Guan Y, Liu XJ, Zhang CF, Wang P, Liang HL, Guo QS
OncoTargets and Therapy 2016, 9:5693-5698
Published Date: 16 September 2016
MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma
Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng HX, Hu XX, Wang SK
OncoTargets and Therapy 2016, 9:5679-5692
Published Date: 15 September 2016
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
Doan HQ, Silapunt S, Migden MR
OncoTargets and Therapy 2016, 9:5671-5678
Published Date: 14 September 2016
Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
Wang HY, Yao ZH, Tang H, Zhao Y, Zhang XS, Yao SN, Yang SJ, Liu YY
OncoTargets and Therapy 2016, 9:5663-5669
Published Date: 23 September 2016
Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
Tian C, Zhang Y
OncoTargets and Therapy 2016, 9:5659-5661
Published Date: 13 September 2016
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass
Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T
OncoTargets and Therapy 2016, 9:5651-5657
Published Date: 13 September 2016
The association of PTEN hypermethylation and breast cancer: a meta-analysis
Luo S, Chen J, Mo X
OncoTargets and Therapy 2016, 9:5643-5650
Published Date: 12 September 2016
Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas
Halani SH, Adamson DC
OncoTargets and Therapy 2016, 9:5629-5642
Published Date: 12 September 2016
Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survival
Thomas C, Movva S
OncoTargets and Therapy 2016, 9:5619-5627
Published Date: 9 September 2016
Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms
Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG
OncoTargets and Therapy 2016, 9:5611-5617
Published Date: 9 September 2016
Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients
Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C
OncoTargets and Therapy 2016, 9:5603-5609
Published Date: 9 September 2016
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, She J, Yuan J, Wu X
OncoTargets and Therapy 2016, 9:5597-5602
Published Date: 9 September 2016
Role of post mastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
Cihan YB, Sarigoz T
OncoTargets and Therapy 2016, 9:5587-5595
Published Date: 9 September 2016
Proton therapy for early stage prostate cancer: is there a case?
Chan TY, Tan PW, Tang JI
OncoTargets and Therapy 2016, 9:5577-5586
Published Date: 9 September 2016
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
Wei BJ, Yao MY, Xing CY, Wang W, Yao J, Hong Y, Liu Y, Fu PF
OncoTargets and Therapy 2016, 9:5567-5575
Published Date: 8 September 2016
Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program
Koh YV, Tan PW, Buhari SA, Iau P, Chan CW, Shen L, Tan SH, Tang JI
OncoTargets and Therapy 2016, 9:5561-5566
Published Date: 8 September 2016
Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
Xian Y, Zhang S, Wang X, Qin J, Wang W, Wu H
OncoTargets and Therapy 2016, 9:5553-5560
Published Date: 7 September 2016
The clinical effects of low-dose splenic irradiation combined with chest three-dimensional conformal radiotherapy on patients with locally advanced non-small-cell lung cancer: a randomized clinical trial
Yu H, Qu Y, Shang Q, Yan C, Jiang P, Wang X, Liang D, Jiang T
OncoTargets and Therapy 2016, 9:5545-5552
Published Date: 7 September 2016
Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity
Assadi A, Najafabadi VS, Shandiz SAS, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SES, Pirali-Hamedani M, Ardestani MS
OncoTargets and Therapy 2016, 9:5531-5543
Published Date: 7 September 2016
Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socio-economic changes
Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A, Czerw A
OncoTargets and Therapy 2016, 9:5521-5530
Published Date: 7 September 2016
Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population
Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH
OncoTargets and Therapy 2016, 9:5513-5519
Published Date: 7 September 2016
Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report
Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A
OncoTargets and Therapy 2016, 9:5507-5511
Published Date: 7 September 2016
Sunitinib: the antiangiogenic effects and beyond
Hao Z, Sadek I
OncoTargets and Therapy 2016, 9:5495-5505
Published Date: 8 September 2016
Osimertinib making a breakthrough in lung cancer targeted therapy
Zhang H
OncoTargets and Therapy 2016, 9:5489-5493
Published Date: 6 September 2016
Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers
Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B
OncoTargets and Therapy 2016, 9:5483-5488
Published Date: 6 September 2016
A comparison study of pancreatic acinar cell carcinoma with ductal adenocarcinoma using computed tomography in Chinese patients
Wang Q, Wang X, Guo R, Li G
OncoTargets and Therapy 2016, 9:5475-5481
Published Date: 6 September 2016
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence
Wang X, Goldstein D, Crowe PJ, Yang JL
OncoTargets and Therapy 2016, 9:5461-5473
Published Date: 6 September 2016
Association between insulin-like growth factor-binding protein-3 polymorphism -202 A/C and the risk of prostate cancer: a meta-analysis
Qin Z, Li X, Tang J, Jiang X, Yu Y, Wang C, Xu W, Hua Y, Yu B, Zhang W
OncoTargets and Therapy 2016, 9:5451-5459
Published Date: 6 September 2016
Identifying candidate agents for lung adenocarcinoma by walking the human interactome
Sun Y, Zhang R, Jiang Z, Xia R, Zhang J, Liu J, Chen F
OncoTargets and Therapy 2016, 9:5439-5450
Published Date: 1 September 2016
Clinical potential of necitumumab in non-small cell lung carcinoma
Genova C, Hirsch FR
OncoTargets and Therapy 2016, 9:5427-5437
Published Date: 31 August 2016
Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial–mesenchymal transition
Cao D, Ding Q, Yu W, Gao M, Wang Y
OncoTargets and Therapy 2016, 9:5417-5425
Published Date: 30 August 2016
Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis
Wang H, Ma B, Gao P, Song Y, Xu Q, Hu Y, Zhang C, Wang Z
OncoTargets and Therapy 2016, 9:5405-5416
Published Date: 30 August 2016
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example
Gerratana L, De Maglio G, De Pellegrin A, Follador A, Rihawi K, Pizzolitto S, Puglisi F, Fasola G
OncoTargets and Therapy 2016, 9:5399-5404
Published Date: 30 August 2016
Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer
Lv S, Fang M, Yang J, Zhan W, Jia Y, Xu H, Song T
OncoTargets and Therapy 2016, 9:5389-5397
Published Date: 6 September 2016
Pitavastatin suppressed liver cancer cells in vitro and in vivo
You HY, Zhang WJ, Xie XM, Zheng ZH, Zhu HL, Jiang FZ
OncoTargets and Therapy 2016, 9:5383-5388
Published Date: 29 August 2016
Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
Feng J, Gou J, Jia J, Yi T, Cui T, Li Z
OncoTargets and Therapy 2016, 9:5371-5381
Published Date: 29 August 2016
Limb-salvage treatment of en-block resected distal femoral tumors with endoprosthesis of all-polyethylene tibial component: a 9-year follow-up study
Tang F, Zhou Y, Min L, Zhang WL, Shi R, Luo Y, Duan H, Tu CQ
OncoTargets and Therapy 2016, 9:5361-5369
Published Date: 13 September 2016
ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway
Jiang J, Liu Y, Tang Y, Li L, Zeng R, Zeng S, Zhong M
OncoTargets and Therapy 2016, 9:5349-5360
Published Date: 29 August 2016
The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
Song XY, Li BY, Zhou EX, Wu FX
OncoTargets and Therapy 2016, 9:5339-5347
Published Date: 26 August 2016
Knockdown of peroxisome proliferator-activated receptor gamma coactivator-1 alpha increased apoptosis of human endometrial cancer HEC-1A cells
Yang H, Yang R, Liu H, Ren Z, Wang C, Li D, Ma X
OncoTargets and Therapy 2016, 9:5329-5338
Published Date: 24 August 2016
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, Liu C
OncoTargets and Therapy 2016, 9:5317-5328
Published Date: 24 August 2016
Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL
OncoTargets and Therapy 2016, 9:5307-5316
Published Date: 24 August 2016
Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells
Zhu L, Huang FZ, Deng G, Nie W, Huang W, Xu HB, Zheng SP, Yi ZJ, Wan T
OncoTargets and Therapy 2016, 9:5297-5305
Published Date: 24 August 2016
Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1
Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T
OncoTargets and Therapy 2016, 9:5287-5295
Published Date: 24 August 2016
An isolated orbital mass with proptosis and diplopia: an uncommon metastasis from intracranial olfactory neuroblastoma in a Chinese patient
Shen JQ, Cui HG, Feng S
OncoTargets and Therapy 2016, 9:5281-5286
Published Date: 24 August 2016
Expression and prognostic significance of unique ULBPs in pancreatic cancer
Chen J, Zhu XX, Xu H, Fang HZ, Zhao JQ
OncoTargets and Therapy 2016, 9:5271-5279
Published Date: 25 August 2016
Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma
Guo HS, Xing YH, Mu AL, Li X, Li TS, Bian X, Yang CM, Zhang XL, Liu YF, Wang XG
OncoTargets and Therapy 2016, 9:5257-5270
Published Date: 25 August 2016
MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer
Liu D, Xia H, Wang F, Chen C, Long J
OncoTargets and Therapy 2016, 9:5245-5255
Published Date: 23 August 2016
Prognostic significance of TAZ expression in various cancers: a meta-analysis
Feng J, Ren P, Gou J, Li Z
OncoTargets and Therapy 2016, 9:5235-5244
Published Date: 23 August 2016
Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis
Xu Y, Yan C, Hao Z, Zhou J, Fan S, Tai S, Yang C, Zhang L, Liang C
OncoTargets and Therapy 2016, 9:5225-5233
Published Date: 22 August 2016
Evaluation of the characteristics of hepatic focal nodular hyperplasia: correlation between dynamic contrast-enhanced multislice computed tomography and pathological findings
Zhang HT, Gao XY, Xu QS, Chen YT, Song YP, Yao ZW
OncoTargets and Therapy 2016, 9:5217-5224
Published Date: 22 August 2016
Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis
Lei JY, Zhu JQ, Li ZH, Gong RX, Wei T
OncoTargets and Therapy 2016, 9:5209-5216
Published Date: 22 August 2016
B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer
Zhao Q, Gui T, Qian Q, Li L, Shen K
OncoTargets and Therapy 2016, 9:5203-5208
Published Date: 22 August 2016
Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT
Zhang Y, Huang SN, Leng YH, Chen X, Liu TT, Wang HL, Wei FL, Luo DZ, Chen G, Wei ZX
OncoTargets and Therapy 2016, 9:5195-5202
Published Date: 29 August 2016
MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway
Xiao J, Lin HY, Zhu YY, Zhu YP, Chen LW
OncoTargets and Therapy 2016, 9:5181-5193
Published Date: 22 August 2016
Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study
Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW
OncoTargets and Therapy 2016, 9:5163-5180
Published Date: 22 August 2016
EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy
Chang H, Oh J, Zhang X, Kim YJ, Lee JH, Lee CT, Chung JH, Lee JS
OncoTargets and Therapy 2016, 9:5153-5162
Published Date: 19 August 2016
Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma
Qu Z, Yuan CH, Yin CQ, Guan Q, Chen H, Wang FB
OncoTargets and Therapy 2016, 9:5143-5152
Published Date: 18 August 2016
Co-expression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance
Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC, Hu B
OncoTargets and Therapy 2016, 9:5133-5142
Published Date: 18 August 2016
Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma
Lv X, Xia WX, Ke LR, Yang J, Qiu WZ, Yu YH, Liang H, Huang XJ, Liu GY, Zeng Q, Guo X, Xiang YQ
OncoTargets and Therapy 2016, 9:5123-5131
Published Date: 18 August 2016
Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection
Gai XJ, Wei YM, Tao HM, An DZ, Sun JT, Li BS
OncoTargets and Therapy 2016, 9:5117-5121
Published Date: 17 August 2016
Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment
El-Osta HE, Shahid K, Mills GM, Peddi P
OncoTargets and Therapy 2016, 9:5101-5116
Published Date: 16 August 2016
MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK
Cheng Y, Zhang X, Li P, Yang C, Tang J, Deng X, Yang X, Tao J, Lu Q, Li P
OncoTargets and Therapy 2016, 9:5091-5099
Published Date: 16 August 2016
The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review
Han Y, Shi K, Zhou SJ, Yu DP, Liu ZD
OncoTargets and Therapy 2016, 9:5081-5090
Published Date: 16 August 2016
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C
OncoTargets and Therapy 2016, 9:5073-5080
Published Date: 12 August 2016
Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis
Huang WT, Chen ZX, He RQ, Wu YZ, Yin SY, Liang XN, Chen G, Yang H, Peng ZG, Yang LH
OncoTargets and Therapy 2016, 9:5061-5071
Published Date: 12 August 2016
Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X
OncoTargets and Therapy 2016, 9:5049-5059
Published Date: 12 August 2016
New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer
Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB
OncoTargets and Therapy 2016, 9:5041-5047
Published Date: 12 August 2016
PD-L1 expression in human cancers and its association with clinical outcomes
Wang X, Teng FF, Kong L, Yu JM
OncoTargets and Therapy 2016, 9:5023-5039
Published Date: 12 August 2016
Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model
Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH
OncoTargets and Therapy 2016, 9:5015-5022
Published Date: 12 August 2016
Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9
Wang T, Ma SC, Qi X, Tang X, Cui D, Wang Z, Chi J, Li P, Zhai B
OncoTargets and Therapy 2016, 9:5005-5014
Published Date: 12 August 2016
Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer
Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW
OncoTargets and Therapy 2016, 9:4993-5003
Published Date: 16 August 2016
Successful treatment of angiosarcoma of the scalp with apatinib: a case report
Ji G, Hong L, Yang P
OncoTargets and Therapy 2016, 9:4989-4992
Published Date: 11 August 2016
Clinical implications of transforming growth factor-beta–induced gene-h3 protein expression in lung cancer
He CJ, Sun DW, Bai X, Li YB, Xu H, Xu SD
OncoTargets and Therapy 2016, 9:4983-4987
Published Date: 11 August 2016
ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study
Sun SX, Wang ZH, Tang F, Hu PC, Yang ZT, Xue C, Gong J, Shi L, Xie CH
OncoTargets and Therapy 2016, 9:4975-4981
Published Date: 11 August 2016
Anorectal melanoma metastatic to the breast: a case report and review of the literature
Feng L, Qi DJ, Zhang QF
OncoTargets and Therapy 2016, 9:4969-4974
Published Date: 10 August 2016
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases
Zhang Y, Luo J, He RQ, Huang WT, Li ZY, Li P, Dang YW, Chen G, Li SK
OncoTargets and Therapy 2016, 9:4959-4968
Published Date: 10 August 2016
Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned
Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS
OncoTargets and Therapy 2016, 9:4937-4957
Published Date: 10 August 2016
Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting
Seber S, Solmaz D, Yetisyigit T
OncoTargets and Therapy 2016, 9:4929-4935
Published Date: 9 August 2016
A rare case report of primary bone lymphoma and a brief review of the literature
Wang J, Fan S, Liu J, Song B,
OncoTargets and Therapy 2016, 9:4923-4928
Published Date: 9 August 2016
Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
Ma C, Lu B, Diao C, Zhao K, Wang X, Ma B, Lu B, Sun E
OncoTargets and Therapy 2016, 9:4917-4922
Published Date: 8 August 2016
Incidental gallbladder cancer after cholecystectomy: 1990 to 2014
Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, Janczak D
OncoTargets and Therapy 2016, 9:4913-4916
Published Date: 8 August 2016
The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Zhang XL, Yu JM, Li MH, Zhu H, Sun XD, Kong L
OncoTargets and Therapy 2016, 9:4901-4911
Published Date: 8 August 2016
High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway
Yang XY, Zhang MY, Zhou Q, Wu SY, Zhao Y, Gu WY, Pan J, Cen JN, Chen ZX, Guo WG, Chen CS, Yan WH, Hu SY
OncoTargets and Therapy 2016, 9:4887-4899
Published Date: 8 August 2016
A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y
OncoTargets and Therapy 2016, 9:4879-4886
Published Date: 8 August 2016
Modulation of expression of the nuclear receptor NR0B2 (small heterodimer partner 1) and its impact on proliferation of renal carcinoma cells
Prestin K, Olbert M, Hussner J, Isenegger TL, Gliesche DG, Böttcher K, Zimmermann U, Meyer zu Schwabedissen HE
OncoTargets and Therapy 2016, 9:4867-4878
Published Date: 8 August 2016
Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer – SGC-7901cell line
Jiang Z, Liu Y, Wang C
OncoTargets and Therapy 2016, 9:4859-4866
Published Date: 9 August 2016
Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?
Thumallapally N, Yu H, Asti D, Vennepureddy A, Terjanian T
OncoTargets and Therapy 2016, 9:4843-4858
Published Date: 5 August 2016
Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
Xu W, Kuang M, Gong Y, Cao C, Chen J, Tang C
OncoTargets and Therapy 2016, 9:4833-4842
Published Date: 4 August 2016
PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis
Qian D, Cheng J, Ding X, Chen X, Chen X, Guan Y, Zhang B, Wang J, Er P, Qiu M, Zeng X, Guo Y, Wang H, Zhao L, Xie D, Yuan Z, Wang P, Pang Q
OncoTargets and Therapy 2016, 9:4821-4831
Published Date: 3 August 2016
A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S
OncoTargets and Therapy 2016, 9:4815-4820
Published Date: 3 August 2016
Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
Gu X, Gao XS, Xiong W, Guo W, Han L, Bai Y, Peng C, Cui M, Xie M
OncoTargets and Therapy 2016, 9:4805-4813
Published Date: 2 August 2016
Efficacy of targeted agents in the treatment of elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis
Chen J, Chen J, Wu X, Shi T, Kang M
OncoTargets and Therapy 2016, 9:4797-4803
Published Date: 2 August 2016
Cutaneous basal cell carcinoma arising within a keloid scar: a case report
Goder M, Kornhaber R, Bordoni D, Winkler E, Haik J, Tessone A
OncoTargets and Therapy 2016, 9:4793-4796
Published Date: 2 August 2016
Comparison of planning target volumes based on three-dimensional and four-dimensional CT imaging of thoracic esophageal cancer
Wang W, Li JB, Zhang YJ, Shao Q, Xu M, Fan TY, Wang JZ
OncoTargets and Therapy 2016, 9:4785-4791
Published Date: 2 August 2016
Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma
Chen YJ, Chen CC, Huang HL
OncoTargets and Therapy 2016, 9:4773-4783
Published Date: 1 August 2016
Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells
Zhang Y, Chang R, Li MQ, Zhao K, Zheng HZ, Zhou XD
OncoTargets and Therapy 2016, 9:4763-4771
Published Date: 1 August 2016
Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition
Zhang X, Wang P, Zhao L, Yuan Z, Wang P
OncoTargets and Therapy 2016, 9:4757-4762
Published Date: 29 July 2016
Oral administration of sunitinib malate for long-term survival of a patient with multiple lung metastases from renal leiomyosarcoma
Li X, Gao H, Tang C, Liu X
OncoTargets and Therapy 2016, 9:4753-4756
Published Date: 29 July 2016
Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study
Nakamura T, Matsumine A, Yamada S, Tsukushi S, Kawanami K, Ohno T, Katagiri H, Sugiura H, Yamada K, Yamada Y, Sudo A, Nishida Y
OncoTargets and Therapy 2016, 9:4747-4751
Published Date: 29 July 2016
Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis
Wang J, Zhu C
OncoTargets and Therapy 2016, 9:4737-4746
Published Date: 29 July 2016
RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines
Moela P, Motadi LR
OncoTargets and Therapy 2016, 9:4721-4735
Published Date: 29 July 2016
Primary yolk sac tumor of the gluteus: a case report and literature review
Li B, Jiang QQ, Zhang ST, Zhou Y, Zhang QF, OuYang L
OncoTargets and Therapy 2016, 9:4715-4719
Published Date: 2 August 2016
MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4
Yu M, Lin Y, Zhou Y, Jin H, Hou B, Wu Z, Li Z, Jian Z, Sun J
OncoTargets and Therapy 2016, 9:4705-4714
Published Date: 29 July 2016
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M
OncoTargets and Therapy 2016, 9:4695-4703
Published Date: 28 July 2016
The impact of the extent of surgical resection on survival of gastric cancer patients
Angelov KG, Vasileva MB, Grozdev KS, Toshev SY, Sokolov MB, Todorov GT
OncoTargets and Therapy 2016, 9:4687-4694
Published Date: 28 July 2016
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N
OncoTargets and Therapy 2016, 9:4681-4686
Published Date: 28 July 2016
Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
Tang N, Wang Z
OncoTargets and Therapy 2016, 9:4671-4679
Published Date: 27 July 2016
Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer
Sun X, Wang J, Liu J, Chen S, Liu X
OncoTargets and Therapy 2016, 9:4661-4669
Published Date: 27 July 2016
Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
Liu C, Huang Z, Wang QS, Sun B, Ding LJ, Meng XY, Wu SK
OncoTargets and Therapy 2016, 9:4653-4660
Published Date: 27 July 2016
Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients
Xia WK, Lin QF, Shen D, Liu ZL, Su J, Mao WD
OncoTargets and Therapy 2016, 9:4645-4652
Published Date: 26 July 2016
Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
Wang HY, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2016, 9:4639-4644
Published Date: 26 July 2016
MiR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2
Xu L, Shen B, Chen TT, Dong P
OncoTargets and Therapy 2016, 9:4629-4637
Published Date: 26 July 2016
Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study
Mu Y, Wang WH, Xie JP, Zhang YX, Yang YP, Zhou CH
OncoTargets and Therapy 2016, 9:4617-4627
Published Date: 25 July 2016
Identification of crucial microRNAs and genes in hypoxia-induced human lung adenocarcinoma cells
Geng Y, Deng L, Su D, Xiao J, Ge D, Bao Y, Jing H
OncoTargets and Therapy 2016, 9:4605-4616
Published Date: 25 July 2016
Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL
Xie ZB, Wang XB, Fu DL, Zhong JH, Yang XW, Li LQ
OncoTargets and Therapy 2016, 9:4593-4603
Published Date: 25 July 2016
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B
OncoTargets and Therapy 2016, 9:4583-4591
Published Date: 25 July 2016
Network analysis reveals potential markers for pediatric adrenocortical carcinoma
Kulshrestha A, Suman S, Ranjan R
OncoTargets and Therapy 2016, 9:4569-4581
Published Date: 26 July 2016
Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases
Yang Z, Dai HH, Lv DX, Feng AL, Shu WB, Han JQ
OncoTargets and Therapy 2016, 9:4561-4568
Published Date: 25 July 2016
Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposites
Namvar F, Azizi S, Rahman HS, Mohamad R, Rasedee A, Soltani M, Rahim RA
OncoTargets and Therapy 2016, 9:4549-4559
Published Date: 26 July 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-oesophageal junction adenocarcinoma
Davidson M, Smyth EC, Cunningham D
OncoTargets and Therapy 2016, 9:4539-4548
Published Date: 25 July 2016
The effect of clove-based herbal mouthwash on radiation-induced oral mucositis in patients with head and neck cancer: a single-blind randomized preliminary study
Kong M, Hwang DS, Yoon SW, Kim J
OncoTargets and Therapy 2016, 9:4533-4538
Published Date: 22 July 2016
Efficacy of pemetrexed-based regimen in relapsed advanced thymic epithelial tumors and its association with thymidylate synthase level
Qian X, Song Z
OncoTargets and Therapy 2016, 9:4527-4531
Published Date: 22 July 2016
Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies
Ma JT, Sun X, Huang LT, Xiong ZC, Yuan M, Zhang SL, Han CB
OncoTargets and Therapy 2016, 9:4517-4526
Published Date: 22 July 2016
MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
Zhao L, Zheng XY
OncoTargets and Therapy 2016, 9:4505-4516
Published Date: 22 July 2016
Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies
Jiang X, Zhang M, Bai XY, Li S, Wu H
OncoTargets and Therapy 2016, 9:4491-4503
Published Date: 22 July 2016
Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis
Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ
OncoTargets and Therapy 2016, 9:4483-4489
Published Date: 21 July 2016
Clinical significance of TIPE expression in gastric carcinoma
Hu R, Qiu X, Hong S, Meng L, Hong X, Qiu J, Yang J, Zhuang G, Liu Z
OncoTargets and Therapy 2016, 9:4473-4481
Published Date: 25 July 2016
Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery
Ammendola M, Sacco R, Sammarco G, Piardi T, Zuccalà V, Patruno R, Zullo A, Zizzo N, Nardo B, Marech I, Crovace A, Gadaleta CD, Pessaux P, Ranieri G
OncoTargets and Therapy 2016, 9:4465-4471
Published Date: 21 July 2016
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC, Huang HL
OncoTargets and Therapy 2016, 9:4453-4464
Published Date: 20 July 2016
Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
Pham PV, Le HT, Vu BT, Pham VQ, Le PM, Phan NLC, Trinh NV, Nguyen HTL, Nguyen ST, Nguyen TL, Phan NK
OncoTargets and Therapy 2016, 9:4441-4451
Published Date: 21 July 2016
Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature
Deptala A, Romanowicz A, Czerw A, Walecki J, Rogowski W, Nasierowska-Guttmejer A
OncoTargets and Therapy 2016, 9:4435-4440
Published Date: 20 July 2016
JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway
Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP
OncoTargets and Therapy 2016, 9:4425-4433
Published Date: 20 July 2016
Functions and mechanisms of long noncoding RNAs in lung cancer
Peng ZZ, Zhang CF, Duan CJ
OncoTargets and Therapy 2016, 9:4411-4424
Published Date: 20 July 2016
FAT10 is associated with the malignancy and drug resistance of non-small cell lung cancer
Xue F, Zhu L, Meng QW, Wang L, Chen XS, Zhao YB, Xing Y, Wang XY, Cai L
OncoTargets and Therapy 2016, 9:4397-4409
Published Date: 19 July 2016
MK-2206 co-treatment with 5-fluorouracil or doxorubicin enhances chemosensitivity and apoptosis in gastric cancer by attenuation of Akt phosphorylation
Jin PP, Wong CC, Mei SB, He XK, Qian Y, Sun LM
OncoTargets and Therapy 2016, 9:4387-4396
Published Date: 19 July 2016
The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer
Huang WS, Nie WW, Zhang WW, Wang YR, Zhu A, Guan XX
OncoTargets and Therapy 2016, 9:4377-4385
Published Date: 19 July 2016
Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies
Bai K, Cai Q, Jiang Y, Lv L
OncoTargets and Therapy 2016, 9:4369-4375
Published Date: 19 July 2016
Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: in vivo study
Ji JS, Xu M, Song JJ, Zhao ZW, Chen MJ, Chen WQ, Tu JF, Yang XM
OncoTargets and Therapy 2016, 9:4357-4367
Published Date: 19 July 2016
Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer
Ricciardi GR, Franchina T, Russo A, Schifano S, Ferraro G, Adamo V
OncoTargets and Therapy 2016, 9:4351-4355
Published Date: 21 July 2016
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
Lu X, Duan L, Xie H, Lu X, Lu D, Lu D, Jiang N, Chen Y
OncoTargets and Therapy 2016, 9:4343-4349
Published Date: 18 July 2016
Association between CD14 SNP -159 C/T and gastric cancer: an independent case–control study and an updated meta-analysis
Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY
OncoTargets and Therapy 2016, 9:4337-4342
Published Date: 18 July 2016
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
Pyszniak M, Tabarkiewicz J, Łuszczki JJ
OncoTargets and Therapy 2016, 9:4323-4336
Published Date: 18 July 2016
Ectopic micronodular thymoma with lymphoid stroma in the cervical region: a rare case associated with Langerhans cells proliferation
Yu M, Meng Y, Xu B, Zhao L, Zhang QF
OncoTargets and Therapy 2016, 9:4317-4322
Published Date: 18 July 2016
MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12
Liang T, Li L, Cheng Y, Ren C, Zhang G
OncoTargets and Therapy 2016, 9:4307-4315
Published Date: 15 July 2016
Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature
Zhu YC, Xu CW, Ye XQ, Yin MX, Zhang JX, Du KQ, Zhang ZH, Hu J
OncoTargets and Therapy 2016, 9:4301-4305
Published Date: 15 July 2016
Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor
Wang J, Li F, Dong Y, Song Y, Yuan Z
OncoTargets and Therapy 2016, 9:4295-4299
Published Date: 15 July 2016
Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma
Tang WW, Liu ZH, Yang TX, Wang HJ, Cao XF
OncoTargets and Therapy 2016, 9:4289-4293
Published Date: 14 July 2016
Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies
Wu JY, Hu LR, Chen MY, Cao WJ, Chen HC, He TP
OncoTargets and Therapy 2016, 9:4277-4288
Published Date: 14 July 2016
Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma
Shao JP, Meng QY, Li YY
OncoTargets and Therapy 2016, 9:4265-4275
Published Date: 14 July 2016
Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma
Sun P, Chen C, Zhang F, Yang H, Bi XW, An X, Wang FH, Jiang WQ
OncoTargets and Therapy 2016, 9:4257-4264
Published Date: 13 July 2016
Comparison of tumor markers using different detection devices [Retraction]
Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF
OncoTargets and Therapy 2016, 9:4255-4256
Published Date: 15 July 2016
Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis
Liu FT, Xue QZ, Zhu PQ, Luo HL, Zhang Y, Hao TF
OncoTargets and Therapy 2016, 9:4247-4254
Published Date: 12 July 2016
Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP
OncoTargets and Therapy 2016, 9:4239-4246
Published Date: 12 July 2016
Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial–mesenchymal transition, invasion, and metastasis in pancreatic cancer cells
Chen J, Wang S, Su J, Chu G, You H, Chen Z, Sun H, Chen B, Zhou M
OncoTargets and Therapy 2016, 9:4225-4237
Published Date: 11 July 2016
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B
OncoTargets and Therapy 2016, 9:4215-4224
Published Date: 11 July 2016
Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy
Bai H, Xu J, Yang H, Jin B, Lou Y, Wu D, Han B
OncoTargets and Therapy 2016, 9:4207-4213
Published Date: 11 July 2016
Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD
OncoTargets and Therapy 2016, 9:4197-4205
Published Date: 11 July 2016
Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
Zhu Y, Li M, Kong L, Yu J
OncoTargets and Therapy 2016, 9:4187-4196
Published Date: 11 July 2016
Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
Chen D, Song Z, Cheng G
OncoTargets and Therapy 2016, 9:4181-4186
Published Date: 8 July 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
von Au A, Milloth E, Diel I, Stefanovic S, Hennigs A, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C
OncoTargets and Therapy 2016, 9:4173-4180
Published Date: 8 July 2016
Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis
Qie YK, Nian XW, Liu XS, Hu HL, Zhang CW, Xie LG, Han RF, Wu CL, Xu Y
OncoTargets and Therapy 2016, 9:4163-4171
Published Date: 7 July 2016
Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer
Teng Y, Wang ZT, Ma L, Zhang L, Guo Y, Gu M, Wang ZY, Wang Y, Yue W
OncoTargets and Therapy 2016, 9:4151-4162
Published Date: 7 July 2016
Blood oxygenation level-dependent magnetic resonance imaging during carbogen breathing: differentiation between prostate cancer and benign prostate hyperplasia and correlation with vessel maturity
Di N, Mao N, Cheng W, Pang H, Ren Y, Wang N, Liu X, Wang B
OncoTargets and Therapy 2016, 9:4143-4150
Published Date: 7 July 2016
Fundamental effects of PD-1 antibody on the body: a brief report
Wang W, Liu B, Liu G, Guo W
OncoTargets and Therapy 2016, 9:4137-4141
Published Date: 7 July 2016
Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy
Chen ZS, Zhu SL, Qi LN, Li LQ
OncoTargets and Therapy 2016, 9:4129-4135
Published Date: 6 July 2016
Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer
Liu H, Huang C, Wu L, Wen B
OncoTargets and Therapy 2016, 9:4121-4127
Published Date: 6 July 2016
Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer
Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M
OncoTargets and Therapy 2016, 9:4113-4120
Published Date: 7 July 2016
Expression of G protein-coupled receptor 56 is associated with tumor progression in non-small-cell lung carcinoma patients
Song Y, Li A, Zhang L, Duan L
OncoTargets and Therapy 2016, 9:4105-4112
Published Date: 5 July 2016
Targeted therapy for localized non-small-cell lung cancer: a review
Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C
OncoTargets and Therapy 2016, 9:4099-4104
Published Date: 5 July 2016
The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases
Pieper CC, Meyer C, Sprinkart AM, Block W, Ahmadzadehfar H, Schild HH, Mürtz P, Kukuk GM
OncoTargets and Therapy 2016, 9:4089-4098
Published Date: 5 July 2016
LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo
Chen L, Yang HX, Xiao YB, Tang XX, Li YQ, Han QQ, Fu JP, Yang YY, Zhu YC
OncoTargets and Therapy 2016, 9:4075-4087
Published Date: 4 July 2016
A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials
Xu L, Wu X, Hu C, Zhang ZY, Zhang L, Liang SJ, Xu YC, Zhang FC
OncoTargets and Therapy 2016, 9:4061-4074
Published Date: 4 July 2016
Quality of life and cosmetic result of single-port access endoscopic thyroidectomy via axillary approach in patients with papillary thyroid carcinoma
Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM
OncoTargets and Therapy 2016, 9:4053-4059
Published Date: 4 July 2016
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis
De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C
OncoTargets and Therapy 2016, 9:4043-4052
Published Date: 4 July 2016
Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study
He W, Zhang Y, Xiong Y, Dai FJ, Fan QX
OncoTargets and Therapy 2016, 9:4037-4041
Published Date: 1 July 2016
Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma
Xu M, Jia Y, Liu Z, Ding L, Tian R, Gu H, Wang Y, Zhang H, Tu K, Liu Q
OncoTargets and Therapy 2016, 9:4023-4035
Published Date: 1 July 2016
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
Wei B, Yang S, Zhang B, Feng Y
OncoTargets and Therapy 2016, 9:4015-4022
Published Date: 1 July 2016
Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2–p53 signaling
Xie C, Wu B, Chen B, Shi Q, Guo J, Fan Z, Huang Y
OncoTargets and Therapy 2016, 9:4005-4013
Published Date: 4 July 2016
Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report
Sun B, Ding LJ, Wu S, Meng XY, Song S
OncoTargets and Therapy 2016, 9:3997-4003
Published Date: 1 July 2016
ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman
Gao KH, Li HT, Huang CH, Li HZ, Fang J, Tian C
OncoTargets and Therapy 2016, 9:3993-3996
Published Date: 1 July 2016
Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump
Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P
OncoTargets and Therapy 2016, 9:3985-3992
Published Date: 30 June 2016
High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial–mesenchymal transition in gastric cancer
Yan Y, Zhang J, Li JH, Liu X, Wang JZ, Qu HY, Wang JS, Duan XY
OncoTargets and Therapy 2016, 9:3975-3983
Published Date: 30 June 2016
Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
Yang H, Yang R, Liu H,α Ren Z, Kong F, Li D, Ma X
OncoTargets and Therapy 2016, 9:3963-3973
Published Date: 30 June 2016
Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression
Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y
OncoTargets and Therapy 2016, 9:3951-3962
Published Date: 4 July 2016
The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells
Xing YN, Zhang JY, Xu HM
OncoTargets and Therapy 2016, 9:3939-3949
Published Date: 29 June 2016
Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma
Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, Zheng S, Wang W
OncoTargets and Therapy 2016, 9:3925-3937
Published Date: 30 June 2016
Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review
Xia QS, Xu J, Chen HY, Gao YZ, Gong FL, Hu LY, Yang L
OncoTargets and Therapy 2016, 9:3917-3923
Published Date: 29 June 2016
Meta-analysis of cold-knife conization versus loop electrosurgical excision procedure for cervical intraepithelial neoplasia
Jiang YM, Chen CX, Li L
OncoTargets and Therapy 2016, 9:3907-3915
Published Date: 29 June 2016
Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
Zhang B, Li R, Chang CX, Han Y, Shi SB, Tian J
OncoTargets and Therapy 2016, 9:3901-3906
Published Date: 29 June 2016
Association between pesticide exposure and risk of kidney cancer: a meta-analysis
Xie B, Hu YF, Liang Z, Liu B, Zheng XY, Xie LP
OncoTargets and Therapy 2016, 9:3893-3900
Published Date: 28 June 2016
Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis
Zhang CX, Wang SY, Chen SQ, Yang SL, Wan L, Xiong B
OncoTargets and Therapy 2016, 9:3883-3891
Published Date: 27 June 2016
Internal mammary sentinel lymph node biopsy: abandon or persist?
Qiu PF, Liu YB, Wang YS
OncoTargets and Therapy 2016, 9:3879-3882
Published Date: 27 June 2016
Relationship between serum carcinoembryonic antigen level and epidermal growth factor receptor mutations with the influence on the prognosis of non-small-cell lung cancer patients
Cai ZX
OncoTargets and Therapy 2016, 9:3873-3878
Published Date: 27 June 2016
The clinical significance of γ-catenin in acute myeloid leukemia
Xu J, Wu W, Shen W, Liu P
OncoTargets and Therapy 2016, 9:3861-3871
Published Date: 27 June 2016
Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis
Wang HS, Nie XB, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD
OncoTargets and Therapy 2016, 9:3849-3860
Published Date: 27 June 2016
The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
Bai T, Chen J, Xie ZB, Wu FX, Wang SD, Liu JJ, Li LQ
OncoTargets and Therapy 2016, 9:3841-3848
Published Date: 27 June 2016
LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition
Lai F, Liu Q, Liu X, Ji M, Xie P, Chen X
OncoTargets and Therapy 2016, 9:3829-3840
Published Date: 24 June 2016
Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway
Fu X, Li H, Liu C, Hu B, Li T, Wang Y
OncoTargets and Therapy 2016, 9:3815-3827
Published Date: 24 June 2016
Superiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy
Zhao QQ, Wang RB, Zhu J, Jin LZ, Zhu KL, Xu XQ, Feng R, Jiang SM, Qi ZH, Yin Y
OncoTargets and Therapy 2016, 9:3807-3813
Published Date: 24 June 2016
Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
Song G, Ni H, Zou L, Wang S, Tian F, Liu H, Cho WC
OncoTargets and Therapy 2016, 9:3799-3805
Published Date: 23 June 2016
Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix
Li C, Liu WH, Cheng YF
OncoTargets and Therapy 2016, 9:3791-3797
Published Date: 23 June 2016
Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort
Wu ZB, Si ZM, Qian S, Liu LX, Qu XD, Zhou B, Zhang W, Wang GZ, Liu R, Wang JH
OncoTargets and Therapy 2016, 9:3783-3789
Published Date: 23 June 2016
Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials
Liu XQ, Liu XD, Qiao TK, Chen W, Yuan SJ
OncoTargets and Therapy 2016, 9:3771-3781
Published Date: 30 June 2016
In vitro-activated tumor-specific T lymphocytes prolong the survival of patients with advanced gastric cancer: a retrospective cohort study
Kuai J, Yang F, Li GJ, Fang XJ, Gao BQ
OncoTargets and Therapy 2016, 9:3763-3770
Published Date: 23 June 2016
Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment
Qi RX, Qiao TK, Zhuang XB
OncoTargets and Therapy 2016, 9:3753-3762
Published Date: 23 June 2016
The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib
Medina TM, Lewis KD
OncoTargets and Therapy 2016, 9:3739-3752
Published Date: 22 June 2016
Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies
Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C
OncoTargets and Therapy 2016, 9:3727-3737
Published Date: 22 June 2016
Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
Wang J, Wang B, Chu H, Yao Y
OncoTargets and Therapy 2016, 9:3711-3726
Published Date: 22 June 2016
Correlation of primary middle and distal esophageal cancers motion with surrounding tissues using four-dimensional computed tomography
Wang W, Li J, Zhang Y, Shao Q, Xu M, Guo B, Shang D
OncoTargets and Therapy 2016, 9:3705-3710
Published Date: 22 June 2016
Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review
Zhang D, Zhang X, Zhao C
OncoTargets and Therapy 2016, 9:3695-3704
Published Date: 21 June 2016
Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports
Liu H, Shi W, Zhao L, Dai D, Gao J, Kong X
OncoTargets and Therapy 2016, 9:3683-3694
Published Date: 21 June 2016
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment
Bonanno L, Zago G, Marulli G, Del Bianco P, Schiavon M, Pasello G, Polo V, Canova F, Tonetto F, Loreggian L, Rea F, Conte PF, Favaretto A
OncoTargets and Therapy 2016, 9:3671-3681
Published Date: 21 June 2016
Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study
Ma X, Wang J, Xu Y, Zhang W, Liu J, Cao X, He A, Wang F, Gu L, Lei B, Wang J
OncoTargets and Therapy 2016, 9:3661-3669
Published Date: 20 June 2016
Potential role of S-adenosylmethionine in osteosarcoma development
Shi H, Mu WD, Zhang B, Meng T, Zhang ST, Zhou DS
OncoTargets and Therapy 2016, 9:3653-3659
Published Date: 20 June 2016
MicroRNA-190 regulates FOXP2 genes in human gastric cancer
Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X, Xiao G
OncoTargets and Therapy 2016, 9:3643-3651
Published Date: 20 June 2016
The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma
Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY
OncoTargets and Therapy 2016, 9:3633-3642
Published Date: 20 June 2016
A systematic review and meta-analysis of the risk of diarrhea associated with vandetanib treatment in carcinoma patients
Huo Z, Yu S, Hong S, Cao X, Xiu L, Liao Z, Li Y, Xiao H
OncoTargets and Therapy 2016, 9:3621-3631
Published Date: 20 June 2016
Roles of microRNA-99 family in human glioma
Zhang MY, Guo Y, Wu J, Chen FH, Dai ZJ, Fan SS, Li PC, Song T
OncoTargets and Therapy 2016, 9:3613-3619
Published Date: 20 June 2016
XuefuZhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment
Liu JM, Zhang J, Huang LW, Zhu XH, Chen W, Hu P
OncoTargets and Therapy 2016, 9:3603-3612
Published Date: 17 June 2016
High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis
Chen XY, Ru GQ, Ma YY, Xie J, Chen WY, Wang HJ, Wang SB, Li L, Jin KT, He XL, Mou XZ
OncoTargets and Therapy 2016, 9:3595-3602
Published Date: 16 June 2016
Bilateral breast adenocarcinomas with EML4—ALK fusion in a patient with multiple metastases successfully treated with crizotinib: is lung the primary site?
Liu C, Ding L, Sun B, Wu S,
OncoTargets and Therapy 2016, 9:3589-3593
Published Date: 16 June 2016
MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway
Zhang H, Cao H, Xu D, Zhu K
OncoTargets and Therapy 2016, 9:3579-3588
Published Date: 16 June 2016
1p/19q codeletion and RET rearrangements in small-cell lung cancer
Lu H, Xu H, Xie F, Qin J, Han N, Fan Y, Mao W
OncoTargets and Therapy 2016, 9:3571-3577
Published Date: 16 June 2016
Association between GSTP1 Ile105Val polymorphism and urinary system cancer risk: evidence from 51 studies
Zhang Y, Yuan Y, Chen Y, Wang Z, Li F, Zhao Q
OncoTargets and Therapy 2016, 9:3565-3569
Published Date: 15 June 2016
miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1
Zhang C, Chen X, Chen X, Wang X, Ji A, Jiang L, Sang F, Li F
OncoTargets and Therapy 2016, 9:3555-3563
Published Date: 15 June 2016
Intensity-modulated radiotherapy for gliomas: dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue
Yang Z, Zhang Z, Wang X, Hu Y, Lyu Z, Huo L, Wei R, Fu J, Hong J
OncoTargets and Therapy 2016, 9:3545-3554
Published Date: 15 June 2016
MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor
Xiao Y, Tian Q, He J, Huang M, Yang C, Gong L
OncoTargets and Therapy 2016, 9:3535-3544
Published Date: 15 June 2016
Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer
Li K, Chen F, Xie H
OncoTargets and Therapy 2016, 9:3525-3533
Published Date: 14 June 2016
Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals
Li HX, Peng XX, Zong Q, Zhang K, Wang MX, Liu YZ, Han GL
OncoTargets and Therapy 2016, 9:3511-3523
Published Date: 14 June 2016
Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy
Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, Li W
OncoTargets and Therapy 2016, 9:3501-3509
Published Date: 13 June 2016
Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis
Shi J, Duan Y, Pan L, Zhou X
OncoTargets and Therapy 2016, 9:3493-3500
Published Date: 13 June 2016
PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis
Han F, Hu R, Yang H, Liu J, Sui J, Xiang X, Wang F, Chu L, Song S
OncoTargets and Therapy 2016, 9:3485-3492
Published Date: 13 June 2016
Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells
Liu Y, Sun B, Liu T, Zhao X, Wang X, Li Y, Meng J, Gu Q, Liu F, Dong X, Liu P, Sun R, Zhao N
OncoTargets and Therapy 2016, 9:3473-3484
Published Date: 13 June 2016
The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
Song WH, Ma HS
OncoTargets and Therapy 2016, 9:3465-3471
Published Date: 15 June 2016
Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells
Ma H, Yao Y, Wang C, Zhang L, Cheng L, Wang Y, Wang T, Liang E, Jia H, Ye Q, Hou M, Feng F
OncoTargets and Therapy 2016, 9:3451-3463
Published Date: 13 June 2016
Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
Zhang MM, Wei W, Liu JL, Yang HW, Jiang Y, Tang W, Li QY, Liao XM
OncoTargets and Therapy 2016, 9:3443-3450
Published Date: 8 June 2016
Administration of polysaccharide from Panax notoginseng prolonged the survival of H22 tumor-bearing mice
Li HY, Gu LL, Zhong YY, Chen YJ, Zhang L, Zhang AR, Sobol RW, Chen T, Li J
OncoTargets and Therapy 2016, 9:3433-3441
Published Date: 8 June 2016
Comparative efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: a systematic review and meta-analysis
Wang H, Man L, Li G, Huang G, Wang J
OncoTargets and Therapy 2016, 9:3423-3432
Published Date: 8 June 2016
GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2
Huang F, Yin J, Li K, Li Y, Qi H, Fang L, Yuan C, Liu W, Wang M, Li X
OncoTargets and Therapy 2016, 9:3415-3422
Published Date: 7 June 2016
The prognostic roles of ALDH1 isoenzymes in gastric cancer
Li K, Guo X, Wang Z, Li X, Bu Y, Bai X, Zheng L, Huang Y
OncoTargets and Therapy 2016, 9:3405-3414
Published Date: 7 June 2016
CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population
Su L, Gao SJ, Liu XL, Tan YH, Wang L, Li W
OncoTargets and Therapy 2016, 9:3399-3403
Published Date: 3 June 2016
A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors
Jiang Z, Zhang J, Li Z, Liu Y, Wang D, Han G
OncoTargets and Therapy 2016, 9:3387-3398
Published Date: 3 June 2016
Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma
Yuan CS, Yang K, Tang H, Chen D
OncoTargets and Therapy 2016, 9:3381-3386
Published Date: 3 June 2016
Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors
Pop LA, Pileczki V, Cojocneanu-Petric RM, Petrut B, Braicu C, Jurj AM, Buiga R, Achimas-Cadariu P, Berindan-Neagoe I
OncoTargets and Therapy 2016, 9:3369-3380
Published Date: 2 June 2016
Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression
Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang D, Chen Z, Yang D, Xu Z, Yu Z
OncoTargets and Therapy 2016, 9:3359-3368
Published Date: 2 June 2016
ACC interleukin-10 gene promoter haplotype as a breast cancer risk factor predictor among Jordanian females
Atoum MF
OncoTargets and Therapy 2016, 9:3353-3357
Published Date: 2 June 2016
Fast-track surgery protocol in elderly patients undergoing laparoscopic radical gastrectomy for gastric cancer: a randomized controlled trial
Liu G, Jian F, Wang X, Chen L
OncoTargets and Therapy 2016, 9:3345-3351
Published Date: 2 June 2016
Significant association between long non-coding RNA HOTAIR polymorphisms and cancer susceptibility: a meta-analysis
Zhang J, Liu X, You LH, Zhou RZ
OncoTargets and Therapy 2016, 9:3335-3343
Published Date: 1 June 2016
Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report
Zhang Y, Li HS, Li ZJ, Liu M, Yang L, Fan LY, Huang CS, Li BS
OncoTargets and Therapy 2016, 9:3327-3333
Published Date: 2 June 2016
Filtered selection coupled with support vector machines generate a functionally relevant prediction model for colorectal cancer
Gabere MN, Hussein MA, Aziz MA
OncoTargets and Therapy 2016, 9:3313-3325
Published Date: 1 June 2016
The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer
Choi YJ, Chang WJ, Shin SW, Park KH, Kim ST, Kim YH
OncoTargets and Therapy 2016, 9:3307-3312
Published Date: 1 June 2016
Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer
Qiao XJ, Zhai XR, Wang JH, Zhao XT, Yang XJ, Lv JL, Ma L, Zhang LN, Wang Y, Zhang SC, Yue WT
OncoTargets and Therapy 2016, 9:3299-3305
Published Date: 1 June 2016
Clinical significance of B7-H6 protein expression in astrocytoma
Guo JG, Guo CC, He ZQ, Liu ZG, Wang Y, Mou YG
OncoTargets and Therapy 2016, 9:3291-3297
Published Date: 31 May 2016
MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET
Jin H, Yu M, Lin Y, Hou B, Wu Z, Li Z, Sun J
OncoTargets and Therapy 2016, 9:3281-3289
Published Date: 31 May 2016
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
Nema R, Vishwakarma S, Agarwal R, Panday RK, Kumar A
OncoTargets and Therapy 2016, 9:3269-3280
Published Date: 31 May 2016
Anti-colorectal cancer effect of interleukin-2 and interferon-β fusion gene driven by carcinoembryonic antigen promoter
Wang Y, Wang M, Li Y
OncoTargets and Therapy 2016, 9:3259-3267
Published Date: 30 May 2016
Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma
Zhang Y, Zhu SL, Chen J, Li LQ
OncoTargets and Therapy 2016, 9:3249-3257
Published Date: 30 May 2016
The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis
Chen ZL, Shen YW, Li ST, Li CL, Zhang LX, Yang J, Lv M, Lin YY, Wang X, Yang J
OncoTargets and Therapy 2016, 9:3233-3247
Published Date: 30 May 2016
Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells
Liang Y, Mafuvadze B, Aebi JD, Hyder SM
OncoTargets and Therapy 2016, 9:3223-3232
Published Date: 30 May 2016
The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy
Feng X, Zhu K, Liu J, Chen J, Tang J, Liang Y, Jin R, Liang X, Cai X
OncoTargets and Therapy 2016, 9:3213-3221
Published Date: 30 May 2016
Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
Chen XW, Zhao JH, Li AL, Gao P, Sun JX, Song YX, Liu JJ, Chen P, Wang ZN
OncoTargets and Therapy 2016, 9:3205-3212
Published Date: 27 May 2016
Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review
Zhao F, Li MH, Kong L, Zhang GL, Yu JM
OncoTargets and Therapy 2016, 9:3197-3204
Published Date: 27 May 2016
Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer
Ang YLE, Lim JS, Soo RA
OncoTargets and Therapy 2016, 9:3187-3195
Published Date: 30 May 2016
Clinical features and treatment of squamous cell carcinoma of the breast
Zhang XM, Zhang BZ, Zang FL, Zhao LJ, Yuan ZY, Wang P
OncoTargets and Therapy 2016, 9:3181-3185
Published Date: 27 May 2016
Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, Gui J, Wan D, Ma D, Li S, Wang S
OncoTargets and Therapy 2016, 9:3171-3179
Published Date: 27 May 2016
Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study
Mumm JN, Kölbl AC, Jeschke U, Andergassen U
OncoTargets and Therapy 2016, 9:3163-3169
Published Date: 26 May 2016
Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency
Bian X, Wu P, Sha H, Qian H, Wang Q, Cheng L, Yang Y, Yang M, Liu B
OncoTargets and Therapy 2016, 9:3153-3162
Published Date: 27 May 2016
A preliminary study of pamidronic acid downregulation of angiogenic factors IGF-1/PECAM-1 expression in circulating level in bone metastatic breast cancer patients
Wang Z, Lei L, Cai X, Chen LY, Yuan M, Yang G, Huang P, Wang X
OncoTargets and Therapy 2016, 9:3147-3152
Published Date: 26 May 2016
Effect of YAP1 silencing on esophageal cancer
Zhao J, Li X, Yang Y, Zhu D, Zhang C, Liu D, Wu K, Zhao S
OncoTargets and Therapy 2016, 9:3137-3146
Published Date: 26 May 2016
Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study [Corrigendum]
Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y
OncoTargets and Therapy 2016, 9:3135-3136
Published Date: 27 May 2016
Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis
Dong YW, Shi YQ, He LW, Su PZ
OncoTargets and Therapy 2016, 9:3127-3134
Published Date: 25 May 2016
Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis
Liang JX, Liang Y, Gao W
OncoTargets and Therapy 2016, 9:3113-3125
Published Date: 24 May 2016
MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1
Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y, Deng Z, Xiao W
OncoTargets and Therapy 2016, 9:3101-3111
Published Date: 24 May 2016
Analysis of prostate bed motion using an endorectal balloon and cone beam computed tomography during postprostatectomy radiotherapy
Joo JH, Kim YJ, Kim YS, Cho YP, Lee HY, Jeong CY, Kwak J, Cho BC
OncoTargets and Therapy 2016, 9:3095-3100
Published Date: 24 May 2016
Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301
Han K, Meng W, Zhang JJ, Zhou Y, Wang YL, Su Y, Lin SC, Gan ZH, Sun YN, Min DL
OncoTargets and Therapy 2016, 9:3085-3094
Published Date: 26 May 2016
Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer
Lu Y, Zhou XH, Xu L, Rong CH, Shen C, Bian W
OncoTargets and Therapy 2016, 9:3077-3084
Published Date: 24 May 2016
Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells
Chen GS, Zhou N, Li JQ, Li T, Zhang ZQ, Si ZZ
OncoTargets and Therapy 2016, 9:3067-3076
Published Date: 27 May 2016
URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient
Yu G, Meng QX, Zhang T, Zeng C, He BF, Zhang SS
OncoTargets and Therapy 2016, 9:3059-3065
Published Date: 23 May 2016
Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma
Zhang X, Yu J, Li M, Zhu H
OncoTargets and Therapy 2016, 9:3049-3057
Published Date: 23 May 2016
Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis
Liu XD, Luo ZY, Peng HX, Jiang H, Xu L
OncoTargets and Therapy 2016, 9:3039-3047
Published Date: 23 May 2016
Expression of VEGF and HIF-1α in locally advanced cervical cancer: potential biomarkers for predicting preoperative radiochemotherapy sensitivity and prognosis
Zhu PF, Ou YJ, Dong YS, Xu PZ, Yuan L
OncoTargets and Therapy 2016, 9:3031-3037
Published Date: 23 May 2016
Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls
Lu YF, Lin YC, Chen KH, Shueng PW, Yeh HP, Hsieh CH
OncoTargets and Therapy 2016, 9:3025-3030
Published Date: 23 May 2016
Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports
Sun HL, Pan YQ, He BS, Nie ZL, Lin K, Peng HX, Cho WC, Wang SK
OncoTargets and Therapy 2016, 9:3017-3023
Published Date: 20 May 2016
Targeting gastrointestinal stromal tumors: the role of regorafenib
Schroeder B, Li Z, Cranmer LD, Jones RL, Pollack SM
OncoTargets and Therapy 2016, 9:3009-3016
Published Date: 20 May 2016
Onivyde for the therapy of multiple solid tumors
Zhang H
OncoTargets and Therapy 2016, 9:3001-3007
Published Date: 20 May 2016
Prognostic value of the standardized uptake value maximum change calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancer
Jin F, Zhu H, Fu Z, Kong L, Yu J
OncoTargets and Therapy 2016, 9:2993-2999
Published Date: 19 May 2016
Association between cooking oil fume exposure and lung cancer among Chinese nonsmoking women: a meta-analysis
Xue Y, Jiang Y, Jin S, Li Y
OncoTargets and Therapy 2016, 9:2987-2992
Published Date: 19 May 2016
Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer
Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y, Ma L
OncoTargets and Therapy 2016, 9:2975-2986
Published Date: 19 May 2016
Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses
Wang HY, Hsu MK, Wang KH, Tseng CP, Chen FC, Hsu JTA
OncoTargets and Therapy 2016, 9:2961-2973
Published Date: 19 May 2016
Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature
Wang XL, Yan HJ, Luo YJ, Fan TY
OncoTargets and Therapy 2016, 9:2955-2959
Published Date: 18 May 2016
Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
Barrientos JC
OncoTargets and Therapy 2016, 9:2945-2953
Published Date: 18 May 2016
Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors
Wu X, Zhang H, Salmani JMM, Fu R, Chen B
OncoTargets and Therapy 2016, 9:2935-2943
Published Date: 17 May 2016
The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis
Wang Y, Yang H, Duan G, Wang H
OncoTargets and Therapy 2016, 9:2927-2934
Published Date: 17 May 2016
PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population
Wu YB, Lu D, He ZF, Jin CG
OncoTargets and Therapy 2016, 9:2919-2925
Published Date: 17 May 2016
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2016, 9:2911-2917
Published Date: 17 May 2016
Comparative effects of different enteral feeding methods in head and neck cancer patients receiving radiotherapy or chemoradiotherapy: a network meta-analysis
Zhang ZH, Zhu Y, Ling Y, Zhang LJ, Wan HW
OncoTargets and Therapy 2016, 9:2897-2909
Published Date: 18 May 2016
Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway
Zhang JY, Jiang H, Xie L, Hu J, Li L, Yang M, Cheng L, Liu BR, Qian XP
OncoTargets and Therapy 2016, 9:2885-2895
Published Date: 24 May 2016
Recent advancements in erythrocytes, platelets, and albumin as delivery systems
Xu PP, Wang RJ, Wang XH, Ouyang J
OncoTargets and Therapy 2016, 9:2873-2884
Published Date: 17 May 2016
miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma
Liu C, Li M, Hu Y, Shi N, Yu H, Liu H, Lian H
OncoTargets and Therapy 2016, 9:2865-2871
Published Date: 19 May 2016
Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma
Karakiewicz PI, Nott L, Joshi A, Kannourakis G, Tarazi J, Alam M
OncoTargets and Therapy 2016, 9:2855-2863
Published Date: 12 May 2016
Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway
Sun Y, Tao C, Huang X, He H, Shi H, Zhang Q, Wu H
OncoTargets and Therapy 2016, 9:2845-2853
Published Date: 12 May 2016
Transcatheter arterial embolization combined with radiofrequency ablation activates CD8+ T-cell infiltration surrounding residual tumors in the rabbit VX2 liver tumors
Duan XH, Li TF, Zhou GF, Han XW, Zheng CS, Chen PF, Feng GS
OncoTargets and Therapy 2016, 9:2835-2844
Published Date: 17 May 2016
Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration
Xu YW, Zheng SB, Chen BS, Wen Y, Zhu SW
OncoTargets and Therapy 2016, 9:2825-2833
Published Date: 12 May 2016
Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
Shakespeare TP, Wilcox SW, Aherne NJ
OncoTargets and Therapy 2016, 9:2819-2824
Published Date: 11 May 2016
Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage
Zhao W, Zhang C, Bi C, Ye C, Song D, Liu X, Shao R
OncoTargets and Therapy 2016, 9:2805-2817
Published Date: 11 May 2016
Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells
Fan SL, Li X, Li LM, Wang LG, Du ZZ, Yang Y, Zhao JS, Li Y
OncoTargets and Therapy 2016, 9:2795-2803
Published Date: 10 May 2016
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor
Redic KA, Hough SM, Price EM
OncoTargets and Therapy 2016, 9:2783-2793
Published Date: 10 May 2016
Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors
Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B
OncoTargets and Therapy 2016, 9:2769-2781
Published Date: 10 May 2016
Prognostic significance of lymphocyte-to-monocyte ratio and CRP in patients with nonmetastatic clear cell renal cell carcinoma: a retrospective multicenter analysis
Xia WK, Wu X, Yu TH, Wu Y, Yao XJ, Hu H
OncoTargets and Therapy 2016, 9:2759-2767
Published Date: 9 May 2016
Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study
Zhou Q, Jiang Y, Yin W, Wang Y, Lu J
OncoTargets and Therapy 2016, 9:2749-2757
Published Date: 9 May 2016
Orbital metastasis as the initial presentation of lung adenocarcinoma: a case report
Sun LC, Qi YL, Sun XD, Yu JM, Meng X
OncoTargets and Therapy 2016, 9:2743-2748
Published Date: 9 May 2016
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer
Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, Passardi A, Tamberi S, Avanzolini A, Lucci E, Calistri D
OncoTargets and Therapy 2016, 9:2735-2742
Published Date: 6 May 2016
Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
Banzi M, De Blasio S, Lallas A, Longo C, Moscarella E, Alfano R, Argenziano G
OncoTargets and Therapy 2016, 9:2725-2733
Published Date: 6 May 2016
Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile
Zhang M, Li H, Zou D, Gao J
OncoTargets and Therapy 2016, 9:2717-2723
Published Date: 5 May 2016
HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway
Chi F, Wu R, Jin X, Jiang M, Zhu X
OncoTargets and Therapy 2016, 9:2709-2716
Published Date: 5 May 2016
A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy
Wang J, Tian Y, Tang Y, Wang X, Li N, Ren H, Fang H, Feng Y, Wang S, Song Y, Liu Y, Wang W, Li Y, Jin J
OncoTargets and Therapy 2016, 9:2701-2707
Published Date: 5 May 2016
HOXB7 as a promising molecular marker for metastasis in cancers: a meta-analysis
Liu FT, Ou YX, Zhang GP, Qiu C, Luo HL, Zhu PQ
OncoTargets and Therapy 2016, 9:2693-2699
Published Date: 6 May 2016
High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma
Zhao S, Guo W, Li J, Yu W, Guo T, Deng W, Gu C
OncoTargets and Therapy 2016, 9:2683-2692
Published Date: 5 May 2016
Shorter telomere length of T-cells in peripheral blood of patients with lung cancer
Qian Y, Ding T, Wei L, Cao S, Yang L
OncoTargets and Therapy 2016, 9:2675-2682
Published Date: 4 May 2016
Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Luo ZL, Feng C, Hu P, Chen Y, He XF, Li YH, Zhao JB
OncoTargets and Therapy 2016, 9:2667-2674
Published Date: 4 May 2016
Emerging treatment options for myelofibrosis: focus on pacritinib
Chow V, Weissman A, O’Connell CL, Mehrvar A, Akhtari M
OncoTargets and Therapy 2016, 9:2655-2665
Published Date: 4 May 2016
Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
Liu YX, Wang XS, Wang YF, Hu XC, Yan JQ, Zhang YL, Wang W, Yang RJ, Feng YY, Gao SG, Feng XS
OncoTargets and Therapy 2016, 9:2649-2654
Published Date: 4 May 2016
miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7
Hong LQ, Pan F, Jiang HF, Zhang LH, Liu YH, Cai CS, Hua CZ, Luo X, Sun JH, Chen ZJ
OncoTargets and Therapy 2016, 9:2639-2648
Published Date: 4 May 2016
Oncolytic viruses as immunotherapy: progress and remaining challenges
Aurelian L
OncoTargets and Therapy 2016, 9:2627-2637
Published Date: 4 May 2016
Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy [Retraction]
Wei B, Huang Q, Zhong X
OncoTargets and Therapy 2016, 9:2625-2626
Published Date: 5 May 2016
Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis
Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y
OncoTargets and Therapy 2016, 9:2615-2624
Published Date: 4 May 2016
Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study
Lin KY, Cheng SM, Tsai SL, Tsai JY, Lin CH, Cheung CHA
OncoTargets and Therapy 2016, 9:2601-2613
Published Date: 3 May 2016
Screening of biomarkers for prediction of response to and prognosis after chemotherapy for breast cancers
Bing F, Zhao Y
OncoTargets and Therapy 2016, 9:2593-2600
Published Date: 2 May 2016
Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients
Tang Q, Hu QY, Piao YF, Hua YH
OncoTargets and Therapy 2016, 9:2585-2591
Published Date: 2 May 2016
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches
Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi MS, Sachchidanand, Parine NR, Chourasia M
OncoTargets and Therapy 2016, 9:2575-2584
Published Date: 2 May 2016
Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells
Zhang X, Ji JF, Yang Y, Zhang J, Shen LF
OncoTargets and Therapy 2016, 9:2565-2574
Published Date: 29 April 2016
Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience
Mu YS, Qin MQ, Wang B, Li SD, Zhu GH, Zhou X, Yang J, Wang K, Lin W, Zheng HY
OncoTargets and Therapy 2016, 9:2557-2563
Published Date: 2 May 2016
Prognostic significance of miR-126 in various cancers: a meta-analysis
Dong Y, Fu C, Guan H, Zhang Z, Zhou T, Li BS
OncoTargets and Therapy 2016, 9:2547-2555
Published Date: 28 April 2016
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen
Salacz ME, Kast RE, Saki N, Brüning A, Karpel-Massler G, Halatsch ME
OncoTargets and Therapy 2016, 9:2535-2545
Published Date: 27 April 2016
Midazolam regulated caspase pathway, endoplasmic reticulum stress, autophagy, and cell cycle to induce apoptosis in MA-10 mouse Leydig tumor cells
So EC, Chen YC, Wang SC, Wu CC, Huang MC, Lai MS, Pan BS, Kang FC, Huang BM
OncoTargets and Therapy 2016, 9:2519-2533
Published Date: 27 April 2016
Paeoniflorin prevents hypoxia-induced epithelial–mesenchymal transition in human breast cancer cells
Zhou Z, Wang S, Song C, Hu Z
OncoTargets and Therapy 2016, 9:2511-2518
Published Date: 27 April 2016
Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis
Su X, Jiang X, Xu X, Wang W, Teng X, Shao A, Teng L
OncoTargets and Therapy 2016, 9:2495-2509
Published Date: 27 April 2016
Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma
Liu X, Ren G, Li L, Xia T
OncoTargets and Therapy 2016, 9:2489-2494
Published Date: 26 April 2016
Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis
Huang T, Cao YF, Zeng J, Dong J, Sun XY, Chen JX, Gao P
OncoTargets and Therapy 2016, 9:2479-2487
Published Date: 26 April 2016
Long noncoding RNA expression profile analysis of colorectal cancer and metastatic lymph node based on microarray data
Yang P, Xu ZP, Chen T, He ZY
OncoTargets and Therapy 2016, 9:2465-2478
Published Date: 26 April 2016
Serum biomarker panels for diagnosis of gastric cancer
Tong WH, Ye F, He L, Cui LF, Cui M, Hu Y, Li W, Jiang J, Zhang DY, Suo J
OncoTargets and Therapy 2016, 9:2455-2463
Published Date: 26 April 2016
E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations
Ren X, Wang J, Lin X, Wang X
OncoTargets and Therapy 2016, 9:2447-2453
Published Date: 26 April 2016
Irreversible electroporation: state of the art
Wagstaff PGK, Buijs M, van den Bos W, de Bruin DM, Zondervan PJ, de la Rosette JJMCH, Laguna Pes MP
OncoTargets and Therapy 2016, 9:2437-2446
Published Date: 22 April 2016
Metadherin regulates epithelial–mesenchymal transition in carcinoma
Wang Z, Tang ZY, Yin Z, Wei YB, Liu LF, Yan B, Zhou KQ, Nian YQ, Gao YL, Yang JR
OncoTargets and Therapy 2016, 9:2429-2436
Published Date: 21 April 2016
Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials
Lai XX, Xu RA, Li YP, Yang H
OncoTargets and Therapy 2016, 9:2421-2428
Published Date: 21 April 2016
Complete transthoracic resection of giant posterior mediastinal goiter: case report and review of surgical strategies
Zhao H, Ren D, Liu Y, Li X, Wu Y, Chen G, Chen J
OncoTargets and Therapy 2016, 9:2415-2419
Published Date: 22 April 2016
Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
He YY, Sun WW, Wang Y, Ren SX, Li XF, Li JY, Rivard CJ, Zhou CC, Hirsch FR
OncoTargets and Therapy 2016, 9:2409-2414
Published Date: 21 April 2016
Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis
Zhang C, Huang JY, He ZQ, Weng H
OncoTargets and Therapy 2016, 9:2403-2408
Published Date: 20 April 2016
RNA interference-mediated silencing of speckle-type POZ protein promotes apoptosis of renal cell cancer cells
Liu X, Sun G, Sun X
OncoTargets and Therapy 2016, 9:2393-2402
Published Date: 20 April 2016
AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Wang Y, Jin X, Song H, Meng F
OncoTargets and Therapy 2016, 9:2385-2392
Published Date: 20 April 2016
ROI for outlining an entire tumor is a reliable approach for quantification of lung cancer tumor vascular parameters using CT perfusion
Ma E, Ren A, Gao B, Yang M, Zhao Q, Wang W, Li K
OncoTargets and Therapy 2016, 9:2377-2384
Published Date: 27 April 2016
Vitamin D postpones the progression of epithelial ovarian cancer induced by 7, 12-dimethylbenz [a] anthracene both in vitro and in vivo
Liu LZ, Hu ZY, Zhang HM, Hou YF, Zhang ZL, Zhou GM, Li BY
OncoTargets and Therapy 2016, 9:2365-2375
Published Date: 19 April 2016
Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer
Perri F, Lazzari G, Della Vittoria Scarpati G, Silvano G
OncoTargets and Therapy 2016, 9:2359-2364
Published Date: 19 April 2016
Massive chest wall resection and reconstruction for malignant disease
Foroulis CN, Kleontas AD, Tagarakis G, Nana C, Alexiou I, Grosomanidis V, Tossios P, Papadaki E, Kioumis I, Baka S, Zarogoulidis P, Anastasiadis K
OncoTargets and Therapy 2016, 9:2349-2358
Published Date: 19 April 2016
The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas
Zhang HB, Lu C, Lu YJ, Yu B, Lv FZ, Zhu ZH
OncoTargets and Therapy 2016, 9:2337-2348
Published Date: 20 April 2016
Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer
He Q, Xu Q, Wu W, Chen L, Sun W, Ying JE
OncoTargets and Therapy 2016, 9:2329-2335
Published Date: 20 April 2016
Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer
Zheng WQ, Jiang CH, Li RF
OncoTargets and Therapy 2016, 9:2317-2327
Published Date: 18 April 2016
MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial–mesenchymal transition
Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG, Zhang J, Tao HQ
OncoTargets and Therapy 2016, 9:2305-2315
Published Date: 18 April 2016
Carvacrol suppresses proliferation and invasion in human oral squamous cell carcinoma
Dai W, Sun C, Huang S, Zhou Q
OncoTargets and Therapy 2016, 9:2297-2304
Published Date: 18 April 2016
Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People’s Republic of China
Zhou P, Jiang YZ, Hu X, Sun W, Liu YR, Liu F, Luo RC, Shao ZM
OncoTargets and Therapy 2016, 9:2287-2295
Published Date: 18 April 2016
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes
Sochacki AL, Fischer MA, Savona MR
OncoTargets and Therapy 2016, 9:2273-2286
Published Date: 15 April 2016
Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
Liu C, Li Z, Wu D, Li C, Zhang Y
OncoTargets and Therapy 2016, 9:2265-2271
Published Date: 15 April 2016
DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior of papillary thyroid cancer
Ma B, Shi RL, Yang SW, Zhou L, Qu N, Liao T, Wang Y, Wang YL, Ji QH
OncoTargets and Therapy 2016, 9:2255-2263
Published Date: 15 April 2016
Esophageal cancer stem cells and implications for future therapeutics
Qian X, Tan C, Wang F, Yang B, Ge Y, Guan Z, Cai J
OncoTargets and Therapy 2016, 9:2247-2254
Published Date: 19 April 2016
The important tumor suppressor role of PER1 in regulating the cyclin–CDK–CKI network in SCC15 human oral squamous cell carcinoma cells
Fu XJ, Li HX, Yang K, Chen D, Tang H
OncoTargets and Therapy 2016, 9:2237-2245
Published Date: 15 April 2016
Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma
Wu H, Shi XL, Zhang HJ, Song QJ, Yang XB, Hu WD, Mei GL, Chen X, Mao QS, Chen Z
OncoTargets and Therapy 2016, 9:2227-2236
Published Date: 18 April 2016
BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients
Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao XG, Hu HY
OncoTargets and Therapy 2016, 9:2221-2226
Published Date: 15 April 2016
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, Wu YD, Liang YX, Han ZD, Liu JC, Zhong WD
OncoTargets and Therapy 2016, 9:2211-2220
Published Date: 15 April 2016
Short- and long-term outcomes of laparoscopic surgery vs open surgery for transverse colon cancer: a retrospective multicenter study
Kim JW, Kim JY, Kang BM, Lee BH, Kim BC, Park JH
OncoTargets and Therapy 2016, 9:2203-2209
Published Date: 15 April 2016
Ectopic adrenocorticotropic hormone syndrome caused by neuroendocrine tumors of the thymus: 30-year experience with 16 patients at a single institute in the People’s Republic of China
Chen YY, Li SQ, Liu HS, Qin YZ, Li L, Huang C, Bi YL, Meng YX, He J, Zhou XY, Ma DJ
OncoTargets and Therapy 2016, 9:2193-2201
Published Date: 26 April 2016
Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis
Zhang M, Tan X, Huang J, Xie L, Wang H, Shi J, Lu W, Lv Z, Mei H, Liang C
OncoTargets and Therapy 2016, 9:2181-2192
Published Date: 19 April 2016
Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis
Shan N, Zhou W, Zhang S, Zhang Y
OncoTargets and Therapy 2016, 9:2169-2179
Published Date: 13 April 2016
Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails
Zhu G, Zhang X, Wang Y, Xiong H, Zhao Y, Sun F
OncoTargets and Therapy 2016, 9:2153-2168
Published Date: 13 April 2016
Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway
Xu FQ, Zhang ZQ, Fang YC, Li XL, Sun Y, Xiong CZ, Yan LQ, Wang Q
OncoTargets and Therapy 2016, 9:2143-2151
Published Date: 13 April 2016
Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma
Zeng FC, Zeng MQ, Huang L, Li YL, Gao BM, Chen JJ, Xue RZ, Tang ZY
OncoTargets and Therapy 2016, 9:2131-2141
Published Date: 12 April 2016
ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen
Sensorn I, Sukasem C, Sirachainan E, Chamnanphon M, Pasomsub E, Trachu N, Supavilai P, Pinthong D, Wongwaisayawan S
OncoTargets and Therapy 2016, 9:2121-2129
Published Date: 12 April 2016
Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis
Zhu SL, Zhong JH, Gong WF, Li H, Li LQ
OncoTargets and Therapy 2016, 9:2111-2119
Published Date: 15 April 2016
Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma
Pang Q, Bi JB, Wang ZX, Xu XS, Qu K, Miao RC, Chen W, Zhou YY, Liu C
OncoTargets and Therapy 2016, 9:2099-2109
Published Date: 12 April 2016
Are compression corsets beneficial for the treatment of breast cancer-related lymphedema? New opportunities in physiotherapy treatment – a preliminary report
Hansdorfer-Korzon R, Teodorczyk J, Gruszecka A, Lass P
OncoTargets and Therapy 2016, 9:2089-2098
Published Date: 7 April 2016
Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer
Ye H, Liu K, Qian K
OncoTargets and Therapy 2016, 9:2081-2088
Published Date: 7 April 2016
Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes
Sun Y, Joks M, Xu LM, Chen XL, Qian D, You JQ, Yuan ZY
OncoTargets and Therapy 2016, 9:2069-2080
Published Date: 6 April 2016
Use of micro-positron emission tomography with 18F-fallypride to measure the levels of dopamine receptor-D2 and 18F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats
Li P, Gui S, Cao L, Gao H, Bai J, Li C, Zhang Y
OncoTargets and Therapy 2016, 9:2057-2068
Published Date: 6 April 2016
Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects
Yu XJ, Li YL, Yu YD, Lei JH, Wan GX, Cao FJ
OncoTargets and Therapy 2016, 9:2049-2056
Published Date: 6 April 2016
Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition
Wang N, Wang Q, Shen D, Sun X, Cao X, Wu D
OncoTargets and Therapy 2016, 9:2035-2047
Published Date: 6 April 2016
Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma
Chen R, Allibone S, Bartlett NL, Brice P, Chen A, Pose K, Rich L, Bonthapally V, Garfin PM, Fanale M
OncoTargets and Therapy 2016, 9:2027-2034
Published Date: 6 April 2016
The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy
Qie Y, Hu H, Tian D, Zhang Y, Xie L, Xu Y, Wu C
OncoTargets and Therapy 2016, 9:2019-2025
Published Date: 5 April 2016
Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: comments on a meta-analysis by Liang et al
Tu C, He J, Li Z
OncoTargets and Therapy 2016, 9:2017-2018
Published Date: 5 April 2016
Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy
Kwon Y
OncoTargets and Therapy 2016, 9:2007-2016
Published Date: 5 April 2016
Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients
Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L
OncoTargets and Therapy 2016, 9:1997-2005
Published Date: 5 April 2016
Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer
Wen MM, Wang XJ, Sun Y, Xia JH, Fan LB, Xing H, Zhang ZP, Li XF
OncoTargets and Therapy 2016, 9:1989-1995
Published Date: 5 April 2016
Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer
Ma YM, Zhao S
OncoTargets and Therapy 2016, 9:1981-1988
Published Date: 4 April 2016
Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway
Han LT, Fang Y, Cao Y, Wu FH, Liu E, Mo GY, Huang F
OncoTargets and Therapy 2016, 9:1969-1979
Published Date: 5 April 2016
Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis
Zhao XT, Liu FZ, Zhang Y, Li PH
OncoTargets and Therapy 2016, 9:1961-1968
Published Date: 4 April 2016
Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer
Cooper MR, Binkowski C, Hartung J, Towle J
OncoTargets and Therapy 2016, 9:1953-1960
Published Date: 4 April 2016
A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma
Shen LL, Wen J, Zhao TT, Hu ZB, Song C, Gu DY, He ML, Lee NP, Xu Z, Chen JF
OncoTargets and Therapy 2016, 9:1945-1951
Published Date: 4 April 2016
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
Sacco AG, Worden FP
OncoTargets and Therapy 2016, 9:1927-1943
Published Date: 4 April 2016
Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study
Aktas G, Kus T, Kalender ME, Sevinc A, Camci C, Kul S
OncoTargets and Therapy 2016, 9:1921-1926
Published Date: 1 April 2016
Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
Seow HF, Yip WK, Fifis T
OncoTargets and Therapy 2016, 9:1899-1920
Published Date: 31 March 2016
Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis
Qiao GL, Qi WX, Jiang WH, Chen Y, Ma LJ
OncoTargets and Therapy 2016, 9:1889-1897
Published Date: 31 March 2016
Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis
Meng XY, Liao Y, Liu XP, Li S, Shi MJ, Zeng XT
OncoTargets and Therapy 2016, 9:1875-1888
Published Date: 31 March 2016
Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma
Tao HM, Wei YM, Huang W, Gai XJ, Li BS
OncoTargets and Therapy 2016, 9:1865-1873
Published Date: 31 March 2016
A comparison of dosimetric variance for external-beam partial breast irradiation using three-dimensional and four-dimensional computed tomography
Guo B, Li JB, Wang W, Xu M, Li YK, Liu TH
OncoTargets and Therapy 2016, 9:1857-1863
Published Date: 31 March 2016
Pragmatic medicine in solid cancer: a translational alternative to precision medicine
Brábek J, Rosel D, Fernandes M
OncoTargets and Therapy 2016, 9:1839-1855
Published Date: 5 April 2016
Influence of negative lymph node in No 7 on survival of patients with middle thoracic esophageal squamous cell carcinoma
Zhang JL, Heng XY, Luo Y, Fu QX, Li ZR, Che FY, Li BS
OncoTargets and Therapy 2016, 9:1831-1837
Published Date: 30 March 2016
Tumoral angiogenesis in both adrenal adenomas and nonadenomas: a promising computed tomography biomarker for diagnosis
Wang X, Li K, Sun H, Zhao J, Zhang Z, Zheng L, Li W, Bai R, Zhang G
OncoTargets and Therapy 2016, 9:1823-1830
Published Date: 30 March 2016
Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2
Liu J, Wang H, Wang Y, Li Z, Pan Y, Liu Q, Yang M, Wang J
OncoTargets and Therapy 2016, 9:1813-1822
Published Date: 29 March 2016
Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway
Zhang HJ, Tao J, Sheng L, Hu X, Rong RM, Xu M, Zhu TY
OncoTargets and Therapy 2016, 9:1801-1812
Published Date: 29 March 2016
Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma
Zhao H, Wang T, Wang Y, Yu Y, Wang X, Zhao Z, Yang H, Yan B, Wu X, Da W, Zhang Y
OncoTargets and Therapy 2016, 9:1795-1799
Published Date: 24 March 2016
Identification of colorectal cancer-restricted microRNAs and their target genes based on high-throughput sequencing data
Chang J, Huang L, Cao Q, Liu F
OncoTargets and Therapy 2016, 9:1787-1794
Published Date: 24 March 2016
miR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomas
Liu XN, Zhang WC, Guo H, Yue JL, Zhuo SS
OncoTargets and Therapy 2016, 9:1777-1786
Published Date: 23 March 2016
Tremelimumab: research and clinical development
Comin-Anduix B, Escuin-Ordinas H, Ibarrondo FJ
OncoTargets and Therapy 2016, 9:1767-1776
Published Date: 23 March 2016
A meta-analysis of clinical trials assessing the effect of radiofrequency ablation for breast cancer
Chen J, Zhang C, Li F, Xu L, Zhu H, Wang S, Liu X, Zha X, Ding Q, Ling L, Zhou W, Sun X
OncoTargets and Therapy 2016, 9:1759-1766
Published Date: 23 March 2016
Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation
Morichika D, Kubo T, Gotoda H, Tamura T, Ohashi K, Hotta K, Tabata M, Kurozumi K, Tanimoto M, Kiura K
OncoTargets and Therapy 2016, 9:1753-1758
Published Date: 22 March 2016
Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome
Zhao ZG, Wang DQ, Hu DF, Li YS, Liu SH
OncoTargets and Therapy 2016, 9:1743-1752
Published Date: 23 March 2016
Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes
Wang T, Liu Y, Zhou B, Wang Z, Liang NC, Zhang YD, Dong ZH, Li J
OncoTargets and Therapy 2016, 9:1735-1741
Published Date: 22 March 2016
Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis
Li JJ, Liang L, Liu YR, Luo YH, Liang XN, Luo DZ, Feng ZB, Dang YW, Yang LH, Chen G
OncoTargets and Therapy 2016, 9:1721-1734
Published Date: 21 March 2016
The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population
Jia YC, Zang AM, Jiao SC, Chen SM, Yan F
OncoTargets and Therapy 2016, 9:1715-1719
Published Date: 21 March 2016
Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study
Sun JY, Wu SG, Li FY, Lin HX, He ZY
OncoTargets and Therapy 2016, 9:1707-1713
Published Date: 21 March 2016
Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma
Li J, Zhao X, Wang D, He W, Zhang S, Cao W, Huang Y, Wang L, Zhou S, Luo K
OncoTargets and Therapy 2016, 9:1697-1706
Published Date: 21 March 2016
Statin use and mortality of patients with prostate cancer: a meta-analysis
Meng Y, Liao YB, Xu P, Wei WR, Wang J
OncoTargets and Therapy 2016, 9:1689-1696
Published Date: 21 March 2016
Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis
Shen H, Zhan M, Wang W, Yang D, Wang J
OncoTargets and Therapy 2016, 9:1679-1688
Published Date: 22 March 2016
High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma
Zhao Y, Liu ZG, Tang J, Zou RF, Chen XY, Jiang GM, Qiu YF, Wang H
OncoTargets and Therapy 2016, 9:1671-1677
Published Date: 21 March 2016
Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study
Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y
OncoTargets and Therapy 2016, 9:1657-1670
Published Date: 21 March 2016
Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma
Wu MH, Ye XX, Deng XB, Wu YX, Li XF, Zhang L
OncoTargets and Therapy 2016, 9:1647-1656
Published Date: 18 March 2016
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review
Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito KI, Tateishi A, Yoshizawa A, Takayama F
OncoTargets and Therapy 2016, 9:1641-1646
Published Date: 18 March 2016
Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
Shakespeare TP, Wilcox SW, Aherne NJ
OncoTargets and Therapy 2016, 9:1635-1639
Published Date: 17 March 2016
miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1
Huang YW, Liu JT, Fan LL, Wang F, Yu HQ, Wei W, Sun GP
OncoTargets and Therapy 2016, 9:1623-1633
Published Date: 17 March 2016
AA-PMe, a novel asiatic acid derivative, induces apoptosis and suppresses proliferation, migration, and invasion of gastric cancer cells
Jing Y, Wang G, Ge Y, Xu M, Tang S, Gong Z
OncoTargets and Therapy 2016, 9:1605-1621
Published Date: 17 March 2016
The CT and US features of Ewing’s sarcoma/primary neuroectodermal tumor of the kidney: two case reports and review of literature
Zhang DF, Li ZH, Gao DP, Yang GJ, Ding YY, Wang GS, Dong XX
OncoTargets and Therapy 2016, 9:1599-1603
Published Date: 17 March 2016
Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma
Zhao J, Chen F, Zhou Q, Pan W, Wang X, Xu J, Ni L, Yang H
OncoTargets and Therapy 2016, 9:1589-1597
Published Date: 17 March 2016
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Yang CJ, Tsai MJ, Hung JY, Liu TC, Chou SH, Lee JY, Hsu JS, Tsai YM, Huang MS, Chong IW
OncoTargets and Therapy 2016, 9:1579-1587
Published Date: 16 March 2016
The efficacy and safety of nivolumab in the treatment of advanced melanoma: a meta-analysis of clinical trials
Jin CH, Zhang XL, Zhao KL, Xu J, Zhao M, Xu XH
OncoTargets and Therapy 2016, 9:1571-1578
Published Date: 16 March 2016
Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis
Ma M, Yu N
OncoTargets and Therapy 2016, 9:1559-1569
Published Date: 16 March 2016
Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data
Chen C, Zhang LG, Liu J, Han H, Chen N, Yao AL, Kang SS, Gao WX, Shen H, Zhang LJ, Li YP, Cao FH, Li ZG
OncoTargets and Therapy 2016, 9:1545-1557
Published Date: 16 March 2016
Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis
Wu XJ, Zhi Y, He P, Zhou XZ, Zheng J, Chen ZW, Zhou ZS
OncoTargets and Therapy 2016, 9:1535-1543
Published Date: 15 March 2016
miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22
Xiao J, Li Y, Zhang W, Jiang Y, Du B, Tan Y
OncoTargets and Therapy 2016, 9:1525-1534
Published Date: 16 March 2016
Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma
Fu H, Ma C, Guan W, Cheng W, Feng F, Wang H
OncoTargets and Therapy 2016, 9:1519-1523
Published Date: 15 March 2016
Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW
OncoTargets and Therapy 2016, 9:1511-1518
Published Date: 15 March 2016
Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case–control studies
Zhong JH, Zhao Z, Liu J, Yu HL, Zhou JY, Shi R
OncoTargets and Therapy 2016, 9:1499-1510
Published Date: 15 March 2016
miR-32 inhibits proliferation, epithelial–mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells
Li L, Wu DP
OncoTargets and Therapy 2016, 9:1489-1498
Published Date: 14 March 2016
Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis
Ren HY, Zhang YH, Li HY, Xie T, Sun LL, Zhu T, Wang SD, Ye ZM
OncoTargets and Therapy 2016, 9:1477-1487
Published Date: 14 March 2016
Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis
Xiao HQ, Tian RH, Zhang ZH, Du KQ, Ni YM
OncoTargets and Therapy 2016, 9:1471-1476
Published Date: 14 March 2016
Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer
Jiang LP, Zhu ZT, He CY
OncoTargets and Therapy 2016, 9:1461-1469
Published Date: 14 March 2016
Predictive value of mutant p53 expression index obtained from nonenhanced computed tomography measurements for assessing invasiveness of ground-glass opacity nodules
Wang W, Li J, Liu R, Zhang A, Yuan Z
OncoTargets and Therapy 2016, 9:1449-1459
Published Date: 14 March 2016
Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression
Liu T, Zhang X, Yang Y, Du L, Wang C
OncoTargets and Therapy 2016, 9:1437-1448
Published Date: 11 March 2016
Antitumor activity of pluripotent cell-engineered vaccines and their potential to treat lung cancer in relation to different levels of irradiation
Zhang Y, Duan X, Zhang W, Wu A, Yang H, Wu D, Wei Y, Chen X
OncoTargets and Therapy 2016, 9:1425-1436
Published Date: 11 March 2016
The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines
Cheng W, Feng F, Ma C, Wang H
OncoTargets and Therapy 2016, 9:1415-1423
Published Date: 11 March 2016
Ovarian small-cell carcinoma hypercalcemic type successfully treated: a case report and literature review
Wang JJ, Liu Q, Wu N, Zhou XD, Wang H, Wang X, Tu P, Zhou XJ, Shi QL
OncoTargets and Therapy 2016, 9:1409-1414
Published Date: 11 March 2016
Comparison of preoperative neutrophil–lymphocyte, lymphocyte–monocyte, and platelet–lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy
Song X, Zhang GM, Ma XC, Luo L, Li B, Chai DY, Sun LJ
OncoTargets and Therapy 2016, 9:1399-1407
Published Date: 11 March 2016
A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection
Wang Q, Sun T, Cao Y, Gao P, Dong J, Fang Y, Fang Z, Sun X, Zhu Z
OncoTargets and Therapy 2016, 9:1389-1398
Published Date: 11 March 2016
Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population
Tang JJ, Wang G, Li Q, Song RF
OncoTargets and Therapy 2016, 9:1381-1387
Published Date: 10 March 2016
Prognostic role of microRNA-150 in various carcinomas: a meta-analysis
Wang W, Wang X, Zhang Y, Wang D, Gao H, Wang L, Gao S
OncoTargets and Therapy 2016, 9:1371-1379
Published Date: 11 March 2016
Impact of the care provided by gynecologic oncologists on outcomes of cervical cancer patients treated with radical hysterectomy
Wu MF, Li J, Lu HW, Wang LJ, Zhang BZ, Lin ZQ
OncoTargets and Therapy 2016, 9:1361-1370
Published Date: 10 March 2016
p53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer
Zhang L, Yang WP, Zhu X, Wei CY
OncoTargets and Therapy 2016, 9:1351-1360
Published Date: 10 March 2016
Association of thymidylate synthase expression and clinical outcomes of gastric cancer patients treated with fluoropyrimidine-based chemotherapy: a meta-analysis
Gao YH, Cui JX, Xi HQ, Cai AZ, Shen WS, Li JY, Zhang KC, Wei B, Chen L
OncoTargets and Therapy 2016, 9:1339-1350
Published Date: 9 March 2016
Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma
Lu Z, Yao Y, Song Q, Yang J, Zhao X, Yang P, Kang J
OncoTargets and Therapy 2016, 9:1327-1337
Published Date: 9 March 2016
A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer
Kim YJ, Park JH, Yun IH, Kim YS
OncoTargets and Therapy 2016, 9:1319-1325
Published Date: 9 March 2016
Diagnostic value of two-dimensional shear wave elastography in papillary thyroid microcarcinoma
Duan SB, Yu J, Li X, Han ZY, Zhai HY, Liang P
OncoTargets and Therapy 2016, 9:1311-1317
Published Date: 9 March 2016
Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer
Zhang Y, Liu G, Wu S, Jiang F, Xie J, Wang Y
OncoTargets and Therapy 2016, 9:1303-1310
Published Date: 29 March 2016
Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
Li MJ, He Q, Li M, Luo F, Guan YS
OncoTargets and Therapy 2016, 9:1291-1302
Published Date: 9 March 2016
Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type
Quan Q, Chen Q, Chen P, Jiang L, Li T, Qiu H, Zhang B
OncoTargets and Therapy 2016, 9:1281-1290
Published Date: 14 March 2016
Association of OPN rs11730582 polymorphism with cancer risk: a meta-analysis
He LL, Wang Y
OncoTargets and Therapy 2016, 9:1275-1280
Published Date: 7 March 2016
Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery
Liu Y, Feng Y, Gao Y, Hou R
OncoTargets and Therapy 2016, 9:1269-1273
Published Date: 7 March 2016
Circulating interleukin-10 levels and human papilloma virus and Epstein–Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects
Qu K, Pang Q, Lin T, Zhang L, Gu M, Niu W, Liu C, Zhang M
OncoTargets and Therapy 2016, 9:1251-1267
Published Date: 7 March 2016
The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
Liu YL, Zhang HM, Pan HM, Bao YH, Xue J, Wang TC, Dong XC, Li XL, Bao HG
OncoTargets and Therapy 2016, 9:1241-1249
Published Date: 7 March 2016
MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1
He X, Wei Y, Wang Y, Liu L, Wang W, Li N
OncoTargets and Therapy 2016, 9:1231-1239
Published Date: 7 March 2016
Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma
Wang J, Li M, Wang Y, Liu X
OncoTargets and Therapy 2016, 9:1221-1230
Published Date: 7 March 2016
Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma
Shankar A, Borin TF, Iskander A, Varma NR, Achyut BR, Jain M, Mikkelsen T, Guo AM, Chwang WB, Ewing JR, Bagher-Ebadian H, Arbab AS
OncoTargets and Therapy 2016, 9:1205-1219
Published Date: 9 March 2016
The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer
Ding X, Qiu L, Zhang L, Xi J, Li D, Huang X, Zhao Y, Wang X, Sun Q
OncoTargets and Therapy 2016, 9:1189-1204
Published Date: 8 March 2016
Profile of farletuzumab and its potential in the treatment of solid tumors
Sato S, Itamochi H
OncoTargets and Therapy 2016, 9:1181-1188
Published Date: 7 March 2016
The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population
Sha N, Xu H, Chen T, Tian DW, Xie WQ, Xie LG, Zhang Y, Xing C, Liu XT, Shen ZH, Wu ZL, Hu HL, Wu CL
OncoTargets and Therapy 2016, 9:1175-1179
Published Date: 7 March 2016
Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials
Yimaer W, Abudouyimu A, Tian Y, Magaoweiya S, Bagedati D, Wen H
OncoTargets and Therapy 2016, 9:1167-1173
Published Date: 7 March 2016
Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population
Wang X, Chen L, Jin H, Wang S, Zhang Y, Tang X, Tang G
OncoTargets and Therapy 2016, 9:1159-1166
Published Date: 7 March 2016
Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies
Chen L, Lu W, Fang L, Xiong H, Wu X, Zhang M, Wu S, Yu D
OncoTargets and Therapy 2016, 9:1151-1158
Published Date: 4 March 2016
Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
Hu Y, Chen W, Chen S, Huang Z
OncoTargets and Therapy 2016, 9:1145-1149
Published Date: 3 March 2016
Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis
Lu YY, Fan Y
OncoTargets and Therapy 2016, 9:1135-1143
Published Date: 9 March 2016
miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells
Zhang M, Dong BB, Lu M, Zheng MJ, Chen H, Ding JZ, Xu AM, Xu YH
OncoTargets and Therapy 2016, 9:1123-1133
Published Date: 3 March 2016
Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme
Kusumawidjaja G, Gan PZ, Ong WS, Teyateeti A, Dankulchai P, Tan DYH, Chua ET, Chua KL, Tham CK, Wong FY, Chua ML
OncoTargets and Therapy 2016, 9:1115-1122
Published Date: 2 March 2016
YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells
Xiao L, Shi XY, Zhang Y, Zhu Y, Zhu L, Tian W, Zhu BK, Wei ZL
OncoTargets and Therapy 2016, 9:1105-1114
Published Date: 16 March 2016
Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase
Qin T, Zhou NN, Zeng YD, Dinglin XX, Zhao YY, Liu H, Chen LK
OncoTargets and Therapy 2016, 9:1095-1103
Published Date: 1 March 2016
Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma
Li GJ, Xu HW, Ji JJ, Yang F, Gao BQ
OncoTargets and Therapy 2016, 9:1085-1093
Published Date: 1 March 2016
Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective
He DX, Ma X
OncoTargets and Therapy 2016, 9:1077-1084
Published Date: 1 March 2016
SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression
Yan QY, Lou GH, Qian Y, Qin B, Xu XP, Wang YN, Liu YN, Dong XJ
OncoTargets and Therapy 2016, 9:1067-1075
Published Date: 1 March 2016
Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial
Martínez E, Martínez M, Rico M, Hernández B, Casas F, Viñolas N, Pérez-Casas A, Dómine M, Mínguez J
OncoTargets and Therapy 2016, 9:1057-1066
Published Date: 1 March 2016
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
Achyut BR, Arbab AS
OncoTargets and Therapy 2016, 9:1047-1055
Published Date: 1 March 2016
Polymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: a meta-analysis
Fei XW, Liu NN, Li HF, Shen YT, Guo JM, Wu ZQ
OncoTargets and Therapy 2016, 9:1033-1045
Published Date: 1 March 2016
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
Kashima J, Horio H, Okuma Y, Hosomi Y, Hishima T
OncoTargets and Therapy 2016, 9:1029-1032
Published Date: 29 February 2016
Quality of life of patients with lung cancer
Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A
OncoTargets and Therapy 2016, 9:1023-1028
Published Date: 29 February 2016
Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial–mesenchymal transition via NF-κB activation
Ge Y, Cao XK, Wang DL, Sun W, Sun HL, Han B, Cui JP, Liu BL
OncoTargets and Therapy 2016, 9:1011-1021
Published Date: 29 February 2016
Orchestrating epigenetic roles targeting ocular tumors
Wen X, Lu L, Zhang H, Fan X
OncoTargets and Therapy 2016, 9:1001-1009
Published Date: 29 February 2016
The pro-apoptotic effects of TIPE2 on AA rat fibroblast-like synoviocytes via regulation of the DR5–caspase–NF-κB pathway in vitro
Shi C, Zhang S, Hong S, Pang J, Yesibulati Y, Yin P, Zhuang G
OncoTargets and Therapy 2016, 9:993-1000
Published Date: 29 February 2016
A comparative study of idarubicin 12 mg/m2 and 8 mg/m2 combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients
Zhou L, Liu X, Liu H, Zhu W, Cai X, Song K, Zheng C, Tang B, Sun Z
OncoTargets and Therapy 2016, 9:985-991
Published Date: 29 February 2016
Analyses of prognostic factors in cases of non-small cell lung cancer with multiple brain metastases
Gong X, Zhou D, Liang S, Zhou C
OncoTargets and Therapy 2016, 9:977-983
Published Date: 1 March 2016
Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
Ma B, Ma Q, Wang H, Zhang G, Zhang H, Wang X
OncoTargets and Therapy 2016, 9:959-976
Published Date: 29 February 2016
Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
Liu X, Xu P, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X
OncoTargets and Therapy 2016, 9:949-958
Published Date: 26 February 2016
Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
Seber S, Gonultas A, Ozturk O, Yetisyigit T
OncoTargets and Therapy 2016, 9:945-948
Published Date: 25 February 2016
Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases
Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H
OncoTargets and Therapy 2016, 9:937-943
Published Date: 25 February 2016
Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer
Shen YW, Zhang XM, Li ST, Lv M, Yang J, Wang F, Chen ZL, Wang BY, Li P, Chen L, Yang J
OncoTargets and Therapy 2016, 9:929-935
Published Date: 24 February 2016
Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer
Lei T, Xu XL, Chen W, Xu YP, Mao WM
OncoTargets and Therapy 2016, 9:921-928
Published Date: 24 February 2016
Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer
Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M
OncoTargets and Therapy 2016, 9:911-919
Published Date: 24 February 2016
Association between three exonuclease 1 polymorphisms and cancer risks: a meta-analysis
Chen ZY, Zheng SR, Zhong JH, Zhuang XD, Zhou JY
OncoTargets and Therapy 2016, 9:899-910
Published Date: 23 February 2016
Interleukin-27 rs153109 polymorphism and the risk of non-small-cell lung cancer in a Chinese population
Ge P, Xiao G
OncoTargets and Therapy 2016, 9:895-898
Published Date: 23 February 2016
Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells
Zheng L, Jiang H, Zhang ZW, Wang KN, Wang QF, Li QL, Jiang T
OncoTargets and Therapy 2016, 9:885-894
Published Date: 23 February 2016
Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients
Jiang C, Hu WM, Liao FX, Yang Q, Chen P, Rong YM, Guo GF, Yin CX, Zhang B, He WZ, Xia LP
OncoTargets and Therapy 2016, 9:877-883
Published Date: 23 February 2016
Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis
Qiang G, Liang C, Xiao F, Yu Q, Wen H, Song Z, Tian Y, Shi B, Guo Y, Liu D
OncoTargets and Therapy 2016, 9:869-876
Published Date: 22 February 2016
Type I enteropathy-associated T-cell lymphoma in the colon of a 29-year-old patient and a brief literature review
Zhang JC, Wang Y, Wang XF, Zhang FX
OncoTargets and Therapy 2016, 9:863-868
Published Date: 22 February 2016
Potential impact of 18FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus
Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H
OncoTargets and Therapy 2016, 9:855-862
Published Date: 22 February 2016
Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review
Xu XL, Dan L, Chen W, Zhu SM, Mao WM
OncoTargets and Therapy 2016, 9:845-853
Published Date: 22 February 2016
The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
Zheng DF, Wang R, Zhang Y, Pan YJ, Cheng XH, Cheng C, Zheng SB, Li H, Gong RX, Li Y, Shen XX, Sun YH, Chen HQ
OncoTargets and Therapy 2016, 9:833-843
Published Date: 22 February 2016
Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer
Jing X, Meng X, Sun X, Yu J
OncoTargets and Therapy 2016, 9:823-831
Published Date: 19 February 2016
Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis
Xu T, Zong YY, Peng LP, Kong S, Zhou ML, Zou JQ, Liu JL, Miao RZ, Sun XC, Li LP
OncoTargets and Therapy 2016, 9:815-822
Published Date: 19 February 2016
Association of polymorphisms in WWOX gene with risk and outcome of osteosarcoma in a sample of the young Chinese population
Zhang N, Jiang Z, Ren W, Yuan L, Zhu Y
OncoTargets and Therapy 2016, 9:807-813
Published Date: 19 February 2016
Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia
Wu YJ, Wang H, Liang JH, Miao Y, Liu L, Qiu HR, Qiao C, Wang R, Li JY
OncoTargets and Therapy 2016, 9:797-805
Published Date: 18 February 2016
PBOV1 promotes prostate cancer proliferation by promoting G1/S transition
Pan TJ, Wu RP, Liu B, Wen HD, Tu Z, Guo J, Yang JR, Shen GQ
OncoTargets and Therapy 2016, 9:787-795
Published Date: 16 February 2016
Comparative analyses of postoperative complications and prognosis of different surgical procedures in stage II endometrial carcinoma treatment
Yin H, Gui T
OncoTargets and Therapy 2016, 9:781-786
Published Date: 16 February 2016
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
Kaseb AO, Morris JS, Iwasaki M, Al-Shamsi HO, Raghav KP, Girard L, Cheung S, Nguyen V, Elsayes KM, Xiao L, Abdel-Wahab R, Shalaby AS, Hassan M, Hassabo HM, Wolff RA, Yao JC
OncoTargets and Therapy 2016, 9:773-780
Published Date: 15 February 2016
Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics
Yang F, Lyu SX, Dong SY, Liu YH, Zhang XH, Wang OC
OncoTargets and Therapy 2016, 9:761-772
Published Date: 12 February 2016
Association of polymorphisms hOGG1 rs1052133 and hMUTYH rs3219472 with risk of nasopharyngeal carcinoma in a Chinese population
Xie Y, Wu Y, Zhou X, Yao M, Ning S, Wei Z
OncoTargets and Therapy 2016, 9:755-760
Published Date: 12 February 2016
Effects of electromagnetic radiation exposure on bone mineral density, thyroid, and oxidative stress index in electrical workers
Kunt H, Şentürk İ, Gönül Y, Korkmaz M, Ahsen A, Hazman Ö, Bal A, Genç A, Songur A
OncoTargets and Therapy 2016, 9:745-754
Published Date: 12 February 2016
Primary renal carcinoid tumor: case report and review of the literature
Li B, Cui TY, Ban ZQ, Luo L, Sun LJ
OncoTargets and Therapy 2016, 9:741-743
Published Date: 23 February 2016
Monitoring cancer stem cells: insights into clinical oncology
Lin SC, Xu YC, Gan ZH, Han K, Hu HY, Yao Y, Huang MZ, Min DL
OncoTargets and Therapy 2016, 9:731-740
Published Date: 11 February 2016
Values of 99mTc-methoxyisobutylisonitrile imaging after first-time large-dose 131I therapy in treating differentiated thyroid cancer
Pan X, Duan D, Zhu Y, Pang H, Guan L, Lv Z
OncoTargets and Therapy 2016, 9:723-730
Published Date: 10 February 2016
Higher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia
Gao L, Sun J, Liu F, Zhang H, Ma Y
OncoTargets and Therapy 2016, 9:711-722
Published Date: 9 February 2016
Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight
Peddi P, Paryani B, Takalkar A, Bundrick P, Ponugupati J, Nair B, El-Osta H
OncoTargets and Therapy 2016, 9:705-709
Published Date: 9 February 2016
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
Kotteas EA, Syrigos KN, Saif MW
OncoTargets and Therapy 2016, 9:699-704
Published Date: 9 February 2016
Long noncoding RNAs in gastric cancer: functions and clinical applications
Wang J, Sun J, Wang J, Song Y, Gao P, Shi J, Chen P, Wang Z
OncoTargets and Therapy 2016, 9:681-697
Published Date: 10 February 2016
Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation
Liu J, Xing L, Meng X, Yue J, Meng X, Xie P, Li X, Kong L, Yu J
OncoTargets and Therapy 2016, 9:671-679
Published Date: 5 February 2016
Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review
Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, Oh JM
OncoTargets and Therapy 2016, 9:655-669
Published Date: 9 February 2016
Effect of tumor size on prognosis of node-negative lung cancer with sufficient lymph node examination and no disease extension
Zhang Y, Sun Y, Chen H
OncoTargets and Therapy 2016, 9:649-653
Published Date: 5 February 2016
Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report
Ji GH, Hong L, Yang P
OncoTargets and Therapy 2016, 9:643-647
Published Date: 5 February 2016
Radix Tetrastigma hemsleyani flavone inhibits proliferation, migration, and invasion of human lung carcinoma A549 cells
Zhong LR, Zheng JX, Sun QQ, Wei KM, Hu YJ
OncoTargets and Therapy 2016, 9:635-641
Published Date: 4 February 2016
Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein
Mhaidat NM, Al-Balas QA, Alzoubi KH, AlEjielat RF
OncoTargets and Therapy 2016, 9:627-634
Published Date: 3 February 2016
Intracellular calcium is a target of modulation of apoptosis in MCF-7 cells in the presence of IgA adsorbed to polyethylene glycol
Honorio-França AC, Nunes GT, Fagundes DLG, Marchi PGF, Fernandes RTS, França JL, França-Botelho AC, Moraes LCA, Varotti FP, França EL
OncoTargets and Therapy 2016, 9:617-626
Published Date: 3 February 2016
Retraction
Gu J, Sun R, Shen S, Yu Z
OncoTargets and Therapy 2016, 9:615-616
Published Date: 4 February 2016
Retraction
Li JZ, Zhang Y, Wen B, Li M, Wang YJ
OncoTargets and Therapy 2016, 9:613-614
Published Date: 4 February 2016
Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
Zhang Y, Xie LG, Chen T, Xie WQ, Wu ZL, Xu H, Xing C, Sha N, Shen ZH, Qie YK, Liu XT, Hu HL, Wu CL
OncoTargets and Therapy 2016, 9:605-611
Published Date: 28 January 2016
Advances in dosimetry and biological predictors of radiation-induced esophagitis
Yu Y, Guan H, Dong Y, Xing L, Li X
OncoTargets and Therapy 2016, 9:597-603
Published Date: 28 January 2016
Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients
Wang H, Wang L, Lu Y, Chen XQ, Geng QR, Wang WD, Xia ZJ
OncoTargets and Therapy 2016, 9:587-595
Published Date: 28 January 2016
Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis
Liu N, Fei X, Shen Y, Shi W, Ma J
OncoTargets and Therapy 2016, 9:579-586
Published Date: 28 January 2016
Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis
Zhang K, Zhang L, Zhou J, Hao Z, Fan S, Yang C, Liang C
OncoTargets and Therapy 2016, 9:567-577
Published Date: 27 January 2016
Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS
Liu J, Hu J, Cheng L, Ren W, Yang M, Liu B, Xie L, Qian X
OncoTargets and Therapy 2016, 9:557-565
Published Date: 27 January 2016
Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma
Lei ZG, Ren XH, Wang SS, Liang XH, Tang YL
OncoTargets and Therapy 2016, 9:545-555
Published Date: 27 January 2016
Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review
Sopracordevole F, Di Giuseppe J, Cervo S, Buttignol M, Giorda G, Ciavattini A, Canzonieri V
OncoTargets and Therapy 2016, 9:539-544
Published Date: 27 January 2016
Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine
Wittke S, Baxmann S, Fahlenkamp D, Kiessig ST
OncoTargets and Therapy 2016, 9:523-537
Published Date: 27 January 2016
Oct-4 is associated with gastric cancer progression and prognosis
Jiang WL, Zhang PF, Li GF, Dong JH, Wang XS, Wang YY
OncoTargets and Therapy 2016, 9:517-522
Published Date: 27 January 2016
Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors
Kitano H, Mamiya A, Ishikawa T, Egoshi K, Kokubun S, Hidai C
OncoTargets and Therapy 2016, 9:503-516
Published Date: 25 January 2016
PD-1/PD-L1 blockades in non-small-cell lung cancer therapy
Jing W, Li MM, Zhang Y, Teng FF, Han AQ, Kong L, Zhu H
OncoTargets and Therapy 2016, 9:489-502
Published Date: 25 January 2016
Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer
Shao W, Wang Q, Wang F, Jiang Y, Xu M, Xu J
OncoTargets and Therapy 2016, 9:477-487
Published Date: 25 January 2016
Utility of blood procalcitonin concentration in the management of cancer patients with infections
Durnaś B, Wątek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, Góźdź S
OncoTargets and Therapy 2016, 9:469-475
Published Date: 22 January 2016
Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma
Lv Y, Miao LY, Chen QF, Li Y, Shi ZX, Ding XS
OncoTargets and Therapy 2016, 9:461-468
Published Date: 22 January 2016
Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis
Tang WW, Huang CW, Tang CY, Xu J, Wang HJ
OncoTargets and Therapy 2016, 9:455-460
Published Date: 22 January 2016
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
Ma B, Wang J, Song Y, Gao P, Sun J, Chen X, Yang Y, Wang Z
OncoTargets and Therapy 2016, 9:445-453
Published Date: 21 January 2016
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
Xu HX, Tian YJ, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu KM
OncoTargets and Therapy 2016, 9:431-444
Published Date: 21 January 2016
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
Laurenti L, Innocenti I, Autore F, Sica S, Efremov DG
OncoTargets and Therapy 2016, 9:421-429
Published Date: 20 January 2016
TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway
Wang Y, Gan Y, Tan Z, Zhou J, Kitazawa R, Jiang X, Tang Y, Yang J
OncoTargets and Therapy 2016, 9:409-420
Published Date: 20 January 2016
Efficacy and safety of ultrasound-guided continuous hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites: a midterm study of 36 patients
Wu YB, Pan MX, Cui SZ, Ba MC, Chen ZL, Ruan Q
OncoTargets and Therapy 2016, 9:403-407
Published Date: 20 January 2016
Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population
Yin Z, Li H, Cui Z, Ren Y, Li X, Wu W, Guan P, Qian B, Rothman N, Lan Q, Zhou B
OncoTargets and Therapy 2016, 9:395-401
Published Date: 19 January 2016
Expression and prognostic significance of contactin 1 in human hepatocellular carcinoma
Li GY, Huang M, Pan TT, Jia WD
OncoTargets and Therapy 2016, 9:387-394
Published Date: 19 January 2016
High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer
Wang K, Li D, Sun L
OncoTargets and Therapy 2016, 9:377-386
Published Date: 19 January 2016
Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis
Meng YC, Zhang CL, Zhou XH
OncoTargets and Therapy 2016, 9:367-376
Published Date: 19 January 2016
Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
Zhang R, Li Y, Nie X, Dong X, Wu G
OncoTargets and Therapy 2016, 9:355-366
Published Date: 18 January 2016
Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
Chai YL, Wang J, Wang T, Shi F, Wang JQ, Su J, Yang YY, Zhou X, Ma HL, He B, Liu Z
OncoTargets and Therapy 2016, 9:349-354
Published Date: 19 January 2016
Functional divergence and convergence between the transcript network and gene network in lung adenocarcinoma
Hsu MK, Pan CL, Chen FC
OncoTargets and Therapy 2016, 9:335-347
Published Date: 14 January 2016
Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma
Deng L, Yang J, Chen H, Ma B, Pan K, Su C, Xu F, Zhang J
OncoTargets and Therapy 2016, 9:325-333
Published Date: 14 January 2016
Single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case report
Gogakos AS, Paliouras D, Asteriou C, Rallis T, Lazopoulos A, Chatzinikolaou F, Zissimopoulos A, Tsavlis D, Tsirgogianni K, Zarogoulidis K, Porpodis K, Tsakiridis K, Pitsiou G, Kioumis I, Karapantzos I, Karapantzou C, Sachpekidis N, Zarogoulidis P, Barbetakis N
OncoTargets and Therapy 2016, 9:321-323
Published Date: 18 January 2016
Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme
Hou AW, Zhao LZ, Zhao FZ, Wang WL, Niu JY, Li BX, Zhou ZJ, Zhu DY
OncoTargets and Therapy 2016, 9:315-320
Published Date: 13 January 2016
MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells
Ruan WD, Wang P, Feng S, Xue Y, Zhang B
OncoTargets and Therapy 2016, 9:303-313
Published Date: 18 January 2016
The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population
Yu W, Guo R, Qu X, Qiu H, Li J, Zhang R, Chen L
OncoTargets and Therapy 2016, 9:295-302
Published Date: 12 January 2016
WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis
Lu Y, Wang X, Sun X, Feng W, Guo H, Tang C, Deng A, Bao Y
OncoTargets and Therapy 2016, 9:287-293
Published Date: 12 January 2016
Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer
Wu Y, Li G, He D, Yang F, He G, He L, Zhang H, Deng Y, Fan M, Shen L, Zhou D, Zhang Z
OncoTargets and Therapy 2016, 9:279-286
Published Date: 11 January 2016
Polymorphisms in RAD51 and their relation with breast cancer in Saudi females
Tulbah S, Alabdulkarim H, Alanazi M, Parine NR, Shaik J, Pathan AA, Al-Amri A, Khan W, Warsy A
OncoTargets and Therapy 2016, 9:269-277
Published Date: 11 January 2016
ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy
Tian C, Yu Y, Yang HL, Zhu L, Wang YF, Zhang YZ
OncoTargets and Therapy 2016, 9:265-268
Published Date: 11 January 2016
The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro
Pu F, Chen F, Lin S, Chen S, Zhang Z, Wang B, Shao Z
OncoTargets and Therapy 2016, 9:255-263
Published Date: 11 January 2016
Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment
Franco-Molina MA, Miranda-Hernández DF, Mendoza-Gamboa E, Zapata-Benavides P, Coronado-Cerda EE, Sierra-Rivera CA, Saavedra-Alonso S, Taméz-Guerra RS, Rodríguez-Padilla C
OncoTargets and Therapy 2016, 9:243-253
Published Date: 12 January 2016
Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells
Ge Q, Wang C, Ruan Y, Chen Z, Liu J, Ye Z
OncoTargets and Therapy 2016, 9:231-241
Published Date: 8 January 2016
Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer
Chen J, Ying XM, Huang XM, Huang P, Yan SC
OncoTargets and Therapy 2016, 9:223-229
Published Date: 11 January 2016
Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients
Iliev R, Stanik M, Fedorko M, Poprach A, Vychytilova-Faltejskova P, Slaba K, Svoboda M, Fabian P, Pacik D, Dolezel J, Slaby O
OncoTargets and Therapy 2016, 9:217-222
Published Date: 8 January 2016
Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor
Wang WX, Jiang XW, Song ZB, Zhang YP
OncoTargets and Therapy 2016, 9:211-215
Published Date: 8 January 2016
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
Massacesi C, Di Tomaso E, Urban P, Germa C, Quadt C, Trandafir L, Aimone P, Fretault N, Dharan B, Tavorath R, Hirawat S
OncoTargets and Therapy 2016, 9:203-210
Published Date: 7 January 2016
Bioinformatics analysis of hepatitis C virus genotype 2a-induced human hepatocellular carcinoma in Huh7 cells
Xu P, Wu M, Chen H, Xu J, Wu M, Li M, Qian F, Xu J
OncoTargets and Therapy 2016, 9:191-202
Published Date: 8 January 2016
Expression and clinical significance of Nectin-4 in hepatocellular carcinoma
Ma J, Sheng ZY, Lv Y, Liu WB, Yao QY, Pan TT, Xu ZJ, Zhang CH, Xu GL
OncoTargets and Therapy 2016, 9:183-190
Published Date: 6 January 2016
The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis
Xie FJ, Lu HY, Zheng QQ, Qin J, Gao Y, Zhang YP, Hu X, Mao WM
OncoTargets and Therapy 2016, 9:171-181
Published Date: 6 January 2016
The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials
Yu HL, Gu DY, He X, Gao XS, Bian XH
OncoTargets and Therapy 2016, 9:159-170
Published Date: 5 January 2016
Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review
Cao Y, Zhu LZ, Jiang MJ, Yuan Y
OncoTargets and Therapy 2016, 9:149-158
Published Date: 31 December 2015
Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients
Li Z, Ma YY, Wang J, Zeng XF, Li R, Kang W, Hao XK
OncoTargets and Therapy 2016, 9:139-148
Published Date: 31 December 2015
Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features
Cao B, Wei P, Liu Z, Bi R, Lu Y, Zhang L, Zhang J, Yang Y, Shen C, Du X, Zhou X
OncoTargets and Therapy 2016, 9:131-138
Published Date: 31 December 2015
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma
Zhang ZG, Zhang YY, Wang YY, Xu LL, Xu WJ
OncoTargets and Therapy 2016, 9:123-129
Published Date: 31 December 2015
High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
Wang CY, Fu XL, Cai XW, Wu XH, Hu XC, Fan M, Xiang JQ, Zhang YW, Chen HQ, Jiang GL, Zhao KL
OncoTargets and Therapy 2016, 9:117-122
Published Date: 30 December 2015
Dairy consumption and lung cancer risk: a meta-analysis of prospective cohort studies
Yu Y, Li H, Xu K, Li X, Hu C, Wei H, Zeng X, Jing X
OncoTargets and Therapy 2016, 9:111-116
Published Date: 30 December 2015
MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1
Lu Y, Hu JJ, Sun W, Li S, Deng S, Li M
OncoTargets and Therapy 2016, 9:99-109
Published Date: 30 December 2015
Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis
Liu JW, He CY, Yuan Q, Wang ZN, Xing CZ, Yuan Y
OncoTargets and Therapy 2016, 9:87-97
Published Date: 30 December 2015
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer
Patel SB, Gill D, Garrido-Laguna I
OncoTargets and Therapy 2016, 9:75-86
Published Date: 30 December 2015
Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry
Zhou J, Sun JY, Chen SY, Li FY, Lin HX, Wu SG, He ZY
OncoTargets and Therapy 2016, 9:67-73
Published Date: 23 December 2015
Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men
Zhang G, Zhu Y, Liu F, Gu CY, Chen H, Xu JF, Ye DW
OncoTargets and Therapy 2016, 9:61-66
Published Date: 22 December 2015
Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression
Phan NLC, Trinh NV, Pham PV
OncoTargets and Therapy 2016, 9:49-59
Published Date: 23 December 2015
Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis
Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS
OncoTargets and Therapy 2016, 9:37-47
Published Date: 21 December 2015
Expression of interleukin 1β in gastric cancer tissue and its effects on gastric cancer
Yin S, Lan C, Pei H, Zhu Z
OncoTargets and Therapy 2016, 9:31-35
Published Date: 21 December 2015
Dendrobium candidum inhibits MCF-7 cells proliferation by inducing cell cycle arrest at G2/M phase and regulating key biomarkers
Sun J, Guo Y, Fu XQ, Wang YS, Liu Y, Huo B, Sheng J, Hu X
OncoTargets and Therapy 2016, 9:21-30
Published Date: 21 December 2015
Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
Gao Y, Song PP, Li H, Guo HB, Jia H, Zhang BJ
OncoTargets and Therapy 2016, 9:13-20
Published Date: 18 December 2015
Clinical efficacy of computed tomography-guided iodine-125 seed implantation therapy in patients with advanced spinal metastatic tumors
Zhang LY, Lu J, Wang ZM, Cheng YS, Teng GJ, Chen KM
OncoTargets and Therapy 2016, 9:7-12
Published Date: 18 December 2015
Association between an insertion/deletion polymorphism in IL-1A gene and cancer risk: a meta-analysis
Ma L, Zhou N
OncoTargets and Therapy 2016, 9:1-6
Published Date: 18 December 2015
MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma
Fu Y, Cao F
OncoTargets and Therapy 2015, 8:3827-3835
Published Date: 17 December 2015
Validation of a quantitative 12-multigene expression assay (Oncotype DX® Colon Cancer Assay) in Korean patients with stage II colon cancer: implication of ethnic differences contributing to differences in gene expression
Jeong DH, Kim WR, Min BS, Kim YW, Song MK, Kim NK
OncoTargets and Therapy 2015, 8:3817-3825
Published Date: 17 December 2015
Correlation of 18F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool
Lopez WO, Cordeiro JG, Albicker U, Doostkam S, Nikkhah G, Kirch RD, Trippel M, Reithmeier T
OncoTargets and Therapy 2015, 8:3803-3815
Published Date: 17 December 2015
Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis
Wang Z, Wu P, Wu D, Zhang ZG, Hu GM, Zhao S, Lai YC, Huang J
OncoTargets and Therapy 2015, 8:3793-3801
Published Date: 16 December 2015
The role of CD44 in epithelial–mesenchymal transition and cancer development
Xu HX, Tian YJ, Yuan X, Wu H, Liu Q, Pestell RG, Wu KM
OncoTargets and Therapy 2015, 8:3783-3792
Published Date: 16 December 2015
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience
Wang P, Wang C, Li H, Shi B, Wang J, Zhong L
OncoTargets and Therapy 2015, 8:3775-3781
Published Date: 16 December 2015
Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker
Serban F, Artene SA, Georgescu AM, Purcaru SO, Tache DE, Alexandru O, Dricu A
OncoTargets and Therapy 2015, 8:3767-3774
Published Date: 16 December 2015
Role of NSC319726 in ovarian cancer based on the bioinformatics analyses
Xue J, Yang G, Ding H, Wang P, Wang CH
OncoTargets and Therapy 2015, 8:3757-3765
Published Date: 15 December 2015
Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib
Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C
OncoTargets and Therapy 2015, 8:3749-3756
Published Date: 15 December 2015
GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma
Chen J, Yang P, Yang J, Wen Z, Zhang B, Zheng X
OncoTargets and Therapy 2015, 8:3731-3742
Published Date: 15 December 2015
NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway
Wei H, Wang H, Ji Q, Sun J, Tao L, Zhou X
OncoTargets and Therapy 2015, 8:3721-3730
Published Date: 14 December 2015
Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis
Zhu Z, Zhang J, Jiang W, Zhang X, Li Y, Xu X
OncoTargets and Therapy 2015, 8:3715-3720
Published Date: 11 December 2015
Non-leukemic myeloid sarcoma involving the vulva, vagina, and cervix: a case report and literature review
Yu Y, Qin X, Yan S, Wang W, Sun Y, Zhang M
OncoTargets and Therapy 2015, 8:3707-3713
Published Date: 10 December 2015
Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
Yan XB, Peng TC, Huang D
OncoTargets and Therapy 2015, 8:3703-3706
Published Date: 8 December 2015
Profile of nintedanib in the treatment of solid tumors: the evidence to date
Awasthi N, Schwarz RE
OncoTargets and Therapy 2015, 8:3691-3701
Published Date: 8 December 2015
Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis
Xie LG, Sun Y, Chen T, Tian DW, Li YJ, Zhang Y, Ding N, Shen ZH, Xu H, Nian XW, Sha N, Han RF, Hu HL, Wu CL
OncoTargets and Therapy 2015, 8:3679-3690
Published Date: 7 December 2015
Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition
Choe C, Shin YS, Kim C, Choi SJ, Lee J, Kim SY, Cho YB, Kim J
OncoTargets and Therapy 2015, 8:3665-3678
Published Date: 7 December 2015
Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1
Dong L, Wang H, Niu J, Zou M, Wu N, Yu D, Wang Y, Zou Z
OncoTargets and Therapy 2015, 8:3649-3664
Published Date: 8 December 2015
Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer
Qin J, Ke J, Xu JF, Wang FR, Zhou YL, Jiang YS, Wang ZW
OncoTargets and Therapy 2015, 8:3639-3648
Published Date: 7 December 2015
Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
Beck JT
OncoTargets and Therapy 2015, 8:3629-3638
Published Date: 7 December 2015
Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain
Leppert W, Kowalski G
OncoTargets and Therapy 2015, 8:3621-3627
Published Date: 4 December 2015
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
Bongiovanni A, Riva N, Ricci M, Liverani C, La Manna F, De Vita A, Foca F, Mercatali L, Severi S, Amadori D, Ibrahim T
OncoTargets and Therapy 2015, 8:3613-3619
Published Date: 3 December 2015
Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b
Zhou Z, Su Y, Fa X
OncoTargets and Therapy 2015, 8:3603-3612
Published Date: 2 December 2015
Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis
Zhong AY, Xing YF, Pan X, Shi MH, Xu HJ
OncoTargets and Therapy 2015, 8:3595-3601
Published Date: 1 December 2015
Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis
Chen K, Dai W, Wang F, Xia Y, Li J, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, Yin Q, Zheng Y, Abudumijiti H, Chen R, Lu J, Zhou Y, Guo C
OncoTargets and Therapy 2015, 8:3585-3593
Published Date: 1 December 2015
The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer
Xiao XG, Xia S, Zou M, Mei Q, Zhou L, Wang SJ, Chen Y
OncoTargets and Therapy 2015, 8:3575-3583
Published Date: 3 December 2015
Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway
Song HM, Song JL, Li DF, Hua KY, Zhao BK, Fang L
OncoTargets and Therapy 2015, 8:3565-3573
Published Date: 1 December 2015
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy
Williams CB, McMahon C, Ali SM, Abramovitz M, Williams KA, Klein J, McKean H, Yelensky R, George Jr TJ, Elvin JA, Soman S, Lipson D, Chmielecki J, Morosini D, Miller VA, Stephens PJ, Ross JS, Leyland-Jones B
OncoTargets and Therapy 2015, 8:3561-3564
Published Date: 1 December 2015
Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer
Lin RL, Yi S, Gong LL, Liu WS, Wang P, Liu NB, Zhao LJ, Wang P
OncoTargets and Therapy 2015, 8:3549-3559
Published Date: 2 December 2015
Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors
Chen CS, Zhao Q, Qian S, Li HL, Guo CY, Zhang W, Yan ZP, Liu R, Wang JH
OncoTargets and Therapy 2015, 8:3539-3548
Published Date: 27 November 2015
The XRCC1 Arg194Trp polymorphism is significantly associated with lung adenocarcinoma: a case-control study in an Eastern European Caucasian group
Cătană A, Pop M, Hincu BD, Pop IV, Petrişor FM, Porojan MD, Popp RA
OncoTargets and Therapy 2015, 8:3533-3538
Published Date: 27 November 2015
Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis
Wang HP, Li ZJ, Sun YL, Xu ZF, Han JJ, Song B, Song WT, Qin C, Yin L
OncoTargets and Therapy 2015, 8:3523-3531
Published Date: 27 November 2015
The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts
Wang Y, Yang J, Liu H, Bi JR, Liu Y, Chen YY, Cao JY, Lu YJ
OncoTargets and Therapy 2015, 8:3513-3521
Published Date: 26 November 2015
Ability of PITX2 methylation to predict survival in patients with prostate cancer
Li JZ, Zhang Y, Wen B, Li M, Wang YJ
OncoTargets and Therapy 2015, 8:3507-3512
Published Date: 24 November 2015
Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance
Sun HT, Wen X, Han T, Liu ZH, Li SB, Wang JG, Liu XP
OncoTargets and Therapy 2015, 8:3499-3506
Published Date: 26 November 2015
Effect of gyromagnetic fields on human prostatic adenocarcinoma cells
Lei H, Xu Y, Guan R, Li M, Hui Y, Gao Z, Yang B, Xin Z
OncoTargets and Therapy 2015, 8:3489-3497
Published Date: 24 November 2015
Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73
Hu ZB, Xu ZY, Liao XH, Yang X, Dong C, Luk K, Jin AM, Lu H
OncoTargets and Therapy 2015, 8:3475-3488
Published Date: 20 November 2015
Knockdown of a HIF-2α promoter upstream long noncoding RNA impairs colorectal cancer stem cell properties in vitro through HIF-2α downregulation
Yao J, Li J, Geng P, Li Y, Chen H, Zhu Y
OncoTargets and Therapy 2015, 8:3467-3474
Published Date: 25 November 2015
Comparative study on individual aromatase inhibitors on cardiovascular safety profile: misleading analysis and doubtful methodology
Guo WQ, Li L
OncoTargets and Therapy 2015, 8:3465-3466
Published Date: 20 November 2015
Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
Lee VHF, Leung DKC, Luk MY, Tong CC, Law MWM, Ng SCY, Wong KK, Poon RTP, Kwong DLW, Leung TW
OncoTargets and Therapy 2015, 8:3457-3464
Published Date: 20 November 2015
High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma
Liu NB, Zhang JH, Liu YF, Li J, Zhang ZZ, Li JW, Liu WY, Huang C, Shen T, Gu CW, Gao DY, Wu X, Wu X
OncoTargets and Therapy 2015, 8:3449-3455
Published Date: 19 November 2015
Differences in clinical features between laparoscopy and open resection for primary tumor in patients with stage IV colorectal cancer
Kim IY, Kim BR, Kim HS, Kim YW
OncoTargets and Therapy 2015, 8:3441-3448
Published Date: 19 November 2015
Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis
Zhao QT, Guo T, Wang HE, Zhang XP, Zhang H, Wang ZK, Yuan Z, Duan GC
OncoTargets and Therapy 2015, 8:3433-3439
Published Date: 19 November 2015
Profile of bevacizumab and its potential in the treatment of cervical cancer
Fisher CM, Schefter TE
OncoTargets and Therapy 2015, 8:3425-3431
Published Date: 19 November 2015
Baseline blood immunological profiling differentiates between Her2– breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response
Tudoran O, Virtic O, Balacescu L, Lisencu C, Fetica B, Gherman C, Balacescu O, Berindan-Neagoe I
OncoTargets and Therapy 2015, 8:3415-3423
Published Date: 18 November 2015
Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data
Li CL, Zhu B, Chen J, Huang XB
OncoTargets and Therapy 2015, 8:3407-3413
Published Date: 18 November 2015
Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
Sha N, Xie L, Chen T, Xing C, Liu X, Zhang Y, Shen Z, Xu H, Wu Z, Hu H, Wu C
OncoTargets and Therapy 2015, 8:3401-3406
Published Date: 18 November 2015
Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3
Luan YX, Zhang SY, Zuo L, Zhou LX
OncoTargets and Therapy 2015, 8:3391-3400
Published Date: 17 November 2015
Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Zhai RP, Ying HM, Kong FF, Du CR, Huang S, Zhou JJ, Hu CS
OncoTargets and Therapy 2015, 8:3383-3390
Published Date: 18 November 2015
Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death
Jia Y, Zhou L, Tian C, Shi Y, Wang C, Tong Z
OncoTargets and Therapy 2015, 8:3371-3381
Published Date: 16 November 2015
Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review
Zhang J, Wang SF, Wang L, Wang R, Chen SF, Pan B, Sun YH, Chen HQ
OncoTargets and Therapy 2015, 8:3361-3369
Published Date: 18 November 2015
Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
Shen YW, Zhang XM, Lv M, Chen L, Qin TJ, Wang F, Yang J, Liu PJ, Yang J
OncoTargets and Therapy 2015, 8:3349-3359
Published Date: 13 November 2015
Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study
Wang YC, Sun T, Wan DG, Sheng LJ, Li W, Zhu HY, Li YP, Lu J
OncoTargets and Therapy 2015, 8:3337-3348
Published Date: 11 November 2015
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients
Sato Y, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N
OncoTargets and Therapy 2015, 8:3329-3336
Published Date: 11 November 2015
Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients
Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M
OncoTargets and Therapy 2015, 8:3323-3328
Published Date: 11 November 2015
Concurrent radiotherapy with oral fluoropyrimidine versus gemcitabine in locally advanced pancreatic cancer: a systematic review and meta-analysis
Yang YF, Cao XH, Bao CE, Wan X
OncoTargets and Therapy 2015, 8:3315-3322
Published Date: 9 November 2015
O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway
Zhang P, Wang CL, Ma T, You SY
OncoTargets and Therapy 2015, 8:3305-3313
Published Date: 9 November 2015
Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia
Liu CC, Wang H, Wang WD, Zhu MY, Geng QR, Lu Y
OncoTargets and Therapy 2015, 8:3297-3303
Published Date: 12 November 2015
Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer
Guo K, Zhang ZP, Han L, Han J, Wang J, Zhou YA, Liu HG, Tong LP, Li XF, Yan XL
OncoTargets and Therapy 2015, 8:3289-3296
Published Date: 6 November 2015
The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies
Wang F, Zhao Q, He HR, Zhai YJ, Lu J, Hu HB, Zhou JS, Yang YH, Li YJ
OncoTargets and Therapy 2015, 8:3277-3287
Published Date: 6 November 2015
Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies
Tang JT, Wang ZH, Fang JY
OncoTargets and Therapy 2015, 8:3265-3276
Published Date: 5 November 2015
Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis
Tian R, Ye HX, Zhang BG, Gu DY, Zhang BW, Teng ZP, Jin MY, Chen JF, Qi JW
OncoTargets and Therapy 2015, 8:3255-3263
Published Date: 5 November 2015
miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells
Li HQ, Cheng J, Mao YQ, Jiang M, Fan XM
OncoTargets and Therapy 2015, 8:3245-3253
Published Date: 4 November 2015
Management experiences of primary angiosarcoma of breast: a retrospective study from single institute in the People’s Republic of China
Hu QC, Mei X, Feng Y, Ma JL, Yang ZZ, Shao ZM, Yu XL, Guo XM
OncoTargets and Therapy 2015, 8:3237-3243
Published Date: 4 November 2015
Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC
Ni X, Han JQ, Ye X, Wei ZG
OncoTargets and Therapy 2015, 8:3227-3235
Published Date: 3 November 2015
Implication of lncRNAs in pathogenesis of esophageal cancer
Tang WW, Wu QQ, Li SQ, Tong YS, Liu ZH, Yang TX, Xu Y, Cao XF
OncoTargets and Therapy 2015, 8:3219-3226
Published Date: 3 November 2015
miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro
Wang HZ, Li XT, Wu C, Wu ZW, Li YY, Yang TQ, Chen GL, Xie XS, Huang YL, Du ZW, Zhou YX
OncoTargets and Therapy 2015, 8:3211-3218
Published Date: 3 November 2015
Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma
Yang L, Liu Z, Wu R, Yao Q, Gu Z, Liu M
OncoTargets and Therapy 2015, 8:3203-3209
Published Date: 2 November 2015
Impact of more detailed categorization of shrinkage or progression ratio at initial imaging response after sorafenib treatment in advanced hepatocellular carcinoma patients
Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H
OncoTargets and Therapy 2015, 8:3193-3202
Published Date: 2 November 2015
Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma
Cheng L, Xia Z, Bian X, Li G, Hu J, Cao Y, Wang Q, Qian X
OncoTargets and Therapy 2015, 8:3185-3192
Published Date: 2 November 2015
miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
Qin HF, Sha JP, Jiang CX, Gao XM, Qu LL, Yan HY, Xu TJ, Jiang QY, Gao HJ
OncoTargets and Therapy 2015, 8:3175-3184
Published Date: 29 October 2015
Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging
Otowa Y, Yamashita K, Kanemitsu K, Sumi Y, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y
OncoTargets and Therapy 2015, 8:3169-3173
Published Date: 29 October 2015
MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma
Luo X, Yang S, Zhou C, Pan F, Li Q, Ma S
OncoTargets and Therapy 2015, 8:3159-3167
Published Date: 28 October 2015
Perineural invasion correlates with postoperative distant metastasis and poor overall survival in patients with PT1–3N0M0 esophageal squamous cell carcinoma
Sheng L, Ji Y, Du X
OncoTargets and Therapy 2015, 8:3153-3157
Published Date: 27 October 2015
Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
Zhao SL, Guo T, Li JX, Uramoto H, Guan HW, Deng WG, Gu CD
OncoTargets and Therapy 2015, 8:3143-3152
Published Date: 27 October 2015
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L
OncoTargets and Therapy 2015, 8:3135-3142
Published Date: 27 October 2015
SKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca2+ signaling in nasopharyngeal carcinoma cells
Zhang J, Wei J, He Q, Lin Y, Liang R, Ye J, Zhang Z, Li Y
OncoTargets and Therapy 2015, 8:3123-3133
Published Date: 27 October 2015
Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis
Liang B, Zhong L, He Q, Wang S, Pan Z, Wang T, Zhao Y
OncoTargets and Therapy 2015, 8:3115-3122
Published Date: 22 October 2015
Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis
Wu T, Jiao M, Jing L, Wang MC, Sun HF, Li Q, Bai YY, Wei YC, Nan KJ, Guo H
OncoTargets and Therapy 2015, 8:3105-3114
Published Date: 22 October 2015
Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells
Liu XQ, Sun ML, Yu S, Liu K, Li XR, Shi H
OncoTargets and Therapy 2015, 8:3095-3104
Published Date: 22 October 2015
Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer
Song T, Zhang X, Fang M, Wu S
OncoTargets and Therapy 2015, 8:3087-3094
Published Date: 22 October 2015
Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor
Zhong G, Qi J, Huo S, Xue H, Xu Z, Li J, Zhou Y, Wu M, Li L
OncoTargets and Therapy 2015, 8:3079-3086
Published Date: 22 October 2015
A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1
Wang H, Yu J, Li L
OncoTargets and Therapy 2015, 8:3067-3077
Published Date: 23 October 2015
Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer
Xu K, Chen Z, Cui Y, Qin C, He Y, Song X
OncoTargets and Therapy 2015, 8:3047-3054
Published Date: 20 October 2015
rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population
Jiang QH, Peng HX, Zhang Y, Tian P, Xi ZL, Chen H
OncoTargets and Therapy 2015, 8:3041-3045
Published Date: 22 October 2015
Forkhead box protein A1 is a prognostic predictor and promotes tumor growth of gastric cancer
Ren H, Zhang P, Tang Y, Wu M, Zhang W
OncoTargets and Therapy 2015, 8:3029-3039
Published Date: 20 October 2015
miR-195 is a key regulator of Raf1 in thyroid cancer
Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F
OncoTargets and Therapy 2015, 8:3021-3028
Published Date: 20 October 2015
EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma
Ren YY, Yao YB, Ma Q, Zhong DS
OncoTargets and Therapy 2015, 8:3017-3020
Published Date: 20 October 2015
SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas
Zheng S, Pan Y, Wang R, Li Y, Cheng C, Shen X, Li B, Zheng D, Sun Y, Chen H
OncoTargets and Therapy 2015, 8:3009-3016
Published Date: 19 October 2015
Association between pre-miR-27a functional polymorphism and risk of colorectal cancer in north Chinese Han population
Bian Q, Chen JJ, Gu JP, Xu J
OncoTargets and Therapy 2015, 8:3003-3007
Published Date: 19 October 2015
Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial–mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells
Huang XC, Dai SJ, Dai JJ, Xiao YW, Bai YY, Chen BC, Zhou MT
OncoTargets and Therapy 2015, 8:2989-3001
Published Date: 19 October 2015
MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer
Li YC, Li CF, Chen LB, Li DD, Yang L, Jin JP, Zhang B
OncoTargets and Therapy 2015, 8:2981-2988
Published Date: 20 October 2015
Links between cancer stem cells and epithelial– mesenchymal transition
Wang SS, Jiang J, Liang XH, Tang YL
OncoTargets and Therapy 2015, 8:2973-2980
Published Date: 16 October 2015
Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population
Ling YQ, Ling XL, Fan L, Wang Y, Li Q
OncoTargets and Therapy 2015, 8:2967-2972
Published Date: 16 October 2015
Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells
Acuña-Macías I, Vera E, Vázquez-Sánchez AY, Mendoza-Garrido ME, Camacho J
OncoTargets and Therapy 2015, 8:2959-2965
Published Date: 16 October 2015
Molecular profiling in the treatment of colorectal cancer: focus on regorafenib
Yan Y, Grothey A
OncoTargets and Therapy 2015, 8:2949-2957
Published Date: 15 October 2015
Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10,248 cases
Zhao WC, Bi FF, Li D, Yang Q
OncoTargets and Therapy 2015, 8:2943-2948
Published Date: 15 October 2015
A human leucyl-tRNA synthetase as an anticancer target
Gao G, Yao Y, Li K, Mashausi DS, Li D, Negi H, Kamle S, Chen H, Wu Z, Zhou H, Li D
OncoTargets and Therapy 2015, 8:2933-2942
Published Date: 15 October 2015
Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis
Zhou S, Chen L, Mashrah M, Zhu Y, Liu J, Yang X, He Z, Wang L, Xiang T, Yao Z, Guo F, Yang W, Zhang C
OncoTargets and Therapy 2015, 8:2923-2931
Published Date: 14 October 2015
EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?
Milovancev A, Stojsic V, Zaric B, Kovacevic T, Sarcev T, Perin B, Zarogoulidis K, Tsirgogianni K, Freitag L, Darwiche K, Tsavlis D, Zissimopoulos A, Stratakos G, Zarogoulidis P
OncoTargets and Therapy 2015, 8:2915-2921
Published Date: 13 October 2015
The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy
Luan CX, Yang ZX, Chen B
OncoTargets and Therapy 2015, 8:2903-2914
Published Date: 13 October 2015
Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis
Lu J, Zhao Q, Zhai YJ, He HR, Yang LH, Gao F, Zhou RS, Zheng J, Ma XC
OncoTargets and Therapy 2015, 8:2883-2902
Published Date: 12 October 2015
The association of GSTT1 deletion polymorphism with lung cancer risk among Chinese population: evidence based on a cumulative meta-analysis
Wang Y, Yang H, Wang H
OncoTargets and Therapy 2015, 8:2875-2882
Published Date: 12 October 2015
Study of internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
Cao XS, Cong BB, Sun X, Qiu PF, Wang YS
OncoTargets and Therapy 2015, 8:2873-2874
Published Date: 9 October 2015
Changing attitudes toward needle biopsies of breast cancer in Shanghai: experience and current status over the past 8 years
Hao S, Liu ZB, Ling H, Chen JJ, Shen JP, Yang WT, Shao ZM
OncoTargets and Therapy 2015, 8:2865-2871
Published Date: 9 October 2015
Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways
Zhao XZ, Liu Y, Zhou LJ, Wang ZQ, Wu ZH, Yang XY
OncoTargets and Therapy 2015, 8:2849-2863
Published Date: 9 October 2015
Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall
Wang JY, Wang SL, Song YW, Liu XF, Jin J, Wang WH, Yu ZH, Liu YP, Li YX
OncoTargets and Therapy 2015, 8:2843-2847
Published Date: 9 October 2015
CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma
Chen RW, Xu YF, Du XJ, Liu N, Li YQ, He QM, Tang LL, Mao YP, Sun Y, Chen L, Ma J
OncoTargets and Therapy 2015, 8:2835-2842
Published Date: 8 October 2015
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
Zhai LL, Wu Y, Cai CY, Tang ZG
OncoTargets and Therapy 2015, 8:2827-2834
Published Date: 7 October 2015
Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis
Rao D, Yu H, Bai Y, Zheng X, Xie L
OncoTargets and Therapy 2015, 8:2817-2826
Published Date: 5 October 2015
Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing
Ikeda H, Ishiguro K, Igarashi T, Aoki Y, Hayashi T, Ishida T, Sasaki Y, Tokino T, Shinomura Y
OncoTargets and Therapy 2015, 8:2805-2815
Published Date: 5 October 2015
Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies
Zhou Q, Wang Y, Chen AH, Tao YL, Song HM, Li W, Tao J, Zuo MZ
OncoTargets and Therapy 2015, 8:2791-2803
Published Date: 5 October 2015
Spotlight on decitabine for myelodysplastic syndromes in Chinese patients
Jing Y, Shen X, Mei Q, Han W
OncoTargets and Therapy 2015, 8:2783-2790
Published Date: 3 October 2015
Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials
Zhao LD, Li W, Zhang HY, Hou N, Guo LW, Gao QL
OncoTargets and Therapy 2015, 8:2775-2781
Published Date: 3 October 2015
ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
Ungur R, Tempescul A, Berthou C, Bagacean C, Radeanu D, Muresan A, Zdrenghea M
OncoTargets and Therapy 2015, 8:2771-2773
Published Date: 1 October 2015
Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
Chen DW, Zhang Y, Shi F, Li MH, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2015, 8:2767-2770
Published Date: 1 October 2015
Increased risk of developing lung cancer in Asian patients carrying the TERT rs2736098 G>A polymorphism: evidence from 3,354 cases and 3,518 controls
Yang ZH, Zhang XL, Fang SR, Tan Y, Yan HJ, Gu W, Wang JH
OncoTargets and Therapy 2015, 8:2757-2765
Published Date: 30 September 2015
Anti-DR5 mAb inhibits proliferation of human fibroblast-like synovial cells and reduces their cytokine secretion in vitro
Zhang M, Shi C, Xia C, Yang J, Niu X, Zhuang G, Yin P
OncoTargets and Therapy 2015, 8:2745-2755
Published Date: 29 September 2015
Advanced lung adenocarcinoma with spinal cord metastasis successfully treated with second EGFR-TKI treatment: a case report and literature review
Li X, Yang H, Zhao J, Gao H
OncoTargets and Therapy 2015, 8:2739-2743
Published Date: 29 September 2015
Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients
Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, Wang ZK, Yuan Z, Duan GC
OncoTargets and Therapy 2015, 8:2731-2738
Published Date: 29 September 2015
Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis
Zhao XH, Liu L, Li K, Li WS, Zhao L, Zou HW
OncoTargets and Therapy 2015, 8:2721-2730
Published Date: 29 September 2015
The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis
Wang J, Dan GR, Zhao JQ, Ding Y, Ye F, Sun HQ, Jiang F, Cheng J, Yuan FH, Zou ZM
OncoTargets and Therapy 2015, 8:2709-2719
Published Date: 25 September 2015
Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer
Cong BB, Cao XS, Qiu PF, Liu YB, Zhao T, Chen P, Wang CJ, Zhang ZP, Sun X, Wang YS
OncoTargets and Therapy 2015, 8:2705-2708
Published Date: 24 September 2015
A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer
Jia W, Fei GH, Hu JG, Hu XW
OncoTargets and Therapy 2015, 8:2699-2704
Published Date: 23 September 2015
miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer
Ni R, Huang Y, Wang J
OncoTargets and Therapy 2015, 8:2689-2697
Published Date: 22 September 2015
Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma
Sun J, Wen X, Jin F, Li Y, Hu J, Sun Y
OncoTargets and Therapy 2015, 8:2681-2688
Published Date: 22 September 2015
Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population
Huang Z, Yuan L, Jiang Z, Wang D
OncoTargets and Therapy 2015, 8:2675-2680
Published Date: 22 September 2015
Clinical significance of locoregional and systemic treatment in operable high-risk breast cancer patients with more than four positive axillary lymph nodes
Yin K, Zhou L, Shao Z, Yin W, Lu J
OncoTargets and Therapy 2015, 8:2665-2673
Published Date: 21 September 2015
Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway
Cai Y, He J, Zhang D
OncoTargets and Therapy 2015, 8:2657-2664
Published Date: 21 September 2015
Diarrhea as initial manifestation of pulmonary artery intimal sarcoma: a case report and literature review
Xu X, Zhang R, Hu H, Ye W, Wang J, Chen L, Qiu L, Ying K
OncoTargets and Therapy 2015, 8:2651-2656
Published Date: 18 September 2015
Combination of Bcl-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma
Wang J, Zhou M, Xu JY, Chen B, Ouyang J
OncoTargets and Therapy 2015, 8:2645-2650
Published Date: 18 September 2015
Comparing two assays for clinical genomic profiling: the devil is in the data [Letter of clarification]
Weiss GJ, Khemka V
OncoTargets and Therapy 2015, 8:2643-2644
Published Date: 18 September 2015
miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma MG-63 cells by targeting VEGFA
Wang L, Shan M, Yang F, Liu Y, Qi H, Zhou L, Qiu L, Li Y
OncoTargets and Therapy 2015, 8:2635-2642
Published Date: 16 September 2015
Polymorphism in miR-146a associated with clinical characteristics and outcomes in gastric cancer patients treated with adjuvant oxaliplatin and fluoropyrimidines
Liao YQ, Liao YL, Li J, Peng LX, Wan YY, Zhong R
OncoTargets and Therapy 2015, 8:2627-2633
Published Date: 16 September 2015
The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysis
Huang B, Chen L, Bao C, Sun C, Li J, Wang L, Zhang X
OncoTargets and Therapy 2015, 8:2617-2625
Published Date: 15 September 2015
Role of DFNA5 in hearing loss and cancer – a comment on Rakusic et al
Croes L, Op de Beeck K, Van Camp G
OncoTargets and Therapy 2015, 8:2613-2615
Published Date: 15 September 2015
Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
Dai F, Zhang XM, Shen WR, Chen J, Liu LC, Gao GJ
OncoTargets and Therapy 2015, 8:2601-2611
Published Date: 15 September 2015
Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy
Wang H, Wang L, Wuxiao ZJ, Huang HQ, Jiang WQ, Li ZM, Lu Y, Xia ZJ
OncoTargets and Therapy 2015, 8:2589-2599
Published Date: 14 September 2015
Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2
Wu YF, Li R, Zhang JY, Wang G, Liu B, Huang XF, Zhang T, Luo RC
OncoTargets and Therapy 2015, 8:2577-2587
Published Date: 14 September 2015
Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer
Zhao W, Gao J, Wu J, Liu Q, Wang Z, Li H, Xing L
OncoTargets and Therapy 2015, 8:2571-2576
Published Date: 15 September 2015
Prognostic role of LSD1 in various cancers: evidence from a meta-analysis
Wu J, Hu LX, Du YY, Kong FL, Pan YY
OncoTargets and Therapy 2015, 8:2565-2570
Published Date: 15 September 2015
The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma
Chen JQ, Zhan YF, Wang W, Jiang SN, Li XY
OncoTargets and Therapy 2015, 8:2555-2563
Published Date: 15 September 2015
Different setup errors assessed by weekly cone-beam computed tomography on different registration in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
Su JQ, Chen W, Yang HY, Hong JD, Zhang ZJ, Yang GZ, Li L, Wei R
OncoTargets and Therapy 2015, 8:2545-2553
Published Date: 14 September 2015
New developments in the management of advanced melanoma – role of pembrolizumab
Improta G, Leone I, Donia M, Gieri S, Pelosi G, Fraggetta F
OncoTargets and Therapy 2015, 8:2535-2543
Published Date: 14 September 2015
The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation
Ji YL, Han Z, Shao LM, Li YL, Zhao L, Zhao YH
OncoTargets and Therapy 2015, 8:2527-2533
Published Date: 11 September 2015
Association between promoter polymorphisms of matrix metalloproteinase-1 and risk of gastric cancer
Peng QS, Xu Y
OncoTargets and Therapy 2015, 8:2519-2526
Published Date: 10 September 2015
The expression and clinical significance of HDGF in osteosarcoma
Chen Z, Qiu S, Lu X
OncoTargets and Therapy 2015, 8:2509-2517
Published Date: 9 September 2015
Treatment and survival analyses of completely resected thymic carcinoma patients
Mao Y, Wu S
OncoTargets and Therapy 2015, 8:2503-2507
Published Date: 9 September 2015
Association between the polymorphisms of urokinase plasminogen activation system and cancer risk: a meta-analysis
Xu Z, Meng LL, Lin JZ, Ling Y, Chen SX, Lin N
OncoTargets and Therapy 2015, 8:2493-2502
Published Date: 9 September 2015
Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
Xia L, Qian W, Yang M, Li Q, Liu F, Xie Y
OncoTargets and Therapy 2015, 8:2485-2492
Published Date: 7 September 2015
GSTM1 null genotype may be associated with an increased nasopharyngeal cancer risk in South China: an updated meta-analysis and review
Li YN, Wan WH, Li T, Cao J, Xu G
OncoTargets and Therapy 2015, 8:2479-2484
Published Date: 7 September 2015
Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma
Zhao QC, Xu S, Liu JH, Li Y, Fan YG, Shi T, Wei S, Tang SC, Liu HY, Chen J
OncoTargets and Therapy 2015, 8:2469-2478
Published Date: 7 September 2015
Three-dimensional conformal radiotherapy by delineations on CT-based simulation in different respiratory phases for the treatment of senile patients with non-small cell lung cancer
Wang WF, Yuan F, Wang GP, Lin ZR, Pan YL, Chen LH
OncoTargets and Therapy 2015, 8:2461-2467
Published Date: 7 September 2015
No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients
Alanazi M, Alabdulkarim HA, Shaik JP, Al Naeem A, Elrobh M, Al Amri A, al-Mukaynizi FB, Semlali A, Warsy A, Parine NR
OncoTargets and Therapy 2015, 8:2453-2459
Published Date: 3 September 2015
A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence
Zhang XX, Du YF, Zhai YJ, Gao F, Yang YJ, Ma XC, Lu J, Zheng J
OncoTargets and Therapy 2015, 8:2443-2451
Published Date: 7 September 2015
Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer
Chrisoulidou A, Mandanas S, Margaritidou E, Mathiopoulou L, Boudina M, Georgopoulos K, Pazaitou-Panayiotou K
OncoTargets and Therapy 2015, 8:2435-2442
Published Date: 3 September 2015
The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis
Ying J, Xu Q, Liu B, Zhang G, Chen L, Pan H
OncoTargets and Therapy 2015, 8:2427-2433
Published Date: 1 September 2015
Dietary fiber, whole grains, carbohydrate, glycemic index, and glycemic load in relation to risk of prostate cancer
Wang RJ, Tang JE, Chen Y, Gao JG
OncoTargets and Therapy 2015, 8:2415-2426
Published Date: 2 September 2015
Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
Yang Q, Yin CX, Liao FX, Huang YY, He WZ, Jiang C, Guo GF, Zhang B, Xia LP
OncoTargets and Therapy 2015, 8:2407-2413
Published Date: 1 September 2015
The distinctive nature of adenocarcinoma of the lung
Roviello G
OncoTargets and Therapy 2015, 8:2399-2406
Published Date: 2 September 2015
Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
Hill BT, Kalaycio M
OncoTargets and Therapy 2015, 8:2391-2397
Published Date: 31 August 2015
Chronic neutrophilic leukemia: a clinical perspective
Menezes J, Cigudosa JC
OncoTargets and Therapy 2015, 8:2383-2390
Published Date: 1 September 2015
The impact of histological types on the efficacy of angiogenesis inhibitors in the treatment of advanced NSCLC: a meta-analysis of randomized controlled trials
Zhang J, Liu J, Chen HG, Wu WB, Li XJ, Wu YH, Zhang K, Gu LJ
OncoTargets and Therapy 2015, 8:2375-2382
Published Date: 31 August 2015
Increased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis
Ma Q, Gu LY, Ren YY, Zeng LL, Gong T, Zhong DS
OncoTargets and Therapy 2015, 8:2361-2374
Published Date: 28 August 2015
Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells
Kang FC, Chen PJ, Pan BS, Lai MS, Chen YC, Huang BM
OncoTargets and Therapy 2015, 8:2345-2360
Published Date: 1 September 2015
The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas
Hou HL, Meng MB, Chen XL, Zhao LJ, Zhu L, Zhang BL, Wang P
OncoTargets and Therapy 2015, 8:2339-2344
Published Date: 28 August 2015
Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer
Sokolov M, Angelov K, Vasileva M, Atanasova MP, Vlahova A, Todorov G
OncoTargets and Therapy 2015, 8:2329-2337
Published Date: 1 September 2015
Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione
Jia Y, Zhang C, Zhou L, Xu H, Shi Y, Tong Z
OncoTargets and Therapy 2015, 8:2319-2327
Published Date: 28 August 2015
Screening of feature genes in distinguishing different types of breast cancer using support vector machine
Wang Q, Liu XD
OncoTargets and Therapy 2015, 8:2311-2317
Published Date: 27 August 2015
Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting miR-199a expression
Shi Y, Song Q, Yu S, Hu D, Zhuang X
OncoTargets and Therapy 2015, 8:2303-2310
Published Date: 27 August 2015
Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy
Zhang H, Wang M, Shi T, Shen L, Zhu J, Sun M, Deng Y, Liang L, Li G, Wu Y, Fan M, Wei Q, Zhang Z
OncoTargets and Therapy 2015, 8:2291-2301
Published Date: 27 August 2015
Effects of magnetic nanoparticles of Fe3O4 combinated with gambogic acid on apoptosis of SMMC-7721 cells
Tian L, Chen BA, Cheng J, Guo QL
OncoTargets and Therapy 2015, 8:2285-2290
Published Date: 26 August 2015
Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
Dequanter D, Shahla M, Aubert C, Deniz Y, Lothaire P
OncoTargets and Therapy 2015, 8:2279-2283
Published Date: 26 August 2015
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas
Cong D, He MZ, Chen SL, Liu XL, Liu XD, Sun H
OncoTargets and Therapy 2015, 8:2271-2277
Published Date: 26 August 2015
Cemented allograft-prosthesis composite reconstruction for the proximal femur tumor
Min L, Tang F, Duan H, Zhou Y, Zhang WL, Shi R, Tu CQ
OncoTargets and Therapy 2015, 8:2261-2269
Published Date: 25 August 2015
Trametinib: a MEK inhibitor for management of metastatic melanoma
Lugowska I, Koseła-Paterczyk H, Kozak K, Rutkowski P
OncoTargets and Therapy 2015, 8:2251-2259
Published Date: 25 August 2015
Expressions and clinical significance of autophagy-related markers Beclin1, LC3, and EGFR in human cervical squamous cell carcinoma
Hu YF, Lei X, Zhang HY, Ma JW, Yang WW, Chen ML, Cui J, Zhao H
OncoTargets and Therapy 2015, 8:2243-2249
Published Date: 24 August 2015
Comparing two assays for clinical genomic profiling: the devil is in the data
Squillace RM, Frampton GM, Stephens PJ, Ross JS, Miller VA
OncoTargets and Therapy 2015, 8:2237-2242
Published Date: 24 August 2015
MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1
Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng C, Zhang L, Feng Y, Zhou H, Zhou B, Zeng T
OncoTargets and Therapy 2015, 8:2227-2235
Published Date: 24 August 2015
The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer
Gu J, Sun R, Shen S, Yu Z
OncoTargets and Therapy 2015, 8:2215-2225
Published Date: 21 August 2015
Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
Xiao XG, Wang SJ, Xia S, Zou M, Li Y, Wei Y, Mei Q, Chen Y
OncoTargets and Therapy 2015, 8:2209-2214
Published Date: 21 August 2015
Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells
Song T, Li H, Tian Z, Xu C, Liu J, Guo Y
OncoTargets and Therapy 2015, 8:2199-2208
Published Date: 20 August 2015
Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Bamias A
OncoTargets and Therapy 2015, 8:2187-2198
Published Date: 20 August 2015
The association between miR-499 polymorphism and cancer susceptibility: a meta-analysis
Xu Z, Zhang E, Duan W, Sun C, Bai S, Tan X
OncoTargets and Therapy 2015, 8:2179-2186
Published Date: 20 August 2015